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ABSTRACT 
Peptide microarrays may prove to be a powerful tool for proteomics research and 
clinical diagnosis applications. Fodor et al. and Maurer et al. have shown proof-of-
concept methods of light- and electrochemically-directed peptide microarray fabrication 
on glass and semiconductor microchips respectively. In this work, peptide microarray 
fabrication based on the abovementioned techniques were optimized. In addition, 
MALDI mass spectrometry based peptide synthesis characterization on semiconductor 
microchips was developed and novel applications of a CombiMatrix (CBMX) platform 
for electrochemically controlled synthesis were explored.   
We have investigated performance of 2-(2-nitrophenyl)propoxycarbonyl 
(NPPOC) derivatives as photo-labile protecting group. Specifically, influence of 
substituents on 4 and 5 positions of phenyl ring of NPPOC group on the rate of photolysis 
and the yield of the amine was investigated. The results indicated that substituents 
capable of forming a π-network with the nitro group enhanced the rate of photolysis and 
yield. Once such properly substituted NPPOC groups were used, the rate of 
photolysis/yield depended on the nature of protected amino group indicating that a 
different chemical step during the photocleavage process became the rate limiting step.  
We also focused on electrochemically-directed parallel synthesis of high-density 
peptide microarrays using the CBMX technology referred to above which uses 
electrochemically generated acids to perform patterned chemistry. Several issues related 
to peptide synthesis on the CBMX platform were studied and optimized, with emphasis 
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placed on the reactions of electro-generated acids during the deprotection step of peptide 
synthesis.  
We have developed a MALDI mass spectrometry based method to determine the 
chemical composition of microarray synthesis, directly on the feature. This method 
utilizes non-diffusional chemical cleavage from the surface, thereby making the chemical 
characterization of high-density microarray features simple, accurate, and amenable to 
high-throughput.  
CBMX Corp. has developed a microarray reader which is based on electro-
chemical detection of redox chemical species. Several parameters of the instrument were 
studied and optimized and novel redox applications of peptide microarrays on CBMX 
platform were also investigated using the instrument. These include (i) a search of metal 
binding catalytic peptides to reduce overpotential associated with water oxidation 
reaction and (ii) an immobilization of peptide microarrays using electro-polymerized 
polypyrrole. 
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Chapter 1 
General Introduction to Peptide Microarrays 
Abstract 
This chapter provides an introduction to microarrays in general, and establishes 
the need and applications of peptide microarrays. It discusses the difficulty of fabrication 
of peptide microarrays and different approaches applied to this problem. A new approach 
for making peptide microarrays based on a CombiMatrix (CBMX) platform is described.  
A study to improve photo-deprotection efficiency of photo-labile protecting groups, 
which can be useful in photolithography based microarray fabrication, is also described.  
This chapter also discusses various fabrication and characterization techniques used in 
the following chapters. 
Introduction 
Proteins are considered workhorse molecules in biology. They perform a vast 
array of functions such as signaling, catalysis, and DNA replication1. Binding between 
proteins and biomolecules plays a key role in the functioning of proteins2. The binding 
could be based on Fischer’s lock-and-key3 or Koshland’s induced fit concept4. The lock-
and-key concept involves the interaction of spatially complementary regions of binding 
molecules. In the induced-fit concept, the binding partners are conformationally flexible 
to induce a binding interaction. The binding interactions are comprised of several forces: 
vanderwaals, electrostatic, hydrophobic, and hydrogen bonding. The specificity of 
binding could vary from a protein being specific to only one binding partner (e.g., 
glucokinase which catalyzes conversion of glucose to glucose-6-phosphate) to a protein 
2 
being completely non-specific and interacting almost irrespective of the structural 
features of the binding partner (e.g. sticky proteins)5. 
Proteins are made up of one or several three-dimensionally folded polypeptides6. 
A polypeptide is a linear chain comprising of twenty naturally occurring amino acids 
connected to each other through amide bonds. Although no exact definition of length of 
polypeptides is described in literature, some authorities have adopted 10,000 Da as an 
upper limit on the molecular weight of a polypeptide7.  
The diversity of proteins arises because of two different factors. Firstly, there are 
twenty different possibilities (amino acids) for each position in a polypeptide chain. 
Secondly, there are multiple folding possibilities of a linear polypeptide chain, giving rise 
to innumerable conformations. Levinthal’s paradox8 provides an idea of the vast diversity 
of proteins possible with twenty amino acids. It states that a protein of 101 amino acids 
could exist in 3100 = 5 X 1047 configurations. Even if the protein is able to sample new 
configurations at the rate of 1013 per second, or 3 x 1020 per year, it will take 1027 years to 
try them all. Real proteins fold over a time scale of 10-1 to 103 sec. Thus, nature has 
explored a small fraction of the complete possibilities in designing proteins for various 
functions. It has conserved proteins in whole or in part (domains of proteins) across 
different species with minor modifications. 
Protein interactions with a binding partner can be dependent on its constituent 
amino acids at various levels. Sometimes, a single amino acid plays a decisive role in 
protein interaction9. Its replacement could enhance or inhibit a protein’s interaction 
drastically.  Hence, a theoretical understanding of the role of each amino acid in a 
protein’s functioning is important. However, there is a lack of substantial experimental 
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data and a difficulty in modeling various forces of interactions of twenty amino acids. 
This makes the prediction of the role of different entities of a protein individually as well 
as in combination with other entities in binding interactions very difficult. 
One way to approach this problem is to limit the study to protein-peptide 
interactions instead of protein-protein interactions. An increasing number of protein-
protein interactions are being reported to involve interaction of a protein with a peptide of 
the binding protein partner10. The interacting peptide may originate from a loop within a 
well-defined domain, or from an unstructured region between structured domains10. A 
number of protein-protein interactions involved in cell signaling and regulatory systems 
which are basically protein-peptide interactions have been studied10-12. The study of 
protein-peptide interactions is also important for drug discovery and development of 
inhibitory peptides13-15. 
Gaining a deeper understanding of protein-peptide interactions requires an 
experimental system which can evaluate the interactions of a multitude of peptides with a 
specific protein. Time-saving and cost-efficiency capabilities of such a system are also 
highly desirable. Microarray technology has proved to be an experimental system capable 
of meeting these desired features16-18. As a discovery tool, microarray technology has the 
advantage of reading the activity of every single probe of a library. Another great 
advantage of microarray technology is that peptide based systems can be integrated and 
used to study various protein-peptide interactions in a robust and reproducible way. 
Microarray Technology 
Microarray technology involves the assembling of biomolecules in an array 
format on a solid surface. This surface is usually a glass slide or a silicon substrate19. The 
4 
array format is useful for assaying a large number of biomolecules in a high-throughput 
fashion with little consumption of analyte. Each feature on the solid support is 
functionalized with one type of biomolecule. The activity of the biomolecules 
immobilized on different features of the microarray is read-out in a parallel, high-
throughput way. 
The microarray working principle involves the incubation of a microarray 
functionalized with immobilized biomolecules (target probes) such as peptides, proteins, 
DNA, or small molecules with analyte (proteins, virus, cells, single-stranded DNA, 
RNA). The analyte binds to different features of the microarray with different binding 
strength and specificity. Fluorescent molecules that are coupled directly to the analyte 
before incubation, or are bound to the analyte after incubation in a subsequent step, are 
then used to determine the binding characteristics of the whole array when imaged using 
a fluorescence scanner20. Every single feature of the microarray is an assay providing 
information about the binding interaction between the target and analyte molecule. 
Although microarrays of a variety of biomolecules can be generated in theory, 
DNA and peptide microarrays have progressed a great deal in last few years. DNAs 
composed of four building blocks (nucleotides) and peptides composed of twenty 
building blocks (amino acids), when fabricated in a fully combinatorial manner, gives 
rise to comprehensive DNA and peptide microarrays respectively. Because of the high 
number of building blocks (twenty amino acids) and the presence of a variety of side-
chain groups in these building blocks which can lead to side reactions, fabrication of a 
comprehensive and synthetically robust peptide microarray has proved to be challenging. 
5 
Peptides at Molecular Level 
A polymer of amino acid molecules through amide bond formation, usually less 
than 30 – 50 amino acids, is called a peptide. There are twenty types of naturally 
occurring amino acids differing from each other only in their side-chain group. The 
amino acid group (part of an amino acid molecule other than side-chain group) is 
conserved among all the twenty amino acids. All the amino acids can couple with each 
other through a peptide bond leading to the diversity of peptide sequences. More 
information on amino acids can be found in Appendix H. Further information can be 
found in Reference 21. 
Two different stereoisomers, L-amino acid and D-amino acid, are possible for an 
amino acid except glycine, which does not possess any chiral center. All other amino 
acids occur as the L-isomer in nature. The peptide bond formation reaction between two 
amino acids is essentially a dehydration reaction between the α-amino group of one 
amino acid and the carboxyl group of another amino acid. Elongation of a peptide can 
take place from either end: N-terminus or C-terminus. 
Peptide Synthesis 
Chemical synthesis of peptides is mainly based on Bruce Merrifield’s solid-phase 
peptide synthesis technique22. Earlier chemical synthesis was carried out in a solution 
phase and involved multiple synthesis, purification, and characterization steps. The 
development of protecting groups, mainly boc and fmoc groups, has further simplified 
and drastically improved the efficiency of chemical synthesis. 
Merrifield Peptide Synthesis. The solid-phase peptide synthesis technique 
developed by Bruce Merrifield revolutionized the chemical synthesis of peptides22. Using 
6 
this technique, peptides can be synthesized on solid supports functionalized with amino 
or carboxyl groups. The technique overcomes multiple tedious purification and 
characterization steps and facilitates synthesis of very long peptides. Previously this was 
impossible through solution-phase methods. Once the synthesis is complete, the 
fabricated peptide can be cleaved from the solid support, purified, and characterized 
(Figure 1). This technique is also the basis for the chemical-synthesis of peptide libraries.  
Peptide libraries can be fabricated on beads based on a split-mix synthesis method23 and 
can be fabricated on 2D solid substrates in microarray format through several successful 
techniques such as photolithography24,25 and laser printing26. 
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SCHEME 1: Solid-phase peptide synthesis scheme28. 
Peptide Microarray Synthesis 
Peptide synthesis is complicated compared to DNA synthesis due to considerable 
side-chain functional group variability between the twenty naturally occurring amino 
acids. Every amino acid coupling cycle required to grow a peptide on a surface takes 
approximately 1 - 2 hours to complete28,29 and synthesis efficiencies using standard Fmoc 
or t-boc protection strategies are approximately >98%. DNA synthesis is much simpler 
because it involves only four nucleotides and the formation of phosphodiester bonds 
between two nucleotides during oligonucleotide synthesis which is very efficient (>99%).   
8 
It is also  less time consuming (Nimblegen, can now complete each synthesis cycle in 5 
minutes)30 and the  synthesis challenges due to nucleobases have been overcome. 
There are several methods of generating peptide libraries such as phage display31, 
mRNA display32 or combinatorial synthesis on solid supports such as beads. The 
combinatorial synthesis on beads is based on a split-mix synthesis strategy that results in 
one compound per bead33,3. Peptide libraries can also be generated on flat surfaces in a 
rationally-designed pattern. Peptide microarrays with probe sequence densities up to 
200K within a square cm area of a 1 × 3in microscope slide are commercially available35. 
The advantage of an array-based synthesis over other library-generating techniques is that 
the sequence information of every single peptide on the surface is known. Other library-
generating techniques do not have this advantage; though several labor-intensive 
strategies have been devised which permit probe decoding through sequencing 
subsequent to screening36. Peptide library-generating techniques such as phage display 
and mRNA display can generate libraries containing up to 10^10 and 10^15 different 
peptides respectively. In comparison, the largest peptide microarray libraries 
commercially available at present are a few hundreds of thousands as per published 
information37. Although, the library size of peptide microarrays is very small in 
comparison to the library size generated by techniques such as phage display and mRNA 
display, each member of a peptide microarray is defined, unlike other techniques which 
are largely combinatoric. Such defined high-throughput systems when merged with large-
scale computation of libraries can lead to an ever-expanding database through which 
several algorithms can be tested and new concepts in science can be discovered. 
Microarrays can also assist in refining the consensus sequences obtained by other 
9 
techniques. . Microarrays are also robust and reproducible: a peptide microarray platform 
could be fabricated with desired sequences in replicates that could be used multiple times 
for various assays.    
Peptide microarray synthesis may proceed in two general ways: (i) peptide 
printing (robotic deposition of pre-synthesized peptides)38 and (ii) in situ parallel 
synthesis of peptides on microarray surfaces39,40. Microarrays generated by peptide 
printing are best suited for low- and medium-throughput assays. Major issues with 
printed arrays in regards to high throughput assays include maintenance of the peptide 
library and replacement of the library. 
In situ parallel peptide synthesis performed directly on microarray surfaces is a 
preferable method. It is capable of generating on the order of 10^6 peptide sequences; far 
exceeding the size and diversity possible when depositing pre-synthesized peptides 
directly onto microarrays38. Theoretically, a new batch of chips can be generated within a 
week, which is comparable to other library generating techniques such as split-mix 
synthesis. Using a parallel, split-pool method to generate a penta-peptide library, on 
beads, from the twenty naturally-occurring amino acids, would involve 100 coupling 
cycles and likely take 9-10 days to complete. Synthesis automation instruments have the 
capability to perform a microarray synthesis on a chip and produce several replicates of 
the chip within a week’s time that can be used for multiple experiments. 
Several methods have been reported for the in situ parallel synthesis of peptide 
microarrays on 2D surfaces. Early on, one of the most successful approaches was SPOT 
synthesis39,41. In this method, synthetic building blocks, along with the coupling reagents, 
are spotted on a membrane support. The membrane support is generally made up of 
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cellulose or nylon and has functional groups attached to it. The activated incoming 
synthetic building blocks couple with the functional groups. The size of the spot is 
decided by the volume dispensed and the absorptive capacity of the membrane support. 
The feature density of this technique is low (~1mm diameter features) but the site density 
is quite high (~ 0.1 to 1 µmol/cm2). In the past few years, two approaches, Breitling’s 
microparticle-deposition technology42,43 and photolithography based approaches44,45, have 
been very successful in fabricating high density peptide microarrays. In Breitling’s 
technology, spatially defined deposition of microparticles coated with aminoacids is done 
through laser printing. Later, the microparticle is melted and the amino acid is coupled to 
the functionalized microscope glass slide. A German-based company, PEPperPRINT, 
fabricates peptide microarrays based on this technology. Photolithography-based 
approaches involve light irradiation through a real or virtual photomask for the 
deprotection of amine protecting groups from selected features of the surface. Photolabile 
protecting groups (PLPGs) are directly deprotected upon irradiation, and acid-labile 
groups are deprotected by localized generation of acids upon light irradiation of selected 
features43,44. This results in the patterned deprotection of these features on the surface 
which are then coupled with an activated incoming amino acid. This is repeated for 
multiple cycles selecting a different set of features at each light irradiation step. This 
method, although promising, has some limitations. Amino acids protected with PLPGs 
are not readily available, and it is not a simple process to prepare them in-house. In 
addition, diffraction and flare (scattering) issues during light irradiation in both photo-
acid based and PLPGs based techniques can lead to insertion of moieties at undesired 
features.  
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Project Organization   
This thesis was conducted with the aim of optimizing (1) light- and (2) 
electrochemically-directed peptide microarray synthesis, and (3) investigating innovative 
applications of electrochemically-directed peptide microarray synthesis on CBMX chips 
in conjunction with MALDI mass spectrometry and electrochemical detection techniques. 
Optimization of light-directed peptide microarray synthesis. There is a great 
deal of interest in synthesis and characterization of photolabile protective groups 
(PLPGs) that are readily and efficiently removed by irradiation. The success of light 
directed combinatorial synthesis based on PLPGs45 used for development of high density 
microarrays depends on the photo-deprotection efficiency of PLPGs46,47. 
Among the first protective groups used in oligonucleotide and oligopeptide 
synthesis was the o-nitroveratryloxycarbonyl group (NVOC)45,49,50, which has a relatively 
low photo-deprotection yield. It was later discovered that methyl extension of the α-
carbon would enhance the cleavage process by changing the mechanistic pathway as 
demonstrated by the use of α-methyl-o-nitropiperonyloxycarbonyl protective groups 
(MeNPOC)46,51. Further improvement of this process was accomplished by studying the 
cleavage pattern of 2-(2-nitrophenyl)propoxycarbonyl (NPPOC) protected nucleotides52. 
In fact, the NPPOC group turned out to be a better choice for peptide synthesis due to the 
presence of an extra methylene group. This resulted in the formation of less reactive 
intermediates that otherwise would react with the free amine to form undesired 
byproducts53. The NPPOC group has been studied in terms of the rate of photolysis of 
various protected amino acids, and it has been evaluated in terms of its utility for 
photolithographic peptide microarray synthesis54. The photo-deprotection rates of 
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NPPOC protected amino acids were at least twice as fast as NVOC protected amino 
acids. These studies have demonstrated that the NPPOC group exhibits the capacity to 
serve as a reasonable platform for light-sensitive protection of various amines. Yet the 
efficiency of NPPOC is not comparable to Fmoc (base labile), and Boc (acid labile) 
protecting groups which are most commonly used in conventional peptide synthesis. To 
improve the deprotection efficiency, which limits the rate of photolysis and yield of free 
amines, we have tested several derivatives of NPPOC. We have also tested the 
photodeprotection efficiency of the most efficient NPPOC derivative towards different 
kinds of amines. The results derived from this investigation could be useful in preparing a 
more efficient photolabile amino protecting group with applications ranging from organic 
to combinatorial peptide synthesis. 
Optimization of electrochemically-directed peptide microarray synthesis. 
Peptide microarray synthesis based on an electrochemical approach is another promising 
technique for the fabrication of peptide microarrays. This method was devised by Maurer 
et al. in 200555. They produced an electrochemically generated acid (EGA) in a spatially 
defined way on microelectrodes of an electronically addressable array to remove boc 
protecting groups. The substrate used was a CBMX 1K chip developed by CombiMatrix 
Corp., Mukilteo, Washington. It had 1024 individually addressable platinum 
microelectrodes embedded on a silicon substrate. The platinum electrodes of the chip 
were coated with a proprietary polymer possessing hydroxyl groups on which was 
synthesized a DNA oligomer. Previously, a pentapeptide, N-terminal sequence of 
endorphin (YGGFL) was synthesized electrochemically on top of the DNA oligomer of 
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the CMOS chip.  The characterization of the synthesis was done by a fluorescence 
detection method.   
The CMOS chips produced by CombiMatrix (CBMX chips), by virtue of 
possessing electronically addressable arrays of electrodes, are able to fabricate molecular 
libraries electrochemically. The chips are primarily used for the generation of 
oligonucleotide microarrays56,57,58. Details of oligonucleotide microarray fabrication on 
CBMX chips can be seen in Table 1. The YGGFL peptide, synthesized electrochemically 
by Maurer et al. as a proof of concept, did not provide any complications due to side-
chain groups of amino acids. Furthermore, syntheses of only a single peptide and related 
truncated peptides on CBMX chip surface was demonstrated. Several issues in 
electrochemical synthesis such as stability of side-chain protecting groups during the 
gating step (chemical step at which a spatially defined deprotection step takes place), 
containment of EGA, and stability of CBMX chips to strong acids needed for 
deprotection of side-chain protecting groups were not explored by Maurer et al. We chose 
to explore these aspects and optimize the electrochemical synthesis of peptide 
microarrays on CBMX chips. We mainly focused on (i) generation and use of an EGA 
for the removal of acid labile protecting groups from selected positions of the 
electronically addressable CBMX chip and (ii) synthesis of peptide microarrays with the 
optimized EGA system.   
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Table 1: An Overview of the Electrochemical Method for Oligonucleotide Microarray 
Fabrication58,59,60. 
Method Approach Chemistry Current Availability 
In situ parallel 
synthesis  
Use of microarrays of 
individually addressable 
microelectrodes, 
 
diversity achieved 
through gating reaction 
before each nucleotide 
cycle. 
Regular phosphoramidite 
chemistry, 
 
trityl groups are 
deprotected using 
electrogenerated acid 
(gating reaction), 
 
acid electrochemically 
generated through 
oxidation of 
hydroquinone at platinum 
microelectrodes,  
 
hydroquinone is oxidized  
to release protons by 
passing 0.26µA current to 
the addressed 
microelectrodes for 60s. 
50-140mer arrays on 
12K, 90K, and 4X2K 
chips, 
 
25µm - 45µm in feature 
size, 
 
synthesis quality – high 
quality 50-mer arrays; 
quality long 
oligonucleotide arrays, 
 
synthesis 
characterization 
through fluorescence or 
electrochemical-based 
enzyme amplification, 
 
flexible in chip design, 
 
flexible in non-regular 
sequences. 
 
 
 
Peptide microarray synthesis on 12K CBMX chips. 
Complementary metal oxide semiconductor (CMOS) array technology. A key 
component of our microarray synthesis, CBMX’s CMOS array technology, allows 
programmable, spatially selective activation of electrodes of the CBMX chip. Each 
CBMX chip has 12,544 individually, electronically addressable microelectrodes present 
in it (Figure 1). Each microelectrode is spherical in shape, 45µm in diameter, overlayed 
with a three dimensional proprietary biopolymer about 50nm thick, and separated from 
its neighbor electrode by 75µm (Figure 2). Microarray fabrication using this technology 
involves a software compilation of peptide sequences to be synthesized and  a software 
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generation of a minimum number of synthetic steps required for microarray fabrication. It 
also involves  hardware concentrating on a selected set of electrodes at each synthesis 
step to generate acid from electro-generated acid precursor (EGA-P). During the gating 
step in each synthesis cycle, the CBMX hardware unit (electro-synthesis instrument) 
automatically applies voltage/current to the selected set of electrodes and generates acid 
locally from EGA-P that deprotects terminal amino groups of the addressed electrodes. 
 
 
 
 
 
 
FIGURE 2: Light photomicrograph of a CBMX chip. 
 
At the time this research was being performed, CBMX’s main focus was 
fabricating DNA microarrays on the chip and providing products and services in the areas 
of drug development, genetic analysis, molecular diagnostics, nanotechnology, and 
75µm 
45µm 
Block Control, decoders, temperature sensors  
SPI Interface 
Electrode Array 
Electrical Pads 
FIGURE 1: Architecture of CBMX chip. 
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defense and homeland security markets. Currently, they are a genetics-based Clinical 
Laboratory Improvement Amendments (CLIA) lab in Irvine, CA. Our collaboration with 
CBMX was to extend the scope of their technology by developing peptide microarrays 
fabrication capabilities on their chips. 
Electro-generated acid precursor (EGA-P). In CBMX’s CMOS based array 
technology, gating reactions are controlled by applying voltage/current on selected 
electrodes. Electro-generated acid precursor molecules (EGA-P), under the influence of 
electric field, undergo oxidation at the anode and release protons, which deprotect the 
terminal amino group present of the selected electrodes. Specifically, we have tested and 
optimized two EGA systems in terms of the gating step: (i) N,N′-diphenylhydrazine as 
EGA-P, and (ii) Hydroquinone as EGA-P.  
N,N′-substituted hydrazines can be chemically and electrochemically oxidized to 
N,N′-substituted diazene61. Application of N,N′-diphenylhydrazine as EGA-P during the 
gating reaction on CBMX arrays has been demonstrated earlier by Maurer et al. They 
used N,N′-diphenylhydrazine as EGA-P to release acid upon electro-oxidation, which 
then deprotected the Boc group from the terminal amino groups present on the surface. 
Selection of N,N′-diphenyl hydrazine has a few advantages over various other substituted 
hydrazines61. Substitution on Hydrazine can be both aromatic as well as aliphatic. 
Presence of aromatic substitution can lead to a drop in redox potential compared to 
unsubstituted or aliphatic substituted hydrazines. This is due to extended conjugation 
available for radical cation intermediates formed during oxidation. Symmetrical 
substitution of Hydrazines is important for the gating reaction since the corresponding 
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diazene, upon formation, does not decompose further into its corresponding hydrocarbon 
and dinitrogen - a phenomenon observed with unsymmetrical diazenes61.  
Ortho and para aromatic diols can be easily oxidized to respective ketones61. This 
chemical transformation finds wide-scale application due to the low redox potential 
involved (E°=+286mV at pH=7.0, 25ºC), at which most of the redox side reactions can 
be avoided. Montgomery et al. has demonstrated successful use of Hydroquinone as 
EGA-P in the gating reaction of DNA microarray fabrication on CBMX chip62-64. In this 
chemical transformation two protons are released at the anode. The acidic environment 
thus generated deprotects the acid labile protecting groups, such as the trityl group, from 
the selected electrodes. The EGA-P solution also contains quinone which is reduced at 
cathode into a radical anion, which acts as a scavenger by absorbing unreacted protons 
and prevents their diffusion towards the neighboring electrodes. 
A wide variety of protecting groups are available in synthetic chemistry to protect 
the amino group. In peptide chemistry, many of these protecting groups, such as 9-
fluorenylmethyloxycarbonyl (Fmoc), allyloxycarbonyl (alloc) etc., have been used. The 
most common of these protecting groups are base labile, acid labile, catalytically 
reducable, and organometallic labile groups. Of these, base labile and acid labile groups 
are the most common. As stated earlier, we have focused on optimizing two EGA 
systems, N,N′-diphenylhydrazine and Hydroquinone systems, to deprotect the acid labile 
protecting groups. We also explored strategies to electrochemically deprotect other main 
classes of protecting groups. These strategies include (i) generating base 
electrochemically from a probase to deprotect an Fmoc group, (ii) reducing protons to 
hydrogen on the cathode to catalytically deprotect Carboxybenzyl (Cbz) groups on a 
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Platinum electrode surface, and (iii) electrochemically generating Pd(0) from Pd(II) on 
selectively addressed electrodes to deprotect alloc protecting groups. The details of the 
results of each strategy are discussed in Appendix B. 
General Synthesis Scheme. In our research group, a peptide is synthesized on 
platinum microelectrodes of CMOS based CBMX chip. The platinum electrode is 
chemically altered with deposition of roughly 50nm thick proprietary organic polymer by 
CombiMatrix Corp. The organic polymer layer introduces hydroxyl groups to which 
spacers of different lengths can be coupled. The spacer that makes peptide synthesis 
possible on the chip is usually a 20-T or 2-T single stranded nucleotide linker with 
terminal thymidine (T) which is modified to possess an amino group. Another linker, an 
N-terminal Fmoc group protected photo-labile molecule with a caroboxyl group is 
coupled to the 20-T or 2-T linker through amide bond formation. This linker allows 
cleavage of the peptides from the solid-support by UV irradiation for synthesis 
characterization.   
The polymer coated CMOS chip displays the spacer with a terminal amino group. 
Each amino acid involved in the synthesis is Fmoc protected at N-terminus and its side 
chains are protected with acid-labile protecting groups. The C-terminus is preactivated as 
OBt ester, which enables direct coupling of the compound. Once a coupling reaction is 
complete, the unreacted amino groups are capped with acetyl glycine through a standard 
amide bond formation reaction. The Fmoc protecting group is then cleaved from the 
terminal amino acid, making new amino groups available for the next coupling cycle. 
The Fmoc group is deprotected with a base, usually piperidine, leaving the acid-labile 
side chain protecting groups intact. The coupling cycle is repeated until a gating step 
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(spatially controlled deprotection of amino protecting groups) is required for generation 
of the diversity in a peptide sequence. Finally, the peptide is side-chain deprotected with 
trifluoroacetic acid (TFA). 
Our objective with this technique is to produce patterns with high complexity and 
arbitrary configuration, which should allow for a full combinatorial peptide synthesis on 
12K CBMX chips. Therefore, we optimized the gating reaction efficiency by exploring 
the electrochemical deprotection efficiency of trityl (Trt) and dimethoxytrityl (DMT) 
groups using two EGA systems and various electrical titration conditions. Several aspects 
of peptide synthesis such as development of orthogonal synthesis strategy, synthesis 
automation, and other synthesis and instrumentation issues were solved. 
Microarray Synthesis Characterization by MALDI Mass Spectrometry (MALDI-
MS). MALDI-MS provides a way to characterize in situ-synthesized peptide microarrays 
at a molecular level, which is not possible by other means. The deduced masses of the 
peptides observed in the spectrum can be compared to those calculated for the predicted 
peptides on the spots of interest of the microarray65. The working principle of MALDI-
MS involves co-crystallization of the sample with an acidified matrix, which absorbs 
laser light energy and dissipates the energy to the sample. This rapid transfer of energy 
vaporizes the matrix. The vaporized sample acquires charge simultaneously from the 
matrix. A strong electric field between the MALDI plate and the entrance of the time-of-
flight (TOF) tube of MALDI-MS instrument energizes the quasimolecular ions to more 
or less the same extent. Ions with different masses, but similar kinetic energies travel with 
different velocities in TOF and hit the detector at various points within a timeframe of 
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microseconds. The resolution t/∆t, which is proportional to m/∆m is better achieved if all 
the ions at the entrance of the TOF tube are very close in their kinetic energy values.   
A significant advantage of MALDI-TOF is that it is relatively easy to perform 
peptide identification with high-throughput systems. Towards this direction, we have 
developed a MALDI detection method wherein the peptide probes can be immobilized on 
the chip via a cleavable linker. After the fabrication of a microarray, the linker can be 
cleaved under dry conditions to prevent diffusion. A controlled deposition of the matrix 
solution using aerosol on the microarray chip and limiting the diffusion of analytes can 
then provide direct characterization of analytes from each spot of the array. 
Electrochemical detection of microarrays. Currently, microarray synthesis and 
assay characterization based on Fluorescence is arguably the most desirable technique. In 
this technique, the probe molecule present on the chip surface is multiplexed with a target 
molecule, which is in turn conjugated directly or indirectly to a fluorophore molecule to 
collect fluorescence signals (Figure 3). Probes with high binding affinity to target 
molecules endure stringent washing steps, and the corresponding features can be 
visualized in a fluorescence scanner.  
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FIGURE 3: Fluorescence detection scheme of peptide microarrays via biotin-fluorophore 
conjugated streptavidin interaction. ‘B’ stands for biotin, ‘SA’ stands for streptavidin, and 
‘F’ stands for fluorophore.  
Surface plasmon resonance and Quartz crystal balance approaches are other 
techniques that are amenable for microarray detection. These are label-free detection 
methods which also provide information about real-time binding kinetics66,67. CBMX 
manufactures microarray chips that have CMOS technology based underlying integrated 
circuitry which makes electrochemical detection possible on the chips. CBMX custom 
12K array chips have 12,544 electrodes embedded on them, which can be addressed 
individually or in groups through the scripting interface of the PotentioSense and Electro-
synthesis instrument’s software. These custom instruments have been developed by 
CBMX for reading and fabrication of microarrays. The PotentioSense instrument is used 
primarily as a microarray reader based on electrochemical technique. It can also be used 
for fabrication of microarrays, although it would require complicated interfacing with 
third-party instruments. The instrument is sensitive to picoamps (pA) level current signals 
and does not have the problem of surface-quenching of signals observed with 
fluorescence detection on metal surfaces. Detection of pA level steady state currents are 
achieved in a serial read-out of the array in approximately 60s. There are thirteen 
electrical pads made of platinum on one side of the active surface area of the chip, which 
transmits power and electronic signals to the electrodes. The instrument is capable of 
applying both voltage polarities to the microelectrodes of the chip. Some features 
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associated with PotentioSense include low instrument cost, portability, and operational 
convenience.  
 
FIGURE 4: Photograph of a potentiosense instrument. The externalized leads of the 
instrument provide connection between the microelectrodes of the chip and external 
instruments. 
              
 
 
 
 
        
 
FIGURE 5: Electrochemical detection of peptide microarrays via biotin-
horseradishperoxidase (HRP) conjugated streptavidin interaction. Potentiosense can 
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measure signals generated from the HRP mediated redox cycle of 3,3ʹ,5,5ʹ-
tetramethylbenzidine (TMB) molecule. 
We have explored novel applications of peptide microarrays that are possible 
using the CBMX platform. Towards this end, capabilities and functioning of the 
Potentiosense reader was investigated and optimized. Applications such as a search for a 
catalyst for the anodic half-reaction of water splitting and immobilization of peptides on 
microelectrodes of CBMX chips by co-electropolymerization of pyrrole and pyrrole 
modified peptides (peptide-py) were explored. 
Note 
This work was performed between January 2005 and May 2011. In the past few 
years peptide microarray fabrication technology has made rapid progress. Some 
technologies, such as particle-based and photolithography-based peptide synthesis, have 
overcome many synthesis challenges of peptide microarray fabrication. While 
documenting this work, the progress made in the field was researched and contents were 
updated to reflect the current status of the field. The work performed is still relevant, as 
electrochemically-directed peptide microarray fabrication on the CBMX chip is a unique 
approach which no other group has yet explored. Several groups, such as Breitling et al. 
and Price et al., are working towards making their platform electrically active. However, 
no peptide microarray product on an electrically active platform is currently available in 
the market. Nimblegen has introduced more efficient photolabile protecting groups by 
attaching a sensitizer chromophore, such as thioxanthone, to NPPOC groups in their 
DNA microarray fabrication technology68,69. Yet, a study of efficiency of derivatives of 
NPPOC group as photolabile protecting group still holds academic relevance. 
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Chapter 2 
Investigation of the 2-(2-nitrophenyl)propoxycarbonyl Protecting Group 
Substituent-Effect on the Rate of Photolysis and Yield of Amine 
Abstract 
The protecting group 2-(2-nitrophenyl)propoxycarbonyl (NPPOC) has been used 
as a β-linked o-nitrobenzyl protecting group for in situ nucleotide array preparation. It 
was demonstrated that NPPOC can be used as an efficient photo-labile amino protecting 
group. Mechanistic studies have revealed that the photo-cleavage process of this group 
involves the formation of less reactive intermediates than those formed during the 
photocleavage of NVOC and MeNPOC groups leading to suppression of side products 
and increase in yield of free amines. In this chapter, we have investigated the influence of 
substituents on the rate of photolysis and the yield of the amine. The results indicate that 
substituents capable of forming a π-network with the nitro group enhanced the rate of 
photolysis and yield.  Once such properly substituted NPPOC groups were used, the rate 
of photolysis/yield depended on the nature of protected amino group (aromatic amines 
were found to be more efficient than aliphatic amines). This indicated a different 
chemical step during photocleavage process, and became the rate limiting step. The 
deprotection from a primary amine group is faster than deprotection from a secondary 
amine group. Similarly, deprotection from an amine group bonded to an electron 
donating group is faster than deprotection from an amine group bonded to an electron 
withdrawing group. 
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Introduction 
Since their first report by Barltrop and Schofied1, photo-labile protective groups 
have been utilized in a wide range of applications. One the most commonly used groups, 
6-nitroveratroloxycarbonyl (NVOC), was originally introduced by Patchornik, Amit, and 
Woodward2. The mechanistic studies on the NVOC photo-cleavage process revealed 
formation of a Norrish-type II diradical species3 - a characteristic of all o-
nitrobenzylalcohols4. Despite its popularity photo-cleavage of NVOC protected amines 
can result in poor yields due to the formation of the nitrosobenzaldehyde, a chemically 
labile product, which further reacts with the deprotected amine to form diazo or/and 
imine-type products5,6. Thus, presence of additives and scavengers is often required for 
improvement in the yield7. However, the photo-cleavage studies of α-methyl-o-
nitropiperonyloxycarbonyl (MeNPOC) by Holmes et al.8 did reveal some improvements 
due to presence of electron-donating methyl group. However, the mechanism of 
photocleavage is similar to that of NVOC groups and therefore, several side-products are 
formed during photolytic cleavage.  
Various groups have utilized 2-(2-nitrophenyl)propyloxycarbonyl (NPPOC) and 
its thioxanthone derivative for nucleotide protection and reported improved cleavage 
yields9-12. The improved yield was attributed to the NPPOC group having a different 
photo-cleavage mechanism, which resulted in formation of a less reactive end-product, as 
was demonstrated by Hasan et al.13 Finally, the utility of NPPOC for photolithography-
based peptide synthesis was demonstrated by Bhushan et al.14 where relative half-lives of 
protected amino acids and deprotection yields were studied. The higher yields of photo-
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cleavage yield using NPPOC protected amines has inspired us to investigate the influence 
of the substituent on the photo-cleavage rates, half-lives, and yields of various NPPOC 
protected amines. Here, we report synthesis and photolysis studies of various NPPOC-
based carbamate analogues. 
Results and Discussion 
This study included the unsubstituted and six differently substituted NPPOC 
analogues combined with three different amines, N-benzylamine, 4-aminoindole, and 4-
(aminomethyl)-indole. For comparison of efficiency of NVOC, MeNPOC, and NPPOC 
as a photolabile protecting group, tryptophan protected with NVOC, MeNPOC, and 
NPPOC were prepared and studied. Starting from the alcohol forms of the NPPOC 
analogues, two general synthetic strategies were considered for preparation of the 
corresponding carbamates. The first method involved the formation of carbonate 
analogues by reacting NPPOC alcohols with 4-nitrophenylchloroformate (Scheme 1). 
However, it was found that formation of the carbamate was not feasible due to high 
stability of the carbonate bond. Despite multiple attempts using various conditions, this 
route did not result in appreciable product. Alternatively, alkyloxycarbonylimidazole 
NPPOC analogues were prepared by reacting NPPOC alcohols with 1,1ʹ-
carbonyldiimidazole (CDI) and subsequent reaction with various amines, affording the 
carbamate products 1-9 (Scheme 1). The carbamate 10 was prepared from the reaction 
between (L)-tryptophan and the NPPOC-imidazole while carbamates 11 and 12 were 
generated from (L)-tryptophan and MeNPOC/NVOC-chloroformate (Scheme 1). 
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SCHEME 1: General synthetic schemes for compounds 1-12. Top: General synthesis of 
various NPPOC carbamates. Reaction ‘b’ did not occur, as p-nitro phenoxy group proved 
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to be a poor leaving group. Bottom: Reduction of cyanoindole and preparation of 
NPPOC, MeNPOC, and NVOC protected tryptophan. 
The rates of photolysis were determined using UV/Vis spectroscopy with results 
summarized in Table 1. The rate constants varied from 0.756 to 0.009 min-1 
corresponding to half-lives ranging from 0.917 to 77.0 minutes. The comparison among 
analogues 1-7 indicated that the rate of photolysis was improved when an aromatic 
substituent was present at the 5th position of the ring (4, 7). Between these, the rate 
constant was greater for the carbamate bearing the electron rich 3,4-dimethoxyphenyl 
substituent (7) as compared to the phenyl group (4). In comparison, the rate of cleavage 
was significantly decreased for the di-substituted NPPOC (5) bearing both an alkyl and 
an aromatic group. The presence of bromine on the ring adversely affected the photolysis 
rate (2) as compared to the aromatic or unsubstituted NPPOCs. The combination of 
bromo and ethyl groups (3) further decreased the rate of photolysis. Finally, the 
phenylketone substituent (6) did not drastically change the rate of photolysis and 
indicated a half-life similar to that of the unsubstituted NPPOC analogue.  
The comparison among carbamates 4, 8, 9, and 10 indicated that the nature of the 
protected amine significantly influenced the rate of cleavage. This resulted in half-lives 
ranging from 0.917 to 5.55 minutes. The rate was especially accelerated when the 
protected amine was aromatic (8). The comparison between NPPOC, MeNPOC, and 
NVOC protected tryptophan (10, 11, and 12) revealed that the NPPOC did exhibit a 
faster cleavage rate. In fact, the rate constant associated with photo-deprotection of 
NPPOC-Tryptophan was twice as fast as MeNPOC which was still faster than NVOC. 
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The yield of the complete deprotection of amine was quantitatively determined 
using HPLC analysis with the 3,4-dimethoxyphenyl substituted NPPOC, displaying the 
highest yield of 88.7%. The patterns of substitution among carbamates 1-7 indicated that 
the brominated analogue (2) displayed lower yields as compared to the unsubstituted 
NPPOC (1). The presence of the additional ethyl group on the ring (3) decreased the yield 
even more. Furthermore, the electron withdrawing phenylketone (6) also indicated a 
drastic decrease in the yield of the free amine, while the phenyl analogue (4) resulted in 
only 14% reduction as compared to the parent molecule. The comparison between 
carbamates 4, 8, 9, 10 revealed that the yield associated with the aromatic amine was 
slightly higher than those of benzylic/aliphatic amines. Finally, evaluation of the three 
different classes of protective groups indicated that NPPOC-protected tryptophan 
demonstrated 13% higher cleavage yield compared to the MeNPOC-protected 
tryptophan. The MeNPOC-protected tryptophan cleavage yield was 10% higher than that 
of the NVOC-protected amine.                
The photo-cleavage of NPPOC, MeNPOC, and NVOC-protected amines all 
demonstrated first order kinetics as seen from half-life values of photolysis. The half-
lives decreased from NVOC to MeNPOC (as reported in literature) to NPPOC. Among 
the substituents, the half-life values decreased when electron-donating groups where 
substituted, compared to NPPOC groups. The half-life values increased when electron-
withdrawing groups were substituted. The numerical values of half-lives can be seen in 
Table 1. In general, the substitution patterns of the NPPOC ring indicated that presence of 
a π-network para to the nitro group enhanced the rate of cleavage, while halogens/non-
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aromatic substituents adversely affected this process. It appears that conjugation to the 
nitro group provides extra delocalization for the Norrish-type II radical. This is seen in 
the mechanism discussed by Patchomik, Amit, and Woodward, making formation of the 
di-radical species more favorable resulting in an increased rate constant13,16. Consistent 
with this concept, the larger rate constant associated with carbamate 6, compared with 2, 
can be attributed to the additional delocalization provided by the carbonyl group. In 
contrast, the influence of ethyl substituent on the rate constant is less clear. Perhaps the 
presence of an ethyl substitution in the ring makes the phenyl ring twist away from co-
planar conformation, a steric constraint in 5, and changes the electronic conjugation of 
the ring in 3, resulting in a drastic rate decrease. In other words, an ethyl group as a 
substituent distorts the coplanarity and hence the molecule is no longer as aromatic, 
leading to a decrease in photolysis rate and percent yield. Such distortion is not usually 
seen with Br or phenyl groups. From the work performed, it seems with respect to 
carbamates 1-7, formation of the diradical species is the key step in determining the rate 
of the reaction. However, we have observed that rate constants associated with molecules 
4, 8, 9, and 10, all of which have the same substituent, also depend on the elimination of 
the CO2 step as carbamate 8 displayed a significantly faster cleavage process. Perhaps, all 
the transformations during photodeprotection takes place in a concerted manner and 
therefore the nature of the protected amine also plays a role in determining the photolysis 
rate. The photodeprotection mechanism of NPPOC and NVOC groups can be seen in 
Figure 1 & 2. 
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FIGURE 1: Photodeprotection mechanism of NPPOC analogues.  
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FIGURE 2: Photodeprotection mechanism of NVOC group. 
Thus, it appears that nature of the substituent greatly influences the formation of 
the Norrish-type II di-radical. However, having the right substituent, this process occurs 
fast enough that elimination of the CO2 becomes the slow step in the overall process.   
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TABLE 1: Photolysis rate constants, half-lives, and the yields of amine 
R1
R2 NO2
O R3
O
R1 R2 R3Entry
1 H H
HN
HN
2 Br H
3 Br Ethyl
HN
4 Phenyl H
HN
5 Phenyl Ethyl HN
6 Phenylketone H
HN
7 3,4-Dimethoxy
phenyl
H HN
8 Phenyl H 4-Aminoindole
9 Phenyl H 4-(Aminomethyl)-indole
k(min-1)
Yield of
Amine
NO2
O
O
H
N
COOH NH
10
O
O NO2
O N
H
O COOH
HN
11
MeO
MeO NO2
O N
H
O COOH
HN
12
68.2%
61.0%
t/2(min)
0.192 3.61 88.7%
0.103 6.72 31.0%
0.108 6.42 86.7%
0.274 2.53
74.0%
0.088 7.88 59.3%
0.058 11.9
0.041 16.9
76.3%
0.185 3.75
0.756 0.917
0.011 63.0
0.009 77.0
81.0%
25.1%
48.1%
0.125 5.55 78.6%
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TABLE 1: All photolysis, UV/Vis, and HPLC analysis were carried out in 0.80M HCl in 
CH3CN solution. Initial rates were taken at 280-300 nm. Half-lives were determined from 
rate constants, and yields were measured by calculating the area under each HPLC peak.  
With respect to measured yields, there appears to be a correlation between the rate 
of the reaction and the yield of the amine (Table 1). Rates and yields  were found to 
improve in tandem, with different substituents, with the exception of carbamate 6. It is 
believed that low yield, in this case, is due to the formation of an imine-type side-product 
(molecules 1-7), as deprotected amine reacts with the carbonyl of the phenylketone. 
Nevertheless, none of the protective groups could be removed quantitatively (> 95%). 
Thus, it appears that some side reactions may have taken place during the cleavage 
process. This is easily explained with regard to MeNPOC and NVOC, where formation 
of a reactive side product has been documented by McGall6,
 resulting in depletion of the 
deprotected amine. However, the data also indicates that NPPOC photo-cleavage results 
in one or more side-reactions, resulting in a lower yield of the amine. Therefore, the 
addition of nucleophilic scavengers may also be necessary in the NPPOC photo-cleavage 
process. Finally, the comparison between carbamates 10, 11, and 12 further corroborated 
the fact that functional group protection via the β-position of o-nitrobenzyl group would 
result in a faster, cleaner, and more efficient photo-cleavage process as demonstrated for 
nucleotides by Hasan et al.13  
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Materials and Methods 
The NPPOC analogues were obtained as alcohols from NimbleGen system Inc. 
and all reagents were purchased from Sigma-Aldrich. Light-sensitive reactions were 
carried out in the presence of red light only, and kept at 4.0 ˚C in a dark environment. 
Irradiations were carried out in the dark for 30 sec, 1.0 min, and every 30 sec after, up to 
10 min. The UV/Vis spectroscopy was performed using a Cary 50 Bio Varian 
Spectrometer. HPLC data was obtained using Agilent 1100 series instrument, NMR 
spectra were recorded with a 300 MHz instrument, and elemental analyses were 
performed in the Gold Water Center at Arizona State University. 
General Procedure for Photo-cleavage, UV/Vis Spectroscopy and HPLC analysis  
Experiments were carried out in a 2.00 mL-quartz cuvette with a total reaction 
volume of 1.00 mL. For each set of experiments a background spectrum of the solvent 
was first recorded [988 μL of stock solution containing CH3CN/HCl (0.800M HCl)], 
followed by 2.00 μL addition of each NPPOC (5.00 mM stock solution in CH3CN). The 
cuvette was then irradiated at 375-400 nm using a 2mW/cm2 UV-lamp while recording a 
scanning kinetics of the photolysis at 220-370 nm for 12 minutes. The initial rates at 280-
300 nm were then fitted to a first order rate law and the rate constants were obtained. For 
the HPLC analysis, a 10 mM solution of each carbamate in CH3CN/HCl (0.800M HCl) 
was prepared. The solution was then divided into 6 reaction samples (1.0 mL each) and 
samples 1-6 were irradiated from 0, 1, 2, 4, 8, and 16 minutes respectively using a 2 
mW/cm2 UV-lamp. All the groups were deprotected at various time points from 0 to 16 
minutes irradiation as seen from HPLC. Each sample was then analyzed with the HPLC 
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and the areas corresponding to the initial carbamate and final amine were calculated. The 
overall quantitative yield of the amine was obtained by dividing the area of the amine by 
the area of the initial carbamate.  
Synthesis Procedures 
General synthesis of carbamates via 1,1ʹ-carbonyldiimidazole. A solution of 
1,1ʹ-carbonyldiimidazole (1.3 molar excess) dissolved in a minimum amount of 
anhydrous THF was added to a solution of NPPOC-alcohol in anhydrous THF under a 
nitrogen atmosphere. The resulting solution was then warmed up to 45 ˚C and stirred at 
this temperature for 4.0 hours. After completion, (indicated by TLC) the solution was 
poured over neutral water and the product was extracted with chloroform. The extract 
was washed a few times with water, the organic layer was dried over sodium sulfate, and 
the solvent was removed under reduced pressure. The resulting product was then 
dissolved in anhydrous THF under a nitrogen atmosphere and DIPEA was added (10 
molar excess). The desired amine was then added to this solution (1.0-5.0 molar excess 
depending on the nature of amine), the resulting mixture was warmed up to 80 ˚C, and 
stirred at this temperature for 12 hours. The product was then extracted out of 2.0N HCl 
solution with chloroform and the extract was washed multiple times with 2.0N HCl, then 
water. The organic layer was dried over sodium sulfate and removed under reduced 
pressure. Product was purified with silica gel chromatography using DCM/Ethanol 98:2 
as the eluant, resulting in the oily desired carbamate.   
General synthesis of carbonate derivatives. A solution of 4-nitrophenyl 
chloroformate dissolved in a minimum amount of pyridine was added to a solution of 
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NPPOC-alcohol in anhydrous pyridine under nitrogen atmosphere. The resulting mixture 
was brought to reflux and stirred overnight. After the reaction completed (TLC), the 
product was extracted out of 2.0N HCl with DCM. The organic layer was washed 
multiple times with 2.0N HCl solution, dried over sodium sulfate, and removed under 
reduced pressure resulting in the oily carbonate product.  
General Synthesis of Phenyl-NPPOC, MeNPOC, and NVOC Tryptophan. A 
solution of tryptophan (2.0 mM) dissolved in 28 mL CH3CN, 4 mL H2O, 4 mL DIPEA in 
an ice bath was added to phenyl-NPPOC-imidazole/MeNPOC-chloroformate/NVOC-
chloroformate (1.0mM) dissolved in 4 mL CH3CN. The resulting mixture was kept in the 
ice bath and stirred for 4.0 h. The solution was concentrated under reduced pressure and 
the product was extracted with ethyl acetate out of 2.0N HCl solution. The organic layer 
was dried over sodium sulfate and removed under reduced pressure. The product was 
recrystallized from hexanes.       
4-(Aminomethyl)-indole (9a). 4-cyanoindole (0.40g, 2.8mmol) dissolved in 
minimum amount of THF was added drop-wise to a solution of LAH (0.50g, 13mmol) in 
anhydrous THF under a nitrogen atmosphere. The resulting solution was refluxed for 4.0 
hours. The reaction was then cooled down in an ice bath and very carefully a drop of 
water was added every 1-2 minutes until no more hydrogen gas evolved. The solution 
was then filtered and the precipitate was washed with THF. The organic solution was 
then dried over sodium sulfate and removed under reduced pressure. Product was 
recrystalized from hexanes resulting in 9a. Yield: 83%; TLC: 0.12 (DCM/Ethanol 96:4); 
IR: 3347, 2987, 2899, 1575, 1423, 1346, 1053 cm-1; 1H NMR [DMF] δ 11.2 (1H, broad, 
43 
 
indole proton); δ 7.44 (1H, t, J = 3.0 Hz, aromatic proton); δ 7.40 (1H, m, J = 2.1 Hz, 
aromatic proton); δ 7.12 (2H, m, aromatic protons); δ 6.64 (1H, m, aromatic proton); δ 
4.12 (2H, s, methylene protons); δ 3.14 (2H, broad, amine protons). Anal. (C9H10N2): C, 
73.94; H, 6.890; N, 19.16. Found: C, 74.38; H, 7.044; N, 19.18. 
2-(2-Nitrophenyl)-propyl N-Benzyl Carbamate (1). Yield: 82%; TLC: 0.64 
(DCM/Ethanol 96:4); IR: 3329, 3056, 2925, 1703, 1511, 1446,1343, 1229 cm-1; 1H 
NMR [CDCl3] δ 7.72 (1H, dd, J = 1.8 Hz, J = 7.5 Hz, aromatic proton); δ 7.55 (1H, m, 
aromatic proton); δ 7.47 (1H, m, aromatic proton); δ 7.37 (1H, d, J = 8.4 Hz, aromatic 
proton); δ 7.27 (5H, m, aromatic protons); δ 4.92 (1H, broad, carbamate proton); δ 4.31 
(2H, d, J = 6.0 Hz, methylene protons); δ 4.18 (2H, d, J = 8.1 Hz, methylene protons); δ 
3.75 (1H, m, J = 7.2 Hz, methine proton); δ 1.35 (3H, d, J = 7.2 Hz, methyl protons). 
Anal. (C17H18N2O4): C, 64.96; H, 5.770; N, 8.910. Found: C, 64.13; H, 5.580; N, 8.510. 
2-(5-Bromo-2-nitro-phenyl)-propyl N-Benzyl Carbamate (2). Yield: 89%; 
TLC: 0.63 (DCM/Ethanol 96:4); IR: 3434, 3047, 2925, 1715, 1556, 1519, 1453, 1262, 
1225 cm-1; 1H NMR [CDCl3] δ 7.53 (1H, d, J = 9.0 Hz, aromatic proton); δ 7.49 (1H, d, 
J = 1.5 Hz, aromatic proton); δ 7.40 (1H, dd, J = 1.8 Hz, J = 6.6 Hz, aromatic proton); δ 
7.18 (5H, m, aromatic protons); (1H, broad, carbamate proton); δ 4.23 (2H, d, J = 5.4 Hz, 
methylene protons); δ 4.19 (2H, d, J = 6.0 Hz, methylene protons); δ 3.66 (1H, m, J = 7.2 
Hz, methine proton); δ 1.26 (3H, d, J = 7.2 Hz, methyl protons). Anal. (C17H17BrN2O4): 
C, 51.92; H, 4.360; N, 7.120. Found: C, 52.34; H, 4.490; N, 6.850.   
2-(5-Bromo-4-ethyl-2-nitro-phenyl)-propyl N-Benzyl Carbamate (3). Yield: 
85%; TLC: 0.68 (DCM/Ethanol 96:4); IR: 3419, 3321, 2970, 2929, 1703, 1515, 1450, 
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1352, 1225 cm-1; 1H NMR [CDCl3] δ 7.51 (1H, s, aromatic proton); δ 7.50 (1H, s, 
aromatic proton); δ 7.18 (5H, m, aromatic protons); δ 4.85 (1H, broad, carbamate 
proton); δ 4.22 (2H, d, J = 3.3 Hz, methylene protons); δ 4.17 (1H, m, methine proton); δ 
4.00 (1H, m, methylene proton); δ 3.61 (1H, m, methylene proton); δ 2.68 (2H, q, J = 7.8 
Hz, methylene protons); δ 1.82 (6H, m, methyl protons). Anal. (C19H21BrN2O4): C, 
54.17; H, 5.020; N, 6.650. Found: C, 54.15; H, 5.030; N, 6.100.   
2-(5-Phenyl-2-nitro-phenyl)-propyl N-Benzyl Carbamate (4). Yield: 85%; 
TLC: 0.70 (DCM/Ethanol 96:4); IR: 3333, 2917, 1707, 1523, 1453, 1356, 1258 cm-1; 1H 
NMR [CDCl3] δ 7.75 (1H, d, J = 8.4 Hz, aromatic proton); δ 7.54 (1H, d, J = 2.1 Hz, 
aromatic proton); δ 7.46 (6H, m, aromatic protons); δ 7.16 (5H, m, aromatic protons); δ 
4.85 (1H, broad, carbamate proton); δ 4.22 (4H, m, methylene protons); δ 3.75 (1H, m, 
methine proton); δ 1.31 (3H, d, J = 6.6 Hz, methyl protons). Anal. (C23H22N2O4): C, 
70.75; H, 5.680; N, 7.170. Found: C, 70.66; H, 5.830; N, 7.190.   
2-(5-Phenyl-4-ethyl-2-nitro-phenyl)-propyl N-Benzyl Carbamate (5). Yield: 
82%; TLC: 0.72 (DCM/Ethanol 96:4); IR: 3329, 3000, 2917, 1719, 1515, 1348, 1258 
cm-1; 1H NMR [CDCl3] δ 7.62 (1H, s, aromatic proton); δ 7.34 (5H, m, aromatic 
protons); δ 7.20 (6H, m, aromatic protons); δ 4.95 (1H, broad, carbamate proton); δ 4.21 
(4H, m, methylene protons); δ 3.65 (1H, m, methine proton); δ 2.55 (2H, q, J = 7.2 Hz, 
methylene protons); δ 1.26 (3H, d, J = 6.0 Hz, methyl protons); δ 1.02 (3H, t, J = 1.2 Hz, 
methyl protons). Anal. (C25H26N2O4): C, 71.75; H, 6.260; N, 6.690. Found: C, 71.30; H, 
6.950; N, 6.080.   
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2-(5-Phenylketone-2-nitro-phenyl)-propyl N-Benzyl Carbamate (6). Yield: 
87%; TLC: 0.63 (DCM/Ethanol 96:4); IR: 3332, 3058, 2968, 1709, 1659, 1522, 1448, 
1255 cm-1; 1H NMR [CDCl3] δ 7.79 (1H, d, J = 1.8 Hz, aromatic proton); δ 7.67 (4H, m, 
aromatic protons); δ 7.51 (1H, m, aromatic proton); δ 7.40 (2H, m, aromatic protons); δ 
7.16 (5H, m, aromatic protons); δ 4.91 (1H, broad, carbamate proton); δ 4.22 (2H, d, J = 
4.8 Hz, methylene protons); δ 4.08 (2H, m, methylene protons); δ 3.66 (1H, m, J = 6.6 
Hz, methine proton); δ 1.29 (3H, d, J = 6.6 Hz, methyl protons). Anal. (C24H22N2O5): C, 
68.89; H, 5.300; N, 6.690. Found: C, 68.76; H, 5.270; N, 6.430. 
2-[5-(3,4-Dimethoxyphenyl)-2-nitro-phenyl]-propyl N-Benzyl Carbamate (7). 
Yield: 84%; TLC: 0.70 (DCM/Ethanol 96:4); IR: 3434, 3052, 2958, 1715, 1601, 1515, 
1462, 1343, 1245 cm-1; 1H NMR [CDCl3] δ 7.74 (1H, d, J = 8.7 Hz, aromatic proton); δ 
7.51 (1H, d, J = 1.8 Hz, aromatic proton); δ 7.42 (1H, dd, J = 1.8 Hz, J = 8.7 Hz, 
aromatic proton); δ 7.11 (5H, m, aromatic protons); δ 7.04 (1H, d, J = 1.5 Hz, aromatic 
proton); δ 7.00 (1H, d, J = 1.5 Hz, aromatic proton); δ 6.87 (1H, d, J = 8.1 Hz, aromatic 
proton); δ 4.97 (1H, broad, carbamate proton); δ 4.19 (4H, m, methylene protons); δ 3.84 
(3H, s, methoxy protons); δ 3.82 (3H, s, methoxy protons); δ 3.75 (1H, m, methine 
proton); δ 1.30 (3H, d, J = 6.6 Hz, methyl protons). Anal. (C25H26N2O6): C, 66.65; H, 
5.820; N, 6.220. Found: C, 66.97; H, 6.010; N, 6.060.   
2-(5-Phenyl-2-nitro-phenyl)-propyl N-4-Indole Carbamate (8). Yield: 68%; 
TLC: 0.57 (DCM/Ethanol 96:4); IR: 3401, 3301, 2956, 1701, 1602, 1547, 1323, 1232 
cm-1; 1H NMR [CDCl3] δ 7.83 (1H, d, J = 8.4 Hz, aromatic proton); δ 7.61 (1H, d, J = 
1.8 Hz, aromatic proton); δ 7.41 (9H, m, aromatic protons); δ 6.96 (1H, t, J = 8.1 Hz, 
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aromatic proton); δ 6.40 (1H, m, aromatic proton); δ 4.59 (2H, d, J = 7.2 Hz, methylene 
protons); δ 3.93 (1H, m, methine proton); δ 3.79 (1H, broad, carbamate proton); δ 1.44 
(3H, d, J = 7.2 Hz, methyl protons). Anal. (C24H21N3O4): C, 69.39; H, 5.100; N, 10.11. 
2-(5-Phenyl-2-nitro-phenyl)-propyl N-4-methylindole Carbamate (9). Yield: 
76%; TLC: 0.58 (DCM/Ethanol 96:4); IR: 3406, 3305, 2923, 1694, 1603, 1510, 1342, 
1225 cm-1; 1H NMR [CDCl3] δ 8.21 (1H, broad, indole proton); δ 7.74 (1H, d, J = 8.7 
Hz, aromatic proton); δ 7.41 (7H, m, aromatic protons); δ 7.23 (1H, d, J = 7.8 Hz, 
aromatic protons); δ 7.08 (1H, m, aromatic proton); δ 7.01 (1H, t, J = 7.8 Hz, aromatic 
proton); δ 6.88 (1H, d, J = 7.2 Hz, aromatic proton); δ 6.46 (1H, s, aromatic proton); δ 
4.87 (1H, broad, carbamate proton); δ 4.53 (2H, d, J = 5.7 Hz, methylene protons); δ 4.26 
(2H, m, methylene protons); δ 3.74 (1H, m, J = 7.2 Hz, methine proton); δ 1.30 (3H, d, J 
= 6.9 Hz, methyl protons). Anal. (C25H23N3O4): C, 69.92; H, 5.400; N, 9.780.  
2-(5-Phenyl-2-nitro-phenyl)-propyl N-(L)-Tryptophan Carbamate (10). 
Yield: 38%; TLC: 0.15 (DCM/Ethanol 96:4); IR: cm-1; 1H NMR [CDCl3] δ  (1H, broad, 
indole proton); δ  (1H, d, J = 8.7 Hz, aromatic proton); δ  (7H, m, aromatic protons); δ  
(1H, d, J = 7.8 Hz, aromatic protons); δ  (1H, m, aromatic proton); δ  (1H, t, J = 7.8 Hz, 
aromatic proton); δ  (1H, d, J = 7.2 Hz, aromatic proton); δ  (1H, s, aromatic proton); δ  
(1H, broad, carbamate proton); δ  (2H, d, J = 5.7 Hz, methylene protons); δ  (2H, m, 
methylene protons); δ  (1H, m, J = 7.2 Hz, methine proton); δ  (3H, d, J = 6.9 Hz, methyl 
protons). Anal. (C27H25N3O6): C, 66.52; H, 5.170; N, 8.620. 
1-(4,5-Methylenedioxy-2-nitro-phenyl)-ethyl N-(L)-Tryptophan Carbamate 
(11). Yield: 52%; TLC: 0.13 (DCM/Ethanol 96:4); IR: cm-1; 1H NMR [DMSO-d6] δ 
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10.8 (1H, d, indole proton); δ 7.58 (3H, m, aromatic protons); δ 7.32 (1H, t, J = 8.4 Hz, 
aromatic protons); δ 7.06 (3H, m, aromatic protons); δ 6.22  (2H, s, methylene protons); δ 
5.96 (1H, m, J = 6.6 Hz, methine proton); δ 4.14 (1H, m, J = 4.5 Hz, methine proton); δ 
3.13 (1H, m, J = 5.1 Hz, methylene proton); δ 2.98 (1H, dd, J = 9.3 Hz, J = 5.4 Hz, 
methylene proton); δ 1.47 (3H, dd, J = 6.6 Hz, J = 6.0 Hz methyl protons). Anal. 
(C21H19N3O8): C, 60.60; H, 4.580; N, 10.60.  
(4,5-Dimethoxy-2-nitro-phenyl)-methyl N-(L)-Tryptophan Carbamate (12). 
Yield: 42%; TLC: 0.17 (DCM/Ethanol 96:4); IR: cm-1; 1H NMR [DMSO-d6] δ 10.7 
(1H, s, indole proton); δ 7.78 (1H, d, J = 8.1 Hz, aromatic proton); δ 7.58 (1H, s, 
aromatic proton); δ 7.44 (1H, d, J = 8.4 Hz, aromatic proton); δ 7.24 (1H, d, J = 8.1 Hz, 
aromatic proton); δ 7.05 (1H, s, aromatic proton); δ 7.00 (1H, m, aromatic proton); δ 6.85 
(1H, m, aromatic proton); δ 4.13 (1H, m, methine proton); δ 3.79 (3H, s, methoxy 
protons); δ 3.74 (3H, s, methoxy protons); δ 3.51 (2H, s, methylene protons); δ 3.03 (1H, 
m, methylene proton); δ 2.92 (1H, m, methylene proton). Anal. (C21H21N3O8): C, 56.88; 
H, 4.770; N, 9.480.  
Conclusion 
With increasing development and interest in in situ preparation of peptide 
arrays15,16, photo-labile protective groups that exhibit efficient and quantitative yields 
have great appeal. A comparison between NPPOC, MeNPOC, and NVOC revealed that 
all three groups were viable amino photo-labile protective groups, but that NPPOC and 
its derivatives had the highest rates and yields. By comparing the rates and yields of 
photo-cleavage using various substituted NPPOC-amino protective groups, it was 
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determined that aromatic substituents resulted in most effective cleavage. Normally, di-
radical formation is rate limiting in the mechanism. However, for the substituted NPPOC 
groups that gave the highest deprotection rates, formation of the di-radical occurs fast 
enough so that the rate determining step was the elimination of the CO2.  
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Chapter 3 
 
Feature-Level MALDI-MS Characterization of Electrochemically-Directed In situ-
Synthesized Peptide Microarrays 
The contents of this chapter has been extracted from an already published article1. 
Abstract 
Characterizing the chemical composition of microarray features is a difficult yet 
important task in the production of in situ-synthesized microarrays. Here, we describe a 
method to determine the chemical composition of microarray features, directly on the 
feature. This method utilizes non-diffusional chemical cleavage from the surface along 
with techniques from MALDI-MS tissue imaging, thereby making the chemical 
characterization of high-density microarray features simple, accurate, and amenable to 
high-throughput. 
Introduction 
Microarrays are one of the leading platforms used in high-throughput 
experimentation and data acquisition. A primary example is the DNA microarray, which 
serves as an integral experimental platform in genomics2. The information content and 
the throughput achieved with microarrays continue to advance, partly because of 
advances in the fabrication of in situ-synthesized DNA microarrays2-8. This has resulted 
in greatly increased feature densities.  
Advances in DNA microarray fabrication are being applied to the production of 
peptide and other non-nucleic acid microarrays8-17. Synthesis efficiency is essential for 
reliable microarray data; even minor inefficiencies result in cumulative in situ stepwise 
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synthesis errors18. Characterization of the synthesis efficiency of in situ-synthesized DNA 
microarrays is facilitated by the ability to hybridize a complementary strand of DNA and 
the sensitivity of hybridization to base-pair mismatches19-21. However, characterizing the 
synthetic fidelity of peptide arrays and other non-nucleic acid-based microarrays is much 
more difficult given that the hybridization of a complementary strand is not possible.  
In the absence of hybridization, characterization of microarrays is typically done 
using direct-label fluorescence or staining13,15,22, antibody binding to a synthesized 
epitope8,15, protein binding to a known ligand12,23, or molecules are cleaved from the 
surface and then analyzed using traditional methods such as HPLC and mass 
spectrometry9,24,25. Although these methods provide information about the success or 
failure of a particular microarray synthesis, much of the information about the chemical 
composition of the microarray features remains unknown. Labeling particular groups 
using fluorescence simply provides a measure of the number of reactive sites. An 
antibody binding to a known epitope or protein binding to a known ligand indicates if the 
epitope or ligand exists at the spot, but gives no information about what side products 
may be there or in what quantity26-28. Finally, cleaving in situ-synthesized molecules from 
the microarray surface does provide a complete characterization of the synthesis. 
However, this analysis is not compatible with arrayed chemical libraries because of 
diffusion and mixing at the surface upon cleavage and sample collection.  
Here, we describe a mass spectrometry approach to fully characterize the 
composition of arrayed, in situ-synthesized peptide libraries, directly on each feature. 
Direct characterization of in situ-synthesized small-molecule microarrays has been 
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previously described29,30. These studies utilized TOF-SIMS and a custom-synthesized 
cleavable linker. In the characterization of microarrays, TOF-SIMS has significant spatial 
resolution advantages when compared to MALDI-TOF. In addition, TOF-SIMS does not 
require the application of a matrix, thereby limiting the diffusion of analyte between 
microarray features. However, TOF-SIMS is generally limited to low-mass ions, such as 
short peptides or small molecules; whereas, high molecular-weight ions can be detected 
with MALDI-TOF31. The high-mass range of TOF-SIMS can be extended with the 
application of a matrix, similar to that used with MALDI-TOF31. However, the 
application of a matrix confounds the advantage of limited diffusion offered by matrix-
free TOF-SIMS. Also, the hard ionization technique on which TOF-SIMS is based 
produces unwanted fragmentation of analyte molecules. Therefore, although TOF-SIMS 
would likely offer higher spatial resolution than MALDI-TOF, analyte fragmentation 
represents the definitive limitation.  
In the approach described below, microarrays containing various peptide 
sequences, attached to surfaces via commercially-available cleavable linkers, are 
synthesized in situ using electrochemically-patterned synthesis. The resulting features are 
then cleaved and the MALDI matrix is applied in such a way as to limit analyte diffusion. 
After applying the MALDI matrix, the chemical composition of each feature is analyzed 
using MALDI-TOF mass spectrometry directly on the feature. Though MALDI-TOF was 
used to demonstrate the approach in this work, TOF-SIMS could also presumably be 
used, in conjunction with the MALDI matrix to obtain in situ mass spectra from the 
peptide array features32.  
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Results and Discussion 
To demonstrate the generality of this approach in characterizing in situ-
synthesized microarrays on different platforms, both electrochemically- and 
photolithographically-synthesized peptide microarrays have been tested. Electrochemical 
in situ synthesis utilizes electrochemically-generated acids to remove acid-labile 
protecting groups and addressable electrodes to produce distinct microarray features12 
whereas, photolithographic in situ synthesis utilizes photolabile protecting groups and 
masks to selectively deprotect features on a microarray2. In these experiments, 
microarray feature dimensions were limited to several hundred micrometers to 
demonstrate the approach. Here, we focus solely on the characterization of 
electrochemical in situ synthesis, since the photolithographic in situ synthesis 
characterization work was conducted by another graduate student of the Woodbury Lab. 
Direct MALDI-MS Characterization of Electrochemically-Synthesized Peptide 
Microarrays 
Electrochemical peptide microarray synthesis was performed using a mixed 
protecting group approach on 12K CombiMatrix (CBMX) chips sold by CombiMatrix 
Corp., Mukilteo, WA. This strategy utilized base-labile/acid-labile (FMOC/trityl) 
protecting groups (Figure 1). This strategy allowed for the use of commercially available 
amino acids with amino groups protected by FMOC at positions in the peptide that were 
constant across the array and highly acid-labile trityl groups at variable positions in the 
peptide. Using a very acid-labile protecting group, such as trityl, allowed for deprotection 
with electrochemically-generated acids at low applied electrode potentials.   
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FIGURE 1: Scheme of electrochemically directed peptide synthesis on CBMX chips.  
 
For this work, a cleavable linker to the electrode surface was needed for release of 
the peptide at the end of the synthesis for MALDI-TOF analysis. Because the 
electrochemical peptide array synthesis generates acid at each electrode surface, the acid-
cleavable Rink linker could not be used. Instead, an orthogonal linker strategy was used 
to attach peptides to the electrode surface. Use of HMBA linker (base-labile) did not 
prove to be a successful strategy for MALDI-based synthesis characterization due to the 
required application of strong basic conditions for removal of the linker after synthesis. 
The strong basic conditions deteriorated the electrode surfaces and clean removal of the 
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peptide was not possible (no peaks were observed in the appropriate mass range). Instead, 
a photolabile linker (4-{4-[1-(9-Fluorenylmethyloxycarbonyl)ethyl]-2-methoxy-5-
nitrophenoxy}butanoic acid, (Fmoc-Photolabile linker-OH, Cat # RT1095, Advanced 
Chemtech) was used and proved to be beneficial in several ways; (a) the linker could be 
cleaved by UV exposure without damaging the slide or the synthesized molecule and (b) 
UV cleavage could be done under dry conditions. UV cleavage under dry conditions gave 
the flexibility to characterize the synthesis directly from the chip surface and made the 
protocol simpler because there was no need to purify samples collected after cleavage.  
Initially, synthesized peptides were labeled with TMPP [(N-
Succinimidyloxycarbonylmethyl)tris(2,4,6-trimethoxyphenyl)phosphonium bromide] on 
the N-terminus in order to improve their ionization ability in the mass spectrometer 
(Figure 2)33. Later, we successfully tested peptides without TMPP labels. During 
synthesis optimization experiments, we observed that peptide sequences containing lysine 
possessed improved ionization ability due to facile positive charge formation associated 
with lysine. Peptides that did not contain lysine, still resulted in MALDI peaks, but 
sodium and potassium adducts dominated.   
An electrochemical array of four peptides of different lengths; KAFGAFGAFG, 
K(G)AFGAFGAFG, K(FG)AFGAFGAFG, and K(AFG)AFGAFGAFG; was 
synthesized. The residues in parentheses were added electrochemically; all other amino 
acids were coupled using FMOC chemistry. To simplify the task of visualizing array 
features during MALDI-MS analysis, the array was synthesized as a collection of several, 
individual, neighboring electrodes. For MALDI-TOF analysis, the chip was divided in 
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four regions and each peptide was synthesized in a quarter of the chip. Schematic 
diagram of the experiment can be seen in Figure 3 and the corresponding MALDI 
analysis in Figure 4.  
After array synthesis, the dry chip was irradiated with UV light to cleave the 
peptides from the surface without diffusion. The MALDI matrix was applied to the 
surface as small drops with a pipette, and the chip (75 mm X 25 mm dimensions) was 
mounted in the MALDI target plate and then analyzed with MALDI-MS. Surface 
charging during MALDI spectrum acquisition was not a problem because of the 
conductive nature of the electrochemical chip. The resulting spectra (Figure 4) from each 
array feature shows the desired peptide as a dominant peak along with several side-
product peaks. A second electrochemical array using the same array layout but with 
modified peptide sequences produced a similar result (Figure 5).  
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FIGURE 2: MALDI-TOF characterization of Tmpp labeled peptide: Tmpp-FGKFGFG-
CONH2 using Photolabile linker. Peaks in the spectrum correspond to the peptide, 
peptide with deletion of certain amino acids, and an internal calibration peptide. The 
sysnthesis was performed using Fmoc chemistry.  
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FIGURE 3: Schematic diagram of an electrochemical array of four peptides. Each region 
is made up of a quarter of 12K electrodes present on the chip. Letters in parentheses 
denote electrochemical synthesis of corresponding amino acid. 
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FIGURE 4: MALDI-MS characterization of three peptide features with 1, 2 or 3   
electrochemical steps (in parentheses below). Feature 1 was synthesized using FMOC 
chemistry.  
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FIGURE 5: MALDI-MS characterization of three peptide features with 1, 2 or 3 
electrochemical steps (in parentheses below). Feature 1 was synthesized using FMOC 
chemistry only. Sequences of the peptides synthesized are: 1) KGAFGAFGAFG, 2) 
K(G)GAFGAFGAFG, 3) K(GG)GAFGAFGAFG, 4) K(GGG)GAFGAFGAFG. Desired 
product peak mass is noted in each spectrum.  
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The photolabile linker became unavailable at one point during the experimental 
process. Therefore, another photolabile linker (ANP linker) was successfully adapted for 
use in MALDI characterization of synthesis products (Figure 6). This ANP linker is also 
UV-cleavable and is readily available from several vendors. In addition, MALDI 
characterization of synthesis using TFA vapor cleavage of acid-labile linker (Rink linker) 
was also optimized (Figure 7). Though the use of acid-labile linker did not provide an 
orthogonal system for electrochemically-patterned synthesis, several optimization 
experiments were performed which did not require any electrochemical steps. These 
experiments tested the synthesis efficiency of difficult peptide sequences on the CBMX 
chips. Rink linker, an acid-labile linker, was used for these experiments. The linker was 
cleaved by overnight exposure to TFA vapor. 
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FIGURE 6: MALDI-MS characterization of peptide (NH2-KFGKFGKFG-CONH2) 
synthesized on ANP linker.  
  
940.0 967.6 995.2 1022.8 1050.4 1078.0
Mass (m/z)
2549.1
0
10
20
30
40
50
60
70
80
90
100
%
 I
n
te
n
s
it
y
Voyager Spec #1=>MC[BP = 184.1, 60571]
957.5738
1014.5966
Peptide w/o gly 
 Peptide 
 Peptide + Na
+ 
 
Peptide + K+ 
 
Peptide w/o gly +  Na+ 
Peptide w/o gly + K+ 
63 
 
 
FIGURE 7: MALDI-MS characterization of a peptide synthesized on Rink linker. 
Materials and Methods 
Electrochemical Array Synthesis 
Peptide synthesis was performed on 12,500 electrode (12K) Semiconductor 
microchips (CBMX Corporation, Mukilteo, WA). Chip fabrication and its surface 
morphology has been described in detail in Chapter 1. Briefly, the 12K semiconductor 
microchip has 12,500 individually-addressable, circular, porous polymer-coated platinum 
electrodes fabricated in rows and columns on silicon substrate. Electrodes contain either a 
20-nucleotidepoly-T-spacer or 2-nucleotidepoly-T-spacer with an amine-modified 
terminal thymidine protected by monomethoxy trityl group. In all syntheses, an FMOC-
protected photolabile linker (Advanced Chemtech, Louisville, KY) was coupled as the C-
terminal residue. Amino acid residues that are constant in all peptides in the array were 
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coupled and deprotected using standard FMOC synthesis protocols and commercially 
available FMOC-protected amino acids from either NovaBiochem (Affiliate of Merck, 
Darmstadt, Germany) or Anaspec (San Jose, CA). Variable amino acid residues were 
coupled and deprotected using electrochemically-directed peptide synthesis. Briefly, 
during variable amino acid coupling, the Fmoc group from N-terminal amines is 
deprotected and replaced chemically with a trityl group. Later, trityl groups from selected 
electrodes are deprotected by spatially controlled electro-generated acid and finally, the 
variable amino acid is coupled to the addressed electrodes. The following modifications 
to the described electrochemically-directed protocol were made: First, the localized 
generation of acids from 1,2-diphenylhydrazine (Sigma-Aldrich, Milwaukee, WI) by 
application of voltage to the addressed electrodes was conducted on 12K chips instead of 
a 1K chip. Second, voltage and time conditions for the electrochemical generation of 
acids were optimized to 3V and 10 min. for 12K chips. 
Acid based chemical deprotection 
t-butyl groups were chemically deprotected using a cocktail of 94% TFA (Sigma-
Aldrich, St. Louis, MO) + 2.5% triisopropylsilane (TIS) (Sigma-Aldrich, Milwaukee, 
WI) + 3.5% water. The wafer was placed in an acid-resistant chamber and exposed to the 
deprotection cocktail for thirty minutes. At regular time intervals the setup was shaken 
for a better reaction. After thirty minutes, the solution was discarded in acid waste and 
the reaction setup was rinsed 5x with dichloromethane, 5x with 5%DIEA in 
dichloromethane, 3x with DMF, and 5x with water. The chip was then dried with argon 
gas. 
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Non-Diffusional UV-Cleavage of Arrayed Peptides 
After synthesis, the chip was rinsed with N,Nʹ-dimethylformamide (Sigma-
Aldrich, Milwaukee, WI) for 6 minutes, with acetonitrile (Sigma-Aldrich, Milwaukee, 
WI) for 10 minutes, then dried with argon gas. Dry UV cleavage of the photolabile linker 
was carried out by exposing the chip with active surface area of 25 mm2 to 7 mw of 365 
nm UV irradiation for 3 hours. UV light was generated by inserting a U-360 1″ bandpass 
filter (Edmund Optics Inc., Barrington, NJ) in front of the fiber optic cable from a white 
light source (Fiber-lite MH-100, Dollan-Jenner Ind., Boxborough, MA). 
Non-Diffusional TFA Vapor based Cleavage of Arrayed Peptides 
To prevent diffusion across the array, peptides were cleaved from the surface of 
the electrode in a dry state, using acid vapor cleavage. An array substrate containing the 
synthesized peptides was placed in a small glass vacuum chamber, evacuated by vacuum 
and sealed. A corked 100 mL Buchner flask containing 15 mL of neat trifluoroacetic acid 
(TFA) (Sigma-Aldrich, St. Louis, MO) was connected to the evacuated vacuum chamber 
containing the microarray substrate via a tube, thereby connecting the side-vent of the 
flask to the vacuum chamber inlet port. Once connected, the evacuated vacuum chamber 
inlet valve was opened, allowing gas flow between the Buchner flask and the vacuum 
chamber. The low-pressure of this system causes rapid evaporation of the neat TFA, 
forming a saturated TFA vapor in both the vacuum chamber and the Buchner flask. The 
microarray substrate was exposed to the TFA vapor for 2 hours, which was sufficient for 
nearly complete cleavage of Rink-linked peptide from the array substrate as well as 
complete cleavage of acid-labile side-chain protecting groups. 
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MALDI Matrix Application and Characterization of Array Features 
CombiMatrix chips with cleaved peptides were characterized with either an 
ultraflex III MALDI-TOF-TOF (Bruker, Billerica, MA) or a Voyager-DE STR MALDI-
TOF (Applied Biosystems, Foster City, CA). For characterization with the ultraflex III 
TOF-TOF MALDI, microarray substrates containing cleaved peptides and crystallized 
MALDI matrix were mounted in a Bruker (Billerica, MA) MTP Slide-Adapter, which 
holds up to two 75 X 25 mm substrates for MALDI Imaging. Calibration was performed 
by spotting peptide calibration standard II (Bruker, Billerica, MA) and MALDI matrix at 
the array corners to provide a close external standard. Final MALDI Spectra were 
acquired as an average of ~300 individual spectra at 25 Hz laser shot frequency and 40% 
laser power on an ultraflex III TOF-TOF (Bruker, Billerica, MA). MALDI spectra were 
analyzed using FlexAnalysis (Bruker, Billerica, MA). For characterization with Voyager-
DE STR MALDI-TOF, a custom MALDI target plate was used to mount the chip and α-
cyano-4- hydroxycinnamic acid (Sigma-Aldrich, St. Louis, MO) MALDI matrix was 
prepared in 1:1 acetonitrile:H2O with 0.1% trifluoroacetic acid and an internal calibrant 
peptide mixture containing des-Arg1-Bradykinin peptide (904.47Da), Angiotensin1 
peptide (1296.66Da), and Glu1-Fibrinopeptide B peptide (1570.68Da), all purchased 
from Applied Biosystems (Foster city, CA). Stock peptide calibrant was diluted 20x with 
saturated MALDI matrix solution and spotted on the chip surface with a pipette. MALDI 
spectra were analyzed using FlexAnalysis (Bruker, Billerica, MA) or Data Explorer 
(Applied Biosystems, Foster city, CA).  
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Conclusion 
We have developed a simple, accurate, and general MALDI-MS based approach 
to characterize the chemical composition of an in situ-synthesized microarray directly on 
array features. As demonstrated, this approach has sufficient sensitivity to characterize 
array features synthesized on 2D surfaces, in this case, a carbohydrate matrix on an 
electrode. This approach provides significantly more information about microarray spot 
composition than can be gained from traditional approaches, such as fluorescence and 
antibody binding. In addition to the in situ determination of amino acid composition, with 
MALDI-TOF-TOF (MS-MS), it is likely possible to obtain peptide sequence information 
directly from the microarray feature. We recognize that this approach, as described, has 
spatial limitations that make it difficult to analyze array features that are less than 100 μm 
in diameter. The two most significant factors limiting the spatial resolution of this work 
are the limit to which the MALDI laser can be focused and the limited precision in 
positioning the array features inline with the laser. Improvements in either of these 
limiting factors would significantly reduce the array feature sizes that can be analyzed 
with MALDI-TOF. Array spatial resolutions as small as 25 μm may be possible, as has 
already been demonstrated in tissue imaging34. 
Another limitation we need to address is the successful MALDI-TOF 
characterization of large-scale arrays. We have been manually spotting MALDI matrix, 
through pipetting, which covers an area of approximately 750 µm X 750 µm. This area is 
large enough to cover several substrate features. Therefore, the peptide profiles of several 
different features covered in the spotted area appear in the MALDI spectrum, making it 
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complicated to discriminate between them. To overcome this problem, we attempted to 
apply a matrix aerosol using an air brush. However, manual handling of the air brush did 
not result in an even application of the tiny matrix droplets that we were hoping would 
only cover single features at a time. There are precise instruments available which apply 
matrix aerosols to tissue samples but these instruments were unavailable for this study. 
Another approach is to synthesize a subset of peptides (approximately ten) in the region 
covered by the pipetted matrix. The MALDI spectrum of a particular spot would then 
consist of ten peptides whose analysis will be straightforward and easier to interpret. 
Using this method, a small array could be characterized (about 10% of a 1K array), 
though large-scale characterization is not possible with this strategy. 
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Chapter 4 
Optimization of Electrochemically-Directed Peptide Microarray Synthesis 
Abstract 
Technologies enabling the creation of large-scale, miniaturized, spatially 
addressable peptide microarrays are emerging. The focus of this chapter is on the 
synthesis optimization of peptide microarrays; specifically, the electrochemically-
directed parallel synthesis of individually addressable high-density peptide microarrays 
using the electrochemical patterning platform described in previous chapters developed 
by CBMX 1. Synthesis concepts are discussed, with emphasis placed on the reactions of 
electrogenerated acids in the deprotection step of peptide synthesis. Peptide microarrays 
potentially represent a versatile tool for probing antigen-antibody, peptide-protein, and   
peptide-ligand interactions and may prove to be a powerful tool for proteomics research 
and clinical diagnosis applications. 
Introduction 
Microarray technology has become a powerful research means in proteomics and 
genomics studies1,2. Microarrays are used to explore chemical spaces such as 
oligonucleotides, peptides, peptidomimetics, proteins, and small molecules for functional 
activity. This includes binding interactions with proteins, catalytic activity, and fitness as 
enzyme substrate. Microarray based assays involve probing several molecular 
interactions, concurrently on a single platform, at resolutions high enough to discriminate 
between single building blocks at specific positions. DNA Microarrays with probe 
numbers in millions and Peptide Microarrays with probe numbers in tens of thousands 
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are commercially available now3,4. Microarrays have become one of the leading 
platforms used in high-throughput experimentation and data acquisition. Although, only 
DNA and peptides have been explored at a high density, microarrays in principle enjoy 
the advantage of incorporating a varied range of synthetic building blocks when 
compared to other library generating techniques5-9. 
Proteins experience a much more diverse set of chemical interactions, as 
compared to DNA and RNA, since there are twenty different naturally occurring amino 
acids that may comprise proteins versus four nucleotide species that are found in nucleic 
acids. Proteins perform a vast array of functions for e.g., catalysis, regulation, inhibition, 
signaling, etc. They are therefore identified as important biomolecules for several 
research applications, such as therapeutic targets for several diseases, targets for drug 
discovery, models for artificial catalyst development, biomarkers for medical diagnosis, 
etc. Many of the biological interactions are based on the interaction of a protein with 
another protein10. One way to gain a deeper insight into protein-protein interactions is to 
restrict study to protein-peptide interactions, as protein interaction is sometimes only with 
a small continuous (linear) or discontinuous (conformational) region of its partner 
protein. For example, in the immune system, antibodies (protein) interact with a small 
portion of antigen (commonly protein) called epitope. Accordingly, it is desirable to 
fabricate peptide microarrays capable of probing interactions of several peptides with a 
binding protein. These peptide microarrays must be produced at a fast pace and at low 
cost. They must be reproducible, possess high sensitivity and a large dynamic detection 
range, and they should be stable for long-term storage. 
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Peptide microarray fabrication technologies fall into two broad categories; (i) 
direct deposition of presynthesized peptides on surfaces and (ii) parallel in situ synthesis 
of peptides on surfaces. We focused on parallel in situ synthesis of peptides on surfaces. 
The main aim of the research in our lab is to understand chemical spaces. We fabricate 
large arrays of heteropolymers, such as peptides, on surfaces by in situ synthesis utilizing 
technologies developed in the electronics industry. 
Peptide Microarray Synthesis Techniques 
Several techniques have been devised for peptide microarray synthesis. A survey 
of some of the important techniques is described below.   
 SPOT peptide synthesis. This technique was developed by Ronald Frank10. 
It involves spotting liquefied amino acids on a nitrocellulose substrate using a hollow 
needle. The working principle of the SPOT synthesis technique involves spotting of 
amino acid dissolved in a solvent on the substrate. This is done using a print head with a 
hollow needle placed relative to the substrate. The synthesis reaction takes place as soon 
as the drop contacts the surface. The peptide density on a feature using this technique is 
quite high, but the feature density (roughly 25 features per cm2) is quite low. Smaller 
features involve smaller droplets, which tend to evaporate. This limits the feature density.   
Photolithography based peptide synthesis. It was developed by Fodor in 
199111. In this technique light is irradiated through a real or virtual photomask to 
deprotect N-terminal protecting groups. The N-terminal amino groups can be protected 
with photo-labile protecting groups (PLPGs) or acid-labile protecting groups. The real 
and virtual mask approaches can be employed to shine light on selected features in order 
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to deprotect the protecting groups. PLPGs are directly deprotected upon irradiation, and 
acid-labile groups are deprotected by localized generation of acids upon light irradiation 
on selected features11,12. This method has proved to be very successful in DNA 
microarray fabrication, and in the past few years large peptide microarrays also have been 
fabricated successfully. A few limitations are (1) PLPG protected amino acids are not 
readily available and are not simple to prepare in-house and (2) diffraction and scattering 
during light irradiation can lead to insertion of unwanted amino acids at neighboring 
silent features.  
Particle-based peptide synthesis. It was developed by Frank Breitling and has 
proved to be very successful in fabricating large peptide microarrays13,14. In this 
technique, different particles embedding different activated amino acid (-OPfp ester of 
amino acid) are deposited using a laser printer on a substrate (usually glass or silicon) 
functionalized with amino groups. Once the particles are deposited, they are melted so 
that the activated amino acids diffuse and couple with the free amino groups of the 
substrate. The excess particles are then washed away and the unreacted amino groups of 
the substrate are blocked using acetic anhydride. The Fmoc group is then deprotected, 
and the surface is ready for the next coupling cycle. Particles with different amino acids 
are then patterned on the surface through laser printing for the next round of the coupling 
cycle. 
Electrochemical Synthesis of Peptide Microarrays 
Another conceptually interesting method of in situ peptide microarray synthesis 
for producing high density peptide chips is electrochemical parallel synthesis using acid 
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labile protected amino acids as building blocks. This method was first reported by Maurer 
et al. in 200515. An electrochemically generated acid (EGA) was used for the removal of 
the BOC protecting group at selected positions on an electronically addressable array. 
The substrate used was a CBMX chip, which is a semiconductor silicon surface with 
1024 individually electronically addressable platinum microelectrodes15. The platinum 
electrode surface is overlaid with a three-dimensional polymer matrix on which is 
synthesized a DNA oligomer. A successful electrochemical synthesis of a pentapeptide, 
N-terminal sequence of endorphin (YGGFL), was performed on top of the DNA 
oligomer and its characterization by fluorescence was demonstrated. 
The CBMX chips were developed by CombiMatrix Corp. in Seattle, Washington. 
These chips have been primarily used for the generation of DNA microarrays16,17. The 
CBMX chips, by virtue of possessing electronically addressable arrays of electrodes, 
have an additional capability of conducting redox assays on microarrays compared to 
other surfaces. The peptide synthesis demonstrated by Maurer et al. on CBMX chips did 
not involve any complications due to side chain chemistry of amino acids. This is 
because all of the amino acids of the pentapeptide (YGGFL) synthesized did not require 
any side chain protection groups. One of the major factors that contributes to making 
peptide synthesis a difficult synthetic process is the stability of the orthogonal protecting 
groups during peptide synthesis. Also, synthesis of only a single peptide was 
demonstrated on the CBMX chip surface as a proof of the concept. We decided to take 
this work further and optimize the CBMX chips (next generation CBMX chips which 
have 12,544 platinum electrodes present on the silicon surface were used) for peptide 
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microarray synthesis. We focused on various aspects of peptide microarray synthesis on 
CBMX chips. Most notably the  (i) generation and use of an electrochemically generated 
acid (EGA) for the removal of acid labile protecting groups from selected positions of an 
electronically addressable CBMX chip and (ii) the synthesis of peptide microarrays with 
the optimized EGA system.  
The MALDI detection method described in the previous chapter was used to 
characterize the chemical composition of arrayed, in situ synthesized peptide libraries. 
Results and Discussion 
General Synthesis Scheme 
Our method of fabrication of peptide microarrays is based on three components: 
(i) CBMX’s CMOS array technology, (ii) electro-generated acid precursors (EGA-P), and 
(iii) automated solid phase peptide synthesis. The fabrication of peptide and other 
biopolymer microarrays requires a gating step in every synthesis cycle so that the 
biopolymer sequence generation can be spatially controlled. Such synthesis cycles, 
involving a gating step, when executed multiple times, results in fabrication of a 
microarray with a large sequence diversity of biopolymer (in our case, microarray of 
12,544 peptides, peptidomimetics, and other biopolymers can be fabricated) (Scheme 1 in 
Chapter 3). In our method we accomplish gating by generating acid from an electro-
generated acid precursor (EGA-P) molecule. Upon application of electric potential to the 
addressed electrodes, the EGA-P undergoes an electrolytic reaction to generate acid 
(EGA), which deprotects the terminal amino group present on the chip surface. The EGA 
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replaces the use of Trifluoroacetic acid (TFA) as the deprotection reagent commonly used 
in conventional peptide synthesis. 
The synthesis is performed on a CBMX chip surface functionalized with 
monomethoxytrityl (MMT)-protected amino-linker (a 20-nucleotidepoly-T-spacer with 
an amine-modified terminal thymidine protected by MMT group), in a solvent-leak-free 
reaction chamber. A computer-generated voltage/current pattern for the application of 
potential across selected electrodes is focused to the microchip’s constituent electrodes. 
At the selectively addressed electrodes, the electrolytic reaction of EGA-P yields 
acid, which removes the Trityl (Trt) protecting group from the terminal amino group of 
the chip surface. Diffusion of acid from the selected electrode to the neighboring silent 
electrodes is prevented in three ways. Firstly, every single electrode is surrounded by a 
ring-shaped electrode called getter electrode, with opposite polarity which prevents 
protons from diffusing to the neighbor electrode. Then, each electrode is separated from 
its neighbor electrodes through passive silicon nitride layer, and finally, an EGA-P 
solution involves scavenger molecules to absorb unreacted protons and prevent diffusion. 
After every gating reaction, the reaction chamber is washed with diisopropylethylamine 
(DIEA) in dichloromethane (DCM) and N,N′-dimethylformamide (DMF). Then, a Trt-
protected monomer such as Trt-Gly-OH is coupled to deprotected amino groups. The 
unreacted amino groups are capped using Acetyl glycine (Ac-Gly-OH). We have 
observed that the capping reaction (acetylation of unreacted surface amino groups using 
acetic anhydride) does not happen on our chip surface. Therefore, the unreacted amino 
79 
 
groups are capped via an amino acid coupling reaction, where the incoming amino acid is 
acetyl glycine. 
Trt deprotection using EGA 
Trityl (Trt) protecting groups require mild acidic conditions for their deprotection 
from amino groups. Treatment with aqueous solution of 5% trifluoroacetic (TFA) acid 
for 30 minutes is enough for its deprotection. This is compared to Boc groups, which 
require 30 minutes of exposure to 50% TFA in dichloromethane (DCM), and tert-butyl (t-
bu) groups which require 30 – 90 minutes of exposure to 95% aq. TFA. We tested and 
optimized electrochemical deprotection of Trt groups during the gating step using N,N′-
diphenylhydrazine and hydroquinone systems. In this study, a modified Trt group, 
Dimethoxytrityl (DMT) group, which is even more acid labile than Trt, was also 
included. Details of the study can be found in Appendix B. 
From a MALDI based detection, Trt deprotection efficiency at 3.0V and 1 minute 
using N,N′-diphenylhydrazine as EGA-P was found to be approximately 60% per 
electrochemical deprotection step. Titration experiments were then conducted for 
improving the deprotection efficiency. Different conditions, ranging from 3.0V 1 min to 
3.0V 10 min, were tested. At 3.0V 10 min, the deprotection efficiency was approximately 
70%. From 3.0V 4min to 3.0V 10min, not much improvement in deprotection efficiency 
was observed (Figure 1). 
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FIGURE 1: MALDI-MS characterization of electrochemical removal of trityl groups 
using N,N′-diphenylhydrazine as EGA. The two MALDI spectrums correspond to 
electro-deprotection of the trityl group under two different titration conditions, (i) 3.0V 4 
min. and (ii) 3.0V 10 min. The label ‘Fmoc Peptide’ corresponds to NH2-LAGAFGAFG-
CONH2, and the label ‘Full Peptide’ corresponds to NH2-KLAGAFGAFG-CONH2, 
where K was coupled after the gating step. Not much improvement was seen from 3.0V 
4min to 3.0V 10 min. Approximately 70% of Trityl groups got electrochemically 
deprotected at 3.0V 10 min. 
81 
 
 Based on this study, it was determined that with N,N′-diphenylhydrazine as EGA-
P and at 3.0V 10 min, about 70% electrochemical deprotection efficiency of Trt could be 
achieved without any non-specific deprotection. 
Boc electrochemical deprotection efficiency study using MALDI Mass Spectrometry  
Electrochemical deprotection efficiency of boc group using EGA was tested for 
parallel synthesis on CBMX chips. Maurer et al. has reported its deprotection using EGA 
on 1K CBMX chips14. They analyzed the efficiency of the gating step by the fluorescence 
method. Using this method, percent deprotection yield appeared to be in the low nineties 
similar to what Maurer et al. has observed at 3.0V 3 min. In the meantime, we developed 
a MALDI mass spectrometry detection method of parallel syntheses on CBMX chips and 
glass slides. Similar experiments were conducted to confirm the percent deprotection 
yield, however, this time using the MALDI detection method. Surprisingly, the yields 
were not in the low nineties, and instead were in the low sixties. Various side products of 
the synthesis such as deletion peptides and truncated peptides were observed.  
Titration experiments were then planned and different deprotection conditions 
were tested. Concentration of N,N′-diphenylhydrazine, electric potential, and the duration 
of application of potential were varied. Concentrations from 250mM to 750mM, potential 
difference from 2.0V to 3.3V and duration from 1min to 4mins were tested. The 
deprotection yield did not improve significantly and remained in the low sixties. From the 
MALDI detection method it was also observed that the Boc electro-deprotection using 
EGA was inconsistent. In a few trials, Boc electrochemical deprotection could be 
observed and in others no deprotection was seen at all. Some of the experiments which 
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involved two electrochemical deprotection steps in the peptide synthesis, either showed 
one deprotection or none using EGA. Several measures were taken to produce 
consistency in the electrochemical deprotection step. For example, fresh reagents and 
fresh deprotection solution were used, and the chips were kept in an inert atmosphere 
until the completion of the synthesis. Later on, the measurements consistently started 
showing less than 10% deprotection of Boc groups per deprotection step. During this 
series of experiments, CBMX made changes in the fabrication of their chips and started 
providing upgraded chips. In the earlier version of the chips, a bulk electrode of the 
electro-synthesis instrument was employed as a common counter electrode, whereas, in 
the upgraded version, a grid present within the chip can be employed as a counter 
electrode. It is possible that the changes made in chip fabrication resulted in consistent 
results of less than 10% deprotection of Boc groups.  
One of the possible explanations for consistent stability of Boc groups seen during 
N,N′-diphenylhydrazine based gating step with the upgraded version of the 
instrumentation could be due to the ability of platinum to absorb large amounts of 
hydrogen. Microelectrodes involve fast mass transport of the electroactive species 
whereas the distance between the microelectrode and the grid counter electrode is 
extremely small. As a result, reduction of protons at the counter electrode to dihydrogen 
and its absorption by the platinum surface may become a competing reaction to the acidic 
reduction of the Boc groups at the anode. The changes in the chip fabrication may have 
made this phenomenon more prominent and hence Boc groups, which require stronger 
acidic conditions for deprotection via acidic reduction, could no longer be removed. 
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Stability of CBMX Chips to Strong Acids 
Stability of CBMX chips to several acidic conditions was tested in order to 
optimize the side-chain deprotection conditions for in situ peptide synthesis. The general 
synthesis scheme on CBMX chips involves use of amino acids protected by acid-labile 
groups. The side-chains of such amino acids are usually protected with groups which are 
acid-labile under more stringent conditions. Some of the these common side-chain 
protecting groups are Pbf (2,2,4,6,7-pentamethyldihydrbenzofuran-5-sulfonyl), Cbz 
(carboxybenzyl), Bn (benzyl), Bz (benzoyl), and t-butyl groups. Of these groups, Pbf, 
Cbz, Bn, and Bz require use of superacids for deprotection and t-butyl groups require use 
of highly concentrated TFA. In comparison, Boc and trityl groups can be removed using 
relatively weak acidic conditions, such as 50% TFA in DCM and 1% TFA in DCM 
respectively.  
In order to determine the stability of CBMX chips to strong acids, the chip functionalized 
with MMT protected amines was used. The bottom one-third of the chip was 
electrochemically deprotected and 5(6)-carboxy fluorescein dye was coupled.  
Fluorescence imaging of the chip was then carried out. The chip was then exposed to 
95% TFA for 30 min and imaged using a fluorescence scanner. The fluorescence signals 
from the bottom one-third of the chip reduced, but the chip showed no signs of damage.  
The middle portion of the chip was then electrochemically deprotected, labeled with 5(6)-
carboxy fluorescein dye and imaged for fluorescence. It was then exposed to 95% TFA 
for another 30 min, rinsed, and imaged. This time the chip showed signs of deterioration 
indicating that the chip remains stable to 95% TFA for 30 min, but not for a 60 min time 
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interval (Figure 2). In a similar experiment, the chip was exposed to trifluoromethane 
sulfonic acid. The chip did not withstand this treatment for the first 30 min time interval, 
indicating its susceptibility to superacids. 
The stability of CBMX chips to 95% TFA for 30 mins proved to be sufficient for 
acid based chemical deprotection of t-butyl groups. 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: Fluorescence characterization of stability of CBMX chips to trifluoroacetic 
acid. A selected region of the chip was electrochemically deprotected and 5(6)-carboxy 
Fluorescein (fluorophore) was coupled to the free amines generated. Image (2a) is a 
fluorescence scanning image of the selected region after fluorophore coupling to the 
(2a) (2b) 
(2d) 
(2c) 
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electrochemically-deprotected region. Image (2b) is a fluorescence scanning image of the 
selected region after 30 min of exposure to 95% TFA and 5% H2O. Image (2c) is a 
fluorescence scanning image of the chip after fluorophore coupling to the 
electrochemically-deprotected middle region of the chip. Image (2d) is a fluorescence 
scanning image after an additional 30 min of exposure to 95% TFA and 5% H2O. 
The above observations, (1) consistent stability of Boc groups towards N,N′-
diphenylhydrazine system during the gating step, across many experiments with 
upgraded chips, and (2)  stability of chips to 95% TFA for 60 mins exposure enabled the 
development of an orthogonal system, where the primary amine groups protected with trt 
could be deprotected using EGA, keeping the sidechain protecting groups (boc and t-bu) 
intact. The boc and t-bu groups can later be chemically deprotected without deteriorating 
the chip as it was observed in an experiment where t-bu groups got deprotected in near 
stoichiometric ratio upon treatment of the chip with 94% TFA for 30 min. Earlier, it was 
difficult to develop an orthogonal system when Boc was employed as primary amine 
protecting group. This was due to the inability of the chips to sustain superacid conditions 
required for deprotection of side chain groups. 
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FIGURE 3: MALDI-MS characterization of chemical deprotection efficiency of t-butyl 
groups using TFA. A peptide NH2-YAGFGFGAFG-CONH2 was synthesized by Fmoc 
chemistry. The t-butyl group of Tyrosine was chemically deprotected using 94% TFA+ 
5%H2O+1%TIS for 30 minutes. The deprotection was complete as can be seen from the 
MALDI spectrum. 
Capping Reaction Efficiency 
In conventional peptide synthesis, after every coupling step a capping reaction is 
executed. This is done in order to cap the unreacted amines which did not participate in 
coupling step. These amines get capped with an acetyl group, and do not participate in 
further coupling steps. The capping reaction involves acetylation of free amines. The 
acetylation reaction is generally conducted using about 40 fold excess acetic anhydride 
and an organic base, such as pyridine or diisopropylethylamine. The duration of the step 
NH
2
-YAGFGFGAFG-CONH
2 
(992.45D)  
NH
2
-YAGFGFGAFG-CONH
2 
 + Na
+  
              (1012.45D)  
NH
2
-YAGFGFGAFG-CONH
2
 +K
+ 
       (1028.45D) 
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is around 30 minutes. Although capping steps were included during syntheses, MALDI 
spectra truncated and deleted peptides with uncapped N-terminal amino group were often 
observed. One possible reason for the failure of a capping reaction could be the 
hydrolysis of the acetamide bond upon repeated exposure of the chip to EGA-P solution 
containing N,N′-diphenylhydrazine. Hydrazine can hydrolyze an acetamide bond, 
although it normally requires approximately 70°C and 1-12 h for this reaction to reach 
completion. Possibly, the platinum surface and /or voltage application on the chip 
facilitated the reaction. As a result, N-acetyl glycine was coupled after each coupling 
step. The coupling of N-acetyl glycine to the N-terminal of the peptide was done using a 
regular HBTU-based coupling reaction. The efficiency of N-acetyl glycine coupling was 
found to be nearly stoichiometric, similar to any other amino acid coupling in 
conventional Fmoc synthesis Figure 4. 
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FIGURE 4: MALDI-MS characterization of capping reaction efficiency. A peptide N-Ac-
GFAGFAGFAGAGAG-CONH2 (peptide) was synthesized using Fmoc chemistry. The 
final amino acid coupled was N-acetyl glycine. The coupling efficiency of N-acetyl glycine 
was similar to coupling efficiency of any other amino acid in conventional Fmoc synthesis. 
Peptide Synthesis with Three Electrochemical Deprotection Steps 
Having developed an orthogonal system, in which the Trt from primary amine 
groups can be deprotected at the gating step with a 70% stepwise yield without 
deprotecting side-chain groups (boc and t-bu) considerably (less than 10%), we moved 
ahead to optimize peptide library synthesis with these capabilities. We aimed to 
Peptide + Na
+
 
Peptide w/o gly + Na
+
 
Peptide w/o + K
+
 
Peptide + K
+
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synthesize a peptide including three gating steps. The MALDI detection method 
discussed in Chapter 3 was convenient for optimizing the chemistry. A peptide sequence, 
NH2-KAFGAFGAFG-CONH2, was synthesized in which the first six coupling steps were 
performed using conventional Fmoc chemistry, and next three coupling steps involved 
electrochemical deprotection. Final coupling of lysine was done using Fmoc chemistry. 
Lysine was coupled in the final step to make the peptide protonable via its side chain 
amine group for MALDI detection. Only charged molecules can be detected by MALDI 
mass spectrometry and Lysine ɛ-amino group is highly protonable (pKa = 10.5). The rest 
of the peptide sequence does not have strong protonable groups and can only show 
sodium and potassium adducts in the MALDI spectrum, which can be difficult to 
analyze. Amino acids used in the synthesis were Fmoc protected. For electrochemical 
removal of Trt groups, first the Trt was introduced by deprotecting Fmoc and coupling 
Trt in its place using Trt-Cl. Electrochemical deprotection involved N,N′-
diphenlyhydrazine as EGA-P and application of 3.0V for 10 minutes. The chip was 
divided into four sections: a control region involving no electrochemical step, a region 
involving one electrochemical step, a region involving two electrochemical steps, and a 
region involving three electrochemical steps. The MALDI spectra of the experiment 
showed that the peptide made with three electrochemical steps can be synthesized with 
approximately 42% yield. In this experiment, no capping step was involved after Trt 
protection of N-terminal amine groups using Trt-Cl. The synthesis conditions were made 
more stringent in the next experiment by involving capping via N-acetyl glycine after the 
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Trt coupling step. A similar experiment was performed, and the overall synthesis yield 
was found to be approximately 18%. 
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Figure 5: MALDI mass spectra 5a, 5b, and 5c correspond to peptide syntheses involving 
three electrochemical steps; (5a) does not involve capping step, Trt-cl used for Trityl 
incorporation, (5b) involves capping step, Trt-cl used for Trityl incorporation, and (5c) 
involves capping step, Trt-Gly-OH used for Trityl incorporation. Details of the peaks 
observed in MALDI spectra 5a, 5b, and 5c can be found in Tables 1, 2, and 3 
respectively.  
 
 
 
 
 
  
892.0 973.2 1054.4 1135.6 1216.8 1298.0
Mass (m/z)
4729.8
0
10
20
30
40
50
60
70
80
90
100
%
 
I
n
t
e
n
s
i
t
y
Voyager Spec #1=>Adv BC(32,0.5,0.1)=>MC[BP = 723.4, 7742]
904.4681
905.4636
922.4287
1028.5387
1021.4741
1037.4594923.4264
1022.4789
980.4430
941.4970 1085.5652906.4619
1038.4520
900.4167
1086.5652 1142.5926995.4503942.4857
1023.4732 1079.5060998.5246 1051.5371901.4141 1199.6283940.4135 1107.5567
1164.5905966.4323 1200.6205893.0114 999.5207921.4168 1053.4855 1124.54411024.4691 1096.4954955.4641 1222.62311166.5877928.4643 992.4574898.4340
5c. 
92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  P
e
p
ti
d
e
C
h
e
m
ic
a
l 
F
o
rm
u
la
 o
f 
P
e
p
ti
d
e
P
e
p
ti
d
e
 m
/z
 P
e
a
k
%
 y
ie
ld
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
A
F
G
A
F
G
A
F
G
A
F
G
-C
O
N
H
2
1
2
4
6
.6
7
1
8
4
1
.5
9
S
o
d
iu
m
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
A
F
G
A
F
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 N
a+
1
2
6
8
.6
7
1
8
P
o
tt
as
si
um
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
A
F
G
A
F
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 K
+
1
2
8
4
.6
7
2
P
ep
tid
e 
w
ith
 t
w
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
F
G
A
F
G
A
F
G
A
F
G
-C
O
N
H
2
1
1
7
5
.6
2
5
5
8
.4
1
P
ep
tid
e 
w
ith
 o
ne
 e
le
ct
ro
ch
em
ic
al
 s
te
p
N
H
2
-K
G
A
F
G
A
F
G
A
F
G
-C
O
N
H
2
1
0
2
8
.5
3
4
3
C
o
nt
ro
l P
ep
tid
e 
(n
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
)
N
H
2
-K
A
F
G
A
F
G
A
F
G
-C
O
N
H
2
9
7
1
.5
1
1
C
al
ib
ra
tio
n 
P
ep
tid
e
9
0
4
.4
6
8
1
N
/A
T
ab
le
 1
. 
 D
et
ai
ls
 o
f 
th
e 
M
A
L
D
I 
p
ea
k
s 
o
b
se
rv
ed
 i
n
 F
ig
u
re
 5
a.
 
 
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
P
e
p
ti
d
e
C
h
e
m
ic
a
l 
F
o
rm
u
la
 o
f 
P
e
p
ti
d
e
P
e
p
ti
d
e
 m
/z
 P
e
a
k
%
 Y
ie
ld
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
1
1
9
9
.6
2
8
3
9
.4
S
o
d
iu
m
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 N
a+
1
2
2
1
.6
3
2
5
P
o
tt
as
si
um
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 K
+
1
2
3
7
.6
4
1
3
P
ep
tid
e 
w
ith
 t
w
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
1
1
4
2
.5
9
2
6
9
0
.6
S
o
d
iu
m
 o
f 
P
ep
tid
e 
w
ith
 t
w
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 N
a+
1
1
6
4
.5
9
0
5
P
o
tt
as
si
um
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 t
w
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 K
+
1
1
8
0
.5
8
8
6
P
ep
tid
e 
w
ith
 o
ne
 e
le
ct
ro
ch
em
ic
al
 s
te
p
N
H
2
-K
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
1
0
8
5
.5
6
5
2
S
o
d
iu
m
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 o
ne
 e
le
ct
ro
ch
em
ic
al
 s
te
p
N
H
2
-K
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 N
a+
1
1
0
7
.5
5
6
7
P
o
tt
as
si
um
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 o
ne
 e
le
ct
ro
ch
em
ic
al
 s
te
p
N
H
2
-K
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 K
+
1
1
2
4
.4
4
4
1
C
o
nt
ro
l P
ep
tid
e 
(n
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
)
N
H
2
-K
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
1
0
2
8
.5
3
8
7
S
o
d
iu
m
 a
d
d
uc
t 
o
f 
C
o
nt
ro
l P
ep
tid
e
N
H
2
-K
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 N
a+
1
0
5
1
.5
3
7
1
C
al
ib
ra
tio
n 
P
ep
tid
e
9
0
4
.4
6
8
1
N
/A
T
ab
le
 2
. 
 D
et
ai
ls
 o
f 
th
e 
M
A
L
D
I 
p
ea
k
s 
o
b
se
rv
ed
 i
n
 F
ig
u
re
 5
b
 
  
94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
T
ab
le
 1
b
. 
 D
et
ai
ls
 o
f 
th
e 
M
A
L
D
I 
p
ea
k
s 
o
b
se
rv
ed
 i
n
 F
ig
u
re
 5
b
 
  
P
e
p
ti
d
e
C
h
e
m
ic
a
l 
F
o
rm
u
la
 o
f 
P
e
p
ti
d
e
P
e
p
ti
d
e
 m
/z
 P
e
a
k
%
 Y
ie
ld
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
1
1
9
9
.6
2
8
4
1
7
.8
S
o
d
iu
m
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 N
a+
1
2
2
1
.6
3
2
5
P
o
tt
as
si
um
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 t
hr
ee
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 K
+
1
2
3
7
.6
4
1
3
P
ep
tid
e 
w
ith
 t
w
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
1
1
4
2
.5
9
8
8
8
2
.2
S
o
d
iu
m
 o
f 
P
ep
tid
e 
w
ith
 t
w
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 N
a+
1
1
6
4
.5
9
8
7
P
o
tt
as
si
um
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 t
w
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
s
N
H
2
-K
G
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 K
+
1
1
8
0
.5
8
8
6
P
ep
tid
e 
w
ith
 o
ne
 e
le
ct
ro
ch
em
ic
al
 s
te
p
N
H
2
-K
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
1
0
8
5
.5
6
6
2
S
o
d
iu
m
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 o
ne
 e
le
ct
ro
ch
em
ic
al
 s
te
p
N
H
2
-K
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 N
a+
1
1
0
7
.5
6
6
6
P
o
tt
as
si
um
 a
d
d
uc
t 
o
f 
P
ep
tid
e 
w
ith
 o
ne
 e
le
ct
ro
ch
em
ic
al
 s
te
p
N
H
2
-K
G
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
 +
 K
+
1
1
2
3
.5
6
8
3
C
o
nt
ro
l P
ep
tid
e 
(n
o
 e
le
ct
ro
ch
em
ic
al
 s
te
p
)
N
H
2
-K
G
A
G
A
F
G
A
F
G
-C
O
N
H
2
1
0
2
8
.5
4
0
7
C
al
ib
ra
tio
n 
P
ep
tid
e
9
0
4
.4
6
8
1
N
/A
T
ab
le
 3
. 
 D
et
ai
ls
 o
f 
th
e 
M
A
L
D
I 
p
ea
k
s 
o
b
se
rv
ed
 i
n
 F
ig
u
re
 5
c 
  
95 
 
The drop in overall percent yield from 42% to 18% after introduction of the 
capping step clearly indicated that Trt coupling using Trt-Cl was not 100% efficient. In 
related literature, the best overall yield achieved in coupling Trt to amine groups is 
approximately 80%. We emulated those conditions mentioned in the literature in our 
synthesis: 4hrs coupling with Trt-Cl in DMF. In order to improve the overall synthesis 
yield, Trt-Br and Trt-Gly were also tested instead of Trt-Cl. Overall synthesis yield with 
Trt-Br was similar to Trt-Cl, and overall synthesis yield dropped to approximately 9% 
from 18% when Trt-Gly was used instead of Trt-Cl (Figure 5). Trt-Br did not improve Trt 
coupling efficiency, even though Br is a good leaving group compared to Cl. Probably, 
the solvent involved during the step, DMF, was not optimum for maximizing the yield of 
the step. The reaction here is a unimolecular nucleophilic substitution reaction, which is 
favoured by protic solvents (the synthesizer is only compatible with a selected number of 
solvents, mostly aprotic solvents; ethanol, a protic solvent compatible with synthesizer, 
would have competed with amines of the surface as nucleophile). In contrast, here we are 
employing an aprotic solvent, N,N′-dimethylyformamide (DMF). Low efficiency with 
Trt-Gly was expected because Trt-Gly is a large hydrophobic molecule. Its reactivity in a 
polar solvent, such as DMF, as well as owing to its large size, was expected to be low 
when compared to a facile SN1 reaction using Trt-Cl.  
Test of Alternate Linkers 
Two alternate linkers, one photo-labile (ANP linker) and another acid-labile (Rink 
linker) were testd as substitute to Fmoc-PRhotolabile linker. ANP linker underwent 
efficient deprotection under similar conditions as employed for Fmoc-Photolabile linker. 
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Rink linker was deprotected using TFA acid-vapor rather than TFA acid solution in order 
to preserve the capability to characterize the peptide synthesis directly from the chip 
surface using chip MALDI mass spectrometry. Its deprotection efficiency was found to 
be similar to photolabile linkers. A discussion on this topic can be found in Results and 
Discussion section of Chapter 3. 
Peptide Synthesizer and Electro-Synthesis Instrument Integration and Other 
Instrumentation Issues 
 In order to achieve synthesis automation, Peptide Synthesizer and 
Electrosynthesis instruments were integrated using LabView software. The peptide 
synthesizer was programmed to halt during the gating step in a synthesis cycle. During 
this halt period, the electrosynthesis instrument was activated to load a chip map and 
execute the gating step. A manual chamber made of PTFE with low reaction volume 
(100µL) was fabricated for peptide synthesis. Two types of chambers that were available 
at the time had issues. Firstly, a reaction chamber of the manifold, due to greater volume 
(200µL), led to contamination of chemicals from different synthesis steps (the internal 
pressure of peptide synthesizer was not enough to push the chemicals of the chamber out 
for incoming chemicals). Second, a reaction chamber of electrosynthesis instrument had a 
low volume of 100µL, but electronic circuitry present in it would get deteriorated due to 
the seeping of chemicals during synthesis. The electrical pads present on the side of the 
chip get deteriorated upon exposure to chemicals. These pads provide electrical 
connectivity with the electrosynthesis instrument and potentiosense microarray reader. 
Therefore, a teflon based reaction chamber similar to polytetrafluoroethylene (PTFE) 
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based reaction chamber was fabricated to prevent exposure of the pads to TFA solution 
during the side-chain deprotection step. Details of the instrumentation issues are 
discussed in Appendix F. 
Materials and Methods 
Electrochemical Array Synthesis 
Peptide synthesis is performed on 12,544 electrode (12K) semiconductor 
microchips (CBMX Corporation, Seattle, WA). Chip fabrication and its surface 
morphology has been described in detail in Chapter 1. Briefly, the 12K semiconductor 
microchip has 12,544 individually addressable, circular, porous polymer-coated platinum 
electrodes fabricated in rows and columns on silicon substrate. Electrodes contain either a 
20-nucleotidepoly-T-spacer or 2-nucleotidepoly-T-spacer with an amine-modified 
terminal thymidine protected by monomethoxy trityl group. In all syntheses, an FMOC-
protected photolabile linker (Advanced Chemtech, Louisville, KY) was coupled as the C-
terminal residue. Amino acid residues that are constant in all peptides in the array were 
coupled and deprotected using standard FMOC synthesis protocols and commercially 
available FMOC-protected amino acids purchased from either EMD Biosciences 
(Darmstadt, Germany) or Anaspec (San Jose, CA). Variable amino acid residues were 
coupled and deprotected using electrochemically-directed peptide synthesis. The 
following modifications to the described electrochemically-directed protocol were made. 
First, the localized generation of acids from N,N′-diphenylhydrazine (Sigma-Aldrich, 
Milwaukee, WI) by application of voltage to the addressed electrodes was conducted on 
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12K chips instead of a 1K chip. Second, voltage and time conditions for the 
electrochemical generation of acids were optimized to 3V 10 min for 12K chips. 
MALDI Matrix Application and Characterization of Array Features 
Experimental protocol for MALDI matrix application and characterization of 
features is discussed in Chapter 3 Materials and Methods section. 
Non-Diffusional UV-Cleavage of Arrayed Peptides  
Experimental protocol for non-diffusional UV-cleavage of arrayed peptides is 
discussed in Chapter 3 Materials and Methods section. 
Non-Diffusional TFA Vapor Based Cleavage of Arrayed Peptides 
Experimental protocol for non-diffusional TFA vapor based cleavage of arrayed 
peptides is discussed in Chapter 3 Materials and Methods section. 
Preparation of N,N′-diphenylhydrazine Based EGA-P Solution 
N,N′-diphenylhydrazine (200mg, 0.1M) and 
tetrabutylammoniumhexafluorophosphate (400mg, 0.1M) were weighed and added to a 
clean Erlenmeyer flask. Then 10mL of dichloromethane was added and shaken until all 
of the solid is dissolved and forms a pale yellow solution. The flask with the solution is 
kept loosely corked so that dicholoromethane does not evaporate and alter the 
concentration of the solution. Once the electrosynthesis software is ready for the 
application of electric potential to the chip, the synthesis reaction chamber was filled with 
the solution. After the gating step, the solution is discarded and the chamber is rinsed 5x 
with dichloromethane, 3x with 5% DIEA in dichloromethane, and 5x with DMF. At this 
point, the chip is ready to undergo the coupling reaction. 
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Amino Acid Coupling Reaction 
To achieve amino acid coupling, the chip terminating with free amines is exposed 
to a mixture of amino acid (Fmoc-Gly-OH: 37 mg, 137 mM, Trt-Gly-OH: 52mg, 137 
mM), HBTU (O-benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium hexafluorophosphate, 
95 mg, 137 mM), HOBT (N-hydroxybenztriazole, 33.5 mg, 137 mM), and 
diisopropylethylamine (130.5µL, 350mM) in DMF (2mL) for 30 minutes. The chip is 
then rinsed with DMF 3x, dichloromethane 3x, and again with DMF 3x, then re-exposed 
to the coupling mixture for another 30 minutes. After repeating the washing procedure 
(with an additional ethanol rinse to remove any residual DMF or dichloromethane), the 
chip is allowed to dry. 
Trityl Coupling Reaction 
To achieve trityl coupling, the chip terminating with free amines is exposed to a 
mixture of Trt-Cl (76.4mg, 137mM), and diisopropylethylamine (130.5µL, 350mM) in 
DMF (2mL) for 2hrs. The chip is then rinsed with DMF 3x, dichloromethane 3x, and 
again with DMF 3x, then re-exposed to a fresh mixture for another 2hrs. After repeating 
the washing procedure (with an additional ethanol rinse to remove any residual DMF or 
dichloromethane), the chip is allowed to dry. 
Capping with Acetic anhydride 
The chip is first washed 3x with 20mL DMF. It is then incubated with 50% acetic 
anhydride in DMF solution for 30min. The chip is then washed 3x with DMF, 3x with 
DCM, and dried with Argon gas. 
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Dye-Labeling Protocol and Fluorescence Detection 
To achieve dye coupling, the CBMX chip terminated with free amines is exposed 
to a mixture of 5(6)-carboxy fluorescein (103.2mg, 137mM), DIC 
(diisopropylcarbodiimide, 43µL, 137mM), and HOBT (N-hydroxybenztriazole, 33.5mg, 
137mM), in 2mL of 2:1 DMF: DMSO for 60 minutes. The chip is then rinsed 3x with 
DMF, 3x with ethanol, and allowed to dry using argon gas. The chip is then removed and 
washed 3x with 1XTBST, for five minutes each. Next, the chip is washed 3x with 
ddH2O, again for five minutes each. Then the chip is scanned at a 517nm wavelength 
with 70% PMT and 100% laser. ScanArray Express HT (Perkin Elmer Wellesley, MA) 
was used for fluorescence imaging. 
Acid Based Chemical Deprotection 
(a) A cocktail of 95% TFA (Sigma-Aldrich, St. Louis, MO) + 2.5% 
triisopropylsilane (TIS) (Sigma-Aldrich, Milwaukee, WI) + 2.5% water was used for a 
stability test of the CBMX chips to TFA. The chip was placed in an acid-resistant 
chamber and exposed to the deprotection cocktail for thirty minutes. At regular time 
intervals, the setup was shaken for a better reaction. After thirty minutes, the solution was 
discarded in acid waste and the reaction setup was rinsed 5x with dichloromethane, 5x 
with 5% DIEA in dichloromethane, 3x with DMF, and 5x with water. The chip was then 
dried with argon gas.  
(b) The chip was rinsed 3x with DMF, 3x with DCM, and thoroughly dried. The 
chip was then placed in a glass cuvette and 20µL of thioanisole and 10µL of 
ethanedithiol were added. The glass cuvette was then cooled in an ice bath and 1mL of 
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TFA was added. The reaction setup was stirred for 10 minutes. Next 20µL of TFMSA 
was added slowly, drop-wise, with vigorous stirring. The reaction setup was stirred at 
room temperature for 60 minutes. The chip was then rinsed with a small amount of TFA, 
3x with DCM, 3x with DMF, and 5x with H2O followed by drying with argon gas. 
Conclusion 
In conclusion, we have optimized several aspects of peptide synthesis on 12K 
CBMX chips. Specifically, we can deprotect trityl groups per gating step with 70% 
efficiency using N,N′-diphenylhydrazine as EGA-P solution. We have optimized the 
electrosynthesis system to synthesize a peptide with three gating steps involved, with an 
overall yield of 18%. We have developed an orthogonal system for peptide microarray 
synthesis, where the primary amines are protected with trityl groups and side-chain 
groups are protected with t-butyl or Boc groups. The acid generated during the gating 
step is strong enough to remove trityl groups without affecting t-butyl or Boc groups. We 
have done careful study of stability of Trityl and Dimethoxytrityl groups upon exposure 
to N,N′-diphenylhydrazine and Hydroquinone based EGA-P solutions. We determined 
that Trityl groups are stable to N,N′-diphenylhydrazine-based EGA-P solution and have 
optimized peptide synthesis employing trityl as primary amine protecting group. We have 
optimized several aspects of peptide synthesis, such as in situ coupling of trityl groups to 
N-terminal free amines of peptides, efficiency of chemical deprotection of t-butyl groups, 
and stability of chips upon exposure to TFA for t-butyl deprotection. In addition we have 
optimized the  efficiency of the capping reaction, efficiency of alternate linkers, and 
stability of Boc groups during the gating step. Several issues related to the electro-
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synthesis instrument and peptide synthesizer were solved. These were the integration of 
both the instruments to fully automate the synthesis as well as the  fabrication of manual 
reaction chambers with low reaction volumes so that peptide synthesizer can push the 
solutions forward and avoid contamination of solutions from different steps of synthesis 
cycle. Lastly, this included the fabrication of acid resistant chambers to carry out acid-
based chemical deprotection reactions.  
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Chapter 5 
Investigation of Novel Applications of CombiMatrix Microarray Platform In 
Conjunction With MALDI Mass Spectrometry and Electrochemical Detection 
Techniques 
Abstract 
Novel applications of CBMX microarray platform were explored such as 
searching metal binding catalytic peptides to reduce overpotential associated with water 
oxidation reactions. In addition the fabrication of peptide microarrays via co-
electropolymerization of pyrrole as well as peptide derivatized with pyrrole were also 
explored. MALDI mass spectrometry and electrochemical detection techniques were used 
in the investigation of these applications. The Potentiosense microarray reader designed 
for CBMX custom arrays was used for electrochemical detection. Using this reader, 
electrochemical signals from the 12K custom microarray can be collected in 
approximately 60-second time intervals. Several parameters of the instrument have been 
studied and optimized, including its noise characteristics at high and low voltages and the  
manipulation of software to scan in different ways based on voltage, current, and chip-
map parameters. In addition, the determination of the length of the linker for optimal 
signal detection was studied and optimized. Due to the portability of the equipment, the 
absence of quenching of signals, and the capability to measure redox activity, 
electrochemical detection techniques based microarray readers have interesting potential 
applications.  
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Introduction 
Microarray-based research involves probing several molecular interactions, 
concurrently, on a single platform, at resolutions high enough to discriminate between 
single building blocks at specific positions1,2,3. It enjoys the advantage of incorporating a 
varied range of synthetic building blocks when compared to other library generating 
techniques1. Some other advantages of microarray technology are the use of a small 
amount of analyte, a fast and direct read out of the activity of the whole library, 
reproducibility of the microarray for multiple experiments, and the ability to integrate 
systems with desired features. Fluorescence detection methods4 are the most widely-
employed technique in microarray synthesis and binding analysis. In this technique a 
fluorescent dye is associated either directly or indirectly with the analyte and imaged 
using a fluorescence scanner. Fluorescence signals proportional to the strength of binding 
are observed. However, there are some drawbacks of this method. They include the  
difficulty to determine the chemical make-up of microarray synthesis products, 
possibility of influence of fluorophore in peptide-protein binding due to modification in 
surface characteristics of proteins and peptides after labeling. In addition, real-time 
binding kinetics cannot be determined, signal-to-noise ratio is sometimes difficult to 
improve, and labeling efficiency could vary, making quantification of detection error-
prone. Also, the fluorescent microarray scanner is cumbersone, delicate, expensive, and 
usually requires a separate benchtop area. In the past few years microarray analysis based 
on other detection methods have made rapid progress. Examples of this include surface 
plasmon resonance imaging (SPRi)5,6, electrochemical impedance spectroscopy (EIS)7,8, 
106 
 
and mass spectrometry (MS)9,10,11. Different detection methods bring different analytical 
capabilities, and can serve a compliment to the fluorescence detection method or to each 
other. For example, SPRi can be used to study real-time binding kinetics and MS can be 
used to directly characterize microarray synthesis and protein-peptide binding. Similarly, 
electrochemical detection methods bring unique analytical capabilities. The 
instrumentation involved in these methods is simple, portable, and less expensive.  
Conductivity, capacitance and impedance measurements have the capability to directly 
monitor the changes occurring on the electrode surfaces12,13,14,15. An added advantage 
with redox label mediated electrochemical detection method is that signals can be 
amplified, thereby making the detection highly sensitive16. 
Redox Enzyme Mediated Measurements 
One approach to redox enzyme based detection involves a three electrode 
system17. In this approach the enzyme converts a redox inactive compound to a product 
that can be oxidized at one electrode and reduced at another. In this approach, signal 
amplification is dependent on enzyme concentration. A drawback of this approach is that 
the density of electrodes on a single platform is limited, due to large number of leads 
required per electrode. Another approach involves a unique combination of a redox 
enzyme, redox substrate, and an electrode to generate an electronic signal16. With this 
method, signal amplification is independent of the concentration of the enzyme. Since the 
electrode is used to monitor signals, a three-electrode system is not required. As a result, 
the fabrication of a high density of electrodes on a single platform can be achieved. 
CBMX has developed a microarray reader, Potentiosense, which is based on this 
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approach.  It reads each electrode in a serial fashion and measures the redox activity from 
each site.     
In the CBMX electrochemical detection method, horseradish peroxidase is usually 
the redox enzyme. It oxidizes 3,3ʹ,5,5ʹ-Tetramethylbenzidine (TMB) in the presence of 
hydrogen peroxide. The oxidized product is then reduced at the microelectrode of the 
CBMX chip. Signal amplification is achieved in this method because the redox enzyme is 
capable of rapidly oxidizing TMB. The CBMX chip is placed in a chamber and exposed 
to buffers and enzyme substrate. The whole arrangement (chamber with chip and buffer) 
is then placed within the instrument’s holder and an electrical connection with the 
instrument is made. This is done through contact between the electrical pads of the chip 
and several pins of the reader. Each electrode has a capacitor associated with it, in which 
charge gets built-up during the redox process. The built-up charge, when released, results 
in a current flow which upon detection and processing, results in a digital image of the 
binding activity.  
MALDI mass spectrometry is one of the most widely-used analytical techniques 
in proteomics18,19,20. As microarray research advances toward more mature systems, it is 
important to develop protein identification and characterization techniques to meet the 
requirements of high-throughput systems. The combination of microarrays and MALDI-
MS has the potential to become a potent tool to meet this requirement9. 
MALDI-MS can provide chemical make-up information about microarray 
synthesis9 and protein-peptide interaction21. This is difficult to obtain through other 
techniques. Combining MALDI-MS and electrochemical detection techniques could offer 
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new capabilities in protein analysis. In this chapter, we investigate novel applications of 
CBMX microarray platform in conjunction with MALDI mass spectrometry and 
electrochemical detection technique. PotentioSense microarray reader, designed for 
CBMX custom arrays, was used for electrochemical detection. Specifically, microarray 
experiments were conducted to search for metal binding catalytic peptides to reduce 
overpotential associated with anodic half reaction of water splitting22,23. Experiments 
were also conducted to develop a new method of fabricating peptide microarrays using 
electro-polymerized pyrrole polymer. Before conducting these tests several parameters of 
the PotentioSense were studied and optimized. These parameters include inherent noise 
associated with the instrument during electrical measurements at high and low voltages 
and the determination of the length of linker suitable for efficient electrochemical 
detection using HRP conjugated avidin-biotin interaction. Additionally, we investigated 
the electronic communication between peptide probes and electrodes by examining redox 
behavior of Ferrocene, when it was placed at varying distances from the electrode surface 
via peptides of varying lengths. 
Overpotential associated with anodic half-reaction of water splitting: Direct 
conversion of water to molecular hydrogen and oxygen via electrolysis followed by 
regeneration of electrical power in a hydrogen fuel cell would be, in principle, an ideal 
mechanism for the generation and utilization of hydrogen24,25. However, there are a 
number of problems that still have yet to be solved. One of these problems stems from 
the fact that the conversion of water to hydrogen via electrolysis using conventional 
metal electrodes involves substantial activation energy. This  necessitates that the 
109 
 
reaction be driven by a considerably higher potential than simple thermodynamics would 
demand. This overpotential represents a significant energy loss during conversion, 
impacting the economic practicality of using hydrogen as a fuel in this way. 
The biggest part of this overpotential comes from the water-splitting reaction at 
the oxygen evolving electrode (the anode). This is because of the multi-electron nature of 
the reaction and the high energy, as well as the partially oxidized intermediates that must 
be formed in order to generate molecular oxygen and protons from water. Fortunately, 
nature has developed a catalyst, the oxygen evolving complex (OEC) of photosystem II, 
which works with almost no overpotential for this reaction22,26. The OEC contains four 
manganese atoms that have a structure and chemical environment defined by the 
surrounding protein. The manganese cluster is directly involved in the redox process and 
stabilizes the highly reactive intermediates in the oxidation of water. In recent years, a 
considerable amount has been learned about the characteristics of this complex. This 
includes the redox properties of the manganese atoms at various stages during the four 
electron oxidation of water as well as the structure of the surrounding protein at 1.9 Å 
high resolution22. 
We tested a novel combinatorial biochemical approach to develop manganese 
binding peptides for modification of the surface of the electrolysis anode used during 
hydrogen production. The design of these peptides included features of the OEC and of a 
model system developed at Arizona State University. In this design, the bacterial reaction 
centers lacking the OEC have been modified to bind and oxidize manganese27. The 
approach involves the electrochemically-mediated production of a library of manganese-
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binding peptides using a process developed in our lab, with support from researchers at 
CBMX. It involves electrochemical generation of peptide microarrays on CBMX chips. 
Each member of the library is attached to a different microelectrode on a fabricated 
surface. The current/voltage characteristics of each electrode is measured in series, using 
the PotentioSense microarray reader, looking for the peptide/Mn complexes that result in 
the lowest overpotential for water splitting. These peptide sequences will then be used as 
the initial guesses for a subsequent round of molecular evolution, etc. In principle, similar 
techniques could also be used to develop catalysts for the hydrogen evolving cathode 
(e.g., using hydrogenase as a model) or for the electrodes in hydrogen fuel cells. 
Peptide immobilization via co-electro-polymerization of pyrrole modified 
peptide (peptide-py) with pyrrole: Co-electro-polymerization of a peptide-py and 
pyrrole molecules can prove to be an alternative method of fabricating peptide 
microarrays on CBMX chips. Minehan et al. has demonstrated immobilization of 
oligonucleotides on electrodes using electro-polymerized pyrrole polymer28. Since then, 
several electro-active polymers have been studied for DNA immobilization29,30. The 
immobilized oligonucleotides were detected using fluorescence, cyclic voltammetry, and 
impedance-based detection methods. Maurer et al. and Cooper et al. have reported 
immobilization of antibodies and oligonucleotides on CBMX chips using electro-
polymerized pyrrole polymer31,32. They incubated antibodies and oligonucleotides in the 
porous pyrrole polymer, electro-deposited on the electrode surface. Several parameters, 
such as electrical conditions and pyrrole concentration, were optimized to achieve 
optimal incubation. A more pertinent study for our research has been reported by 
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scientists at Bio International. They performed co-electro-polymerization of pyrrole and 
pyrrole modified oligonucleotides on a chip possessing a set of 128 individually 
addressable microelectrodes33,34. We have investigated the possibility of immobilizing 
peptides on CBMX chips by co-electro-polymerizing Ppy with pyrrole molecules. The 
efficiency of the approach was evaluated using the PotentioSense microarray reader. 
Ferrocene as a reference molecule: The ferrocene molecule undergoes 
reversible one-electron reduction/oxidation at 0.5V vs a saturated calomel electrode. 
Substituents on the cyclopentadienyl rings of the molecule alter its redox potential either 
in a positive or negative direction. The electron-donating substituents alter it in a positive 
direction, and the electron-withdrawing substituents alter it in a negative direction. Due to 
its low redox potential and reversible nature, ferrocene is often used as reference 
molecule in electrochemistry35. The cyclopentadienyl rings coupled to the iron atom in 
the ferrocene molecule are amenable for synthetic chemistry36. This capability is 
leveraged to couple the ferrocene molecule to the electrode surface via amide bond 
formation between the carboxylic acid group of ferrocene carboxylic acid and amine 
group present on the surface. Several redox assays would require confirming that 
electronic communication between electrodes and the fabricated molecule on it is 
possible. The ferrocene molecule is an ideal external standard for this purpose due to the 
low and reversible redox potential associated with it, as well as the synthetic 
maneuverability possible with it. The redox behavior of ferrocene tagged on top of a 
peptide of a certain length, if communicates with the electrode would establish that the 
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redox activity of the probe peptides of certain lengths of a microarray could be 
investigated. 
Results and Discussion 
PotentioSense Detection Principle 
A CBMX 12K microarray consists of 12,544 individually addressable 
microelectrodes, underlying CMOS based circuitry, and thirteen electrical contact pads. 
This provides electrical connectivity to the PotentioSense microarray reader. The 
microelectrodes are made up of platinum, and are 45 microns in diameter and spaced 
from each other by 75 microns. These electrodes are coated with a bio-polymer, which 
provides a three dimensional porous milieu. Each electrode is surrounded by a circular 
ring, like a platinum electrode, which acts as counter electrode. The PotentioSense reader 
can read the electrical signals from all the electrodes in approximately 60 seconds, taking 
no more than 5 milliseconds, to read an individual electrode. The instrument is sensitive 
to electrical signals between 100 – 200,000pA, therefore, assays involving large signals 
can be measured using the instrument. A peptide probe on an electrode, chemically 
coupled to biotin at N-terminus, multiplexes with SRP-HRP fusion protein present in the 
solution. The chip, after multiplexing, is exposed to a solution containing 3,3ʹ,5,5ʹ-
tetramethylbenzidine (TMB) and hydrogen peroxide. The oxidized product of TMB 
released from HRP is reduced at the surface of the electrode. The electrochemical signal 
thus obtained is measured using the PotentioSense microarray reader.   
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Determination of the Optimal Length of Linker for Electrochemical Detection 
Initial tests were performed to verify the electrochemical detection capability on an 
array containing biotin-labeled oligos of varying lengths (purchased from CBMX for the 
purposes of testing). This array was incubated with a HRP-streptavidin fusion protein.  
HRP emits a continuous electrochemical signal. We looked at linker-length dependence of 
the electrochemical signals and found that the shorter linkers, which positioned the biotin 
within a nanometer (nm) of the surface, showed the strongest signals. It also showed that 
that the signal decreased rapidly as the linker became longer (Figure 1). The strong linker 
length dependence was surprising, given the size of the HRP-streptavidin fusion protein. 
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FIGURE 1: Electrochemical detection of synthesis by Biotin-SRP-HRP assay. Each 
number represents the length of the Poly T linker on top of which biotin was chemically 
coupled. 
Noise Characteristics of PotentioSense Instrument 
Electrical current signals were read from each electrode in the presence of TRIS 
buffer upon application of voltages ranging from 0.6V – 2.4V. The 12,544 electrodes are 
embedded on the chip in 224 rows and 56 columns. The PotentioSense instrument reads 
current values from each electrode in a serial fashion. Three kinds of noises were 
observed with the instrument. Firstly, a periodic noise; current values from the electrodes 
near the edges were greater compared to the current values from electrodes present in the 
middle of the row. Secondly, a drift in current signals; the electrodes that were read first, 
under the same measurement conditions, gave less current values compared to the 
electrodes that were read later. Lastly, with increase in applied voltage, the periodic as 
well as the drift noise increased. The abovementioned three noise characteristics can be 
seen in Figure 2. The real current values can be differentiated from the noise of the 
instrument by employing mapping strategies and performing statistical analysis. For 
example, several replicates of electrodes can be planned on different parts of the chip so 
that the noise related to drift can be corrected, and high current values from the electrodes 
present at the edges can be neglected. Such steps were taken while searching for catalytic 
peptides for a water oxidation reaction. It can be seen in Figure 2 that no such correction 
steps are required when the applied voltage is less than 1.0V during measurements. 
number of electrodes 
Current in 
µAmps 
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Therefore, assays such as one based on HRP, which requires electrodes at low potential 
(100mV) to monitor electrical signals, does not need any correction. 
 
 
 
 
 
 
 
FIGURE 2: I/V analysis of Potentiosense microarray reader. Currents from all electrodes, 
while stepping down the voltage 200mV each time. Tris Buffer was used for 
measurements. 
Ferrocene as a Reference Molecule 
Because the redox activity of ferrocene is well known, it can be used to determine 
the degree to which synthesized peptides were communicating with electrodes. It can also 
be used to differentiate the peptide signals from the instrument noise. Various ferrocene-
containing peptides were synthesized on a CBMX slide at 40% yield (Figure 3). Some 
positions on the slide contained ferrocene only. Some contained peptides that were four 
amino acids in length (NH2-Fc-GKFG-CONH2) with N-terminal ferrocenes, and some 
peptides were full-length (9 amino acids, NH2-Fc-KFGKFGKFG-CONH2) with N-
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terminal ferrocenes. Some positions on the slide contained neither ferrocene nor peptide. 
All variants occurred in replicate on regions distributed throughout the slide. We then 
measured the redox activity on the slides with a voltage sweep. Figure 4 is an I-V 
comparison of the two extremes: the full-length, ferrocene-coupled peptide versus the 
plain slide containing neither ferrocene nor peptide. In order to get a more complete 
picture, we attempted to run a piece-wise current-voltage curve for the different 
electrodes by cycling through voltages and measuring currents. A bump in the curve at 
the right oxidation potential for ferrocene was observed. This was lacking in the same 
region of the control curve, where no ferrocene was coupled. It is likely the case that 
under the conditions we were running the tests, it was not possible to achieve true 
equilibrium current/voltage relationships. The PotentioSense instrument scans the 
electrodes at fixed voltages, and the scan rates are fixed and cannot be altered. This is 
very different from the Cyclic Voltametry instrument, where the voltage sweep is 
continuous and scan rates can be varied. However, ferrocene, at least, appeared to give a 
signal, which suggested that there was some communication between the surface and the 
peptides. 
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FIGURE 3: MALDI-MS characterization of coupling of ferrocene carboxylic acid to free 
amines on CBMX chip surface. A modified peptide containing ferrocene (Fc), NH2-Fc-
KFGKFGKFG-CONH2, was synthesized and analyzed by MALDI Mass Spectrometry. 
Ferrocene was attached to the peptide through an amide bond formation reaction between 
the ferrocene carboxylic acid and the N-terminal Lysine of the peptide which was 
synthesized in situ on the chip using conventional Fmoc synthesis. 
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FIGURE 4: I/V analysis of ferrocene labeled CBMX chips. Panel (4a) represents current 
measurements at various fixed voltages corresponding to electrodes possessing full-
length, ferrocene-coupled 9-mer peptides and panel (4b) represents measurements from 
the control region.   
Search for peptide catalysts for water oxidation reaction: We (a team of members 
from Prof. Dr. Neal Woodbury, Prof. Dr. James Allen, and Prof. Dr. Trevor Thornton’s 
group) fabricated electrodes in-house to search for peptide catalysts for the anodic 
oxidation of water. Gold electrodes were functionalized with a polyindole layer via 
electropolymerization of aminated indole molecules. Peptides were attached to the gold 
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electrode through amine groups of the polyindole layer. IR analysis revealed the 
successful attachment of the aminated polyindole and the peptide derivatized polyindole 
to the gold electrode. The I/V curves of water electrolysis on bare electrodes, electrodes 
functionalized with electro-polymerized aminated polyindole, and electrodes 
functionalized with electro-polymerized polyindole-peptide all revealed that currents 
from functionalized electrodes were less in comparison to bare electrodes. This was 
expected, due somewhat to insulation caused by the polyindole layer. For the robust 
attachment of polyindole to the electrode, 2% thiolated-indole was added to an indole 
electro-polymerization solution. This improved the attachment as several runs of 
electrolysis experiments could be executed.  
Manganese binding peptides were designed by Prof. Dr. James Allen’s group to 
search for a catalyst for the anodic half-reaction of water splitting. We intended to 
emulate the metal-protein environment in OEC in our catalyst design. In OEC, metal 
atoms, a cluster of four manganese atoms and a calcium atom, coordinated with 
surrounding amino acids catalyze water oxidation reaction. In our initial round of the 
catalyst search, the peptide sequences that would bind single manganese atoms were 
designed. Sequences of some of the designed peptides for the initial round can be seen in 
Figure 5. 
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FIGURE 5: Sequences of designed peptides for initial round of catalyst search for anodic 
half-reaction of water electrolysis. 
Some of the important considerations in the design of the peptide are as follows: 
(1) The presence of proline amino acid to provide a bend in the structure of the peptide, 
(2) The presence of three metal coordinating amino acid residues in the sequence from 
Asp, Glu, and His, (3) The presence of glycine amino acid as spacer, and (4) The 
presence of three non-coordinating amino acids at the C-terminal of the sequence to serve 
as linker. Tyrosine or serine was included in Peptide 1 & 2 to enhance the electron 
transfer between the peptide and the electrode. Peptide 4, the control peptide, did not 
contain metal coordinating amino acids in its sequence. Peptide 5, a polyhistidine, which 
is known to bind Nickel and Cobalt, was designed to test whether the peptide can 
coordinate with a manganese atom and show catalytic activity.  A sketch of peptide 3 can 
be seen in Figure 6.  
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FIGURE 6: A sketch of Peptide 3. The magenta colored ball in the sketch represents 
manganese atom. 
Early measurements on a simple gold electrode showed that peptide 2 & 3 
improved I/V efficiency of water electrolysis. The voltage (and thus the power 
consumption) required to achieve 1.3mA of current dropped by 10% for peptide 2, which 
corresponds to a 15% drop in the overpotential required to achieve this current (Figure 7).  
Subsequently peptide 2, peptide 3 and the control peptide were synthesized in situ 
on CBMX chips, and their catalytic activity was tested using PotentioSense microarray 
reader. Chemical structures of peptide 2, 3, & 4 can be seen in Figure 8.      
MALDI characterization of in situ synthesis of peptides revealed common side-
products associated with specific sequences present in a peptide. For example, peptide 3 
involved Asp-Gly in its sequence. Asp-Gly, when present in a sequence, are known to 
undergo aspartimide formation side-reaction whose corresponding peak can be observed 
at m/z = peptide +67D. This side-reaction can be suppressed using 1%HOBt in DMF 
during the final Fmoc deprotection step. The mechanism of aspartimide formation 
reaction and the MALDI spectrum of peptide 3 before and after use of 1% HOBt in DMF 
can be seen in Figure 9 & 10 respectively. Similarly, the MALDI spectrum of peptide 4 
showed a peak associated with the dehydration reaction when unprotected Asn and Gln 
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were used. Upon use of trityl protected Asn and Gln, a peak related to the dehydration 
reaction disappeared from the MALDI spectrum (Figure 11). 
The catalytic activity of peptides 2, 3, and the control peptide was measured using 
the PotentioSense microarray reader. The I/V step was used to measure currents from 
water electrolysis. The scan involved 0.0V to -2.4V. Currents from peptide 2 and 3 were 
similar to currents from control peptide region. No catalytic activity could be seen on 
CBMX platform. Some of the reasons that could explain why the catalytic activity of the 
peptide could not be seen on CBMX platform are as follows: the signals could not be 
differentiated from the noise of the instrument, and/or the communication between 
peptide and electrode is not optimal. Nevertheless, the instrument has the potential to 
measure electrical signals from high voltage involving redox reactions. Improvement in 
deciphering signals from noise, increase in efficiency in communication of peptides and 
electrodes, and measurements like CV using third-party instruments could make this a 
very useful approach to search for catalytic peptides. A bit of relevant information from 
this experiment is that MALDI based microarray synthesis characterization in 
conjunction with PotentioSense based assay detection could prove to be a powerful 
technique in the microarray field. 
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FIGURE 7: I/V curve comparing catalytic efficiencies of peptides 1, 2, 3 & polyHis, 
bound with Mn and the control peptide (which does not bind Mn) on gold electrodes, for 
anodic oxidation of water during water electrolysis. Full-length peptides were coupled to 
polyindole surfaces on gold electrodes and incubated with sub-mM MnCl2 in PBS buffer. 
Electrolysis measurements were done in TRIS buffer. 
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FIGURE 8: Sequences and chemical structures of catalytic peptides 2, 3, and control 
peptide 4. 
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FIGURE 9: Aspartimide formation reaction mechanism. 
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FIGURE 10: MALDI-MS characterization of synthesis of peptide 3 on CBMX chips. 
MALDI spectrum (10a) corresponds to peptide 3 before optimization: peaks 
corresponding to loss of water molecule and piperidide adduct of peptide (peptide +67D) 
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can be seen. The MALDI spectrum (10b) corresponds to peptide 3 after optimization: the 
peak corresponding to piperidide adduct of peptide (peptide + 67D) is absent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11:  The MALDI spectrum (11a) corresponds to peptide 4 before optimization: the 
peak corresponding to loss of water molecule can be seen. The MALDI spectrum (11b) 
corresponds to peptide 4 after optimization: peak corresponding to loss of water molecule 
is absent.  
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Co-Electropolymerization of Peptide-py with Pyrrole 
We explored another innovative application of CBMX platform: to fabricate 
peptide microarrays via spatially addressed co-electropolymerization of pyrrole modified 
peptide (peptide-py) with pyrrole molecules. Figure 12a shows different 11x5 sectors of a 
CBMX chip treated with solutions of different concentrations of peptide-py in pyrrole. 
The peptide-py used in the experiments was a pyrrole modified N-terminal endorphin 
sequence containing peptide (NH2-YGGFLGGGK(py)-COOH). The numbers reflected in 
the Figure represent a micromolar concentration of peptide-py in pyrrole solution that 
was electrodeposited on the corresponding set of electrodes. After co-
electroplymerization of solutions with different concentrations of peptide-py, the array 
was treated with biotin-labeled goat anti-mouse IgG to which HRP-SRP fusion protein 
was multiplexed. The electrochemical detection of YGGFL containing peptide-py using 
the Potentiosense microarray reader showed that the peptides were localized only on 
electrodes on which electrodeposition took place. The electrodes which remained silent 
during electrodepostion did not show any signal.  
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FIGURE 12a: Electrochemical detection of peptide immobilization via co-
electropolymerization of peptide-py and pyrrole by YGGFL-antibody-HRP assay. 
Specifically, YGGFL containing peptide sequence binds to the biotinylated antibody 
which is multiplexed with SRP-HRP fusion protein. Each number represents micromolar 
concentration of peptide-py in pyrrole solution.            
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Figure 12b.  Electrochemical detection of co-electropolymerization of peptide-py and 
pyrrole using constant voltage 1.0V for 10s. Different concentrations of peptide-py (0.0, 
5, 10, 20, 100, 200 µM) in pyrrole solution  were electro-deposited in different sections 
of a CBMX chip, and peptide immobilization efficiency was detected using YGGFL-
antibody-SRP-HRP assay. 
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FIGURE 12c: Electrochemical detection of peptide immobilization via co-
electropolymerization of peptide-py and pyrrole by YGGFL-antibody-HRP assay. 
Specifically, YGGFL containing peptide sequence binds to the biotinylated antibody 
which is multiplexed with SRP-HRP fusion protein. Each number represents micromolar 
concentration of peptide-py in pyrrole solution. The brighter region did not involve DMF 
wash.  
The experiment involved three kinds of controls: (1) Control-1: electrodes on 
which no electrodeposition of pyrrole took place, (2) Control-2: electrodes on which 
pyrrole was electrodeposited before electrodeposition of mixtures containing peptide-py 
and pyrrole, and (3) Control-3: electrodes on which pyrrole was electrodeposited after 
electrodeposition of different mixtures containing peptide-py and pyrrole. It was 
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observed that with the increase in concentration of peptide-py in the mixture, an increase 
in the electrochemical signal was observed. This is expected if the pyrrole group of 
peptide-py is polymerizing  with simple pyrrole molecules. Details of the mechanism of 
electropolymerization of pyrrole which are not clear can be found in Reference 37, 38 
and Figure 13.   
 
FIGURE 13: A probable mechanism of pyrrole electropolymerization38. 
However, control-3 showed highest signal (Figure 12b). These were simple 
pyrrole molecues, which were electro-polymerized at the last step after the deposition of 
series of solutions with different peptide-py concentrations. If the signals were dependent 
on the concentration of peptide-py in the mixture, control-3 should have shown the 
lowest signal similar to control-2.  
To understand this intriguing observation, in another experiment, solutions were 
electro-deposited in reverse order in a section of the chip. The mixture with highest 
peptide-py concentration was deposited first and mixture with lowest peptide-py 
concentration was deposited last. Similar to the previous experiment, control-2 was 
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electrodeposited before electrodeposition of different mixtures and control-3 was 
electrodeposited after electrodeposition of different mixtures. In this experiment, a 
stringent DMF-based washing step was also included to check if the peptide 
immobilization was covalent or non-covalent. If the immobilization was non-covalent, 
the signal intensities should decrease with stringent washing conditions. The results of 
the experiment can be seen in Figure 12c. It was observed that the electrodes on which 
the peptide-py and pyrrole mixture was deposited last showed the highest signals. The 
signals observed from electrodes on which 5µM peptide-py mixture was electrodeposited 
showed higher signals than electrodes on which 200µM peptide-py mixture was electro-
deposited. Control-3, which was electro-deposited at the very end, showed the highest 
signals. At the same time, electrodes that remained silent throughout the experiment did 
not show any relevant signal. It can be inferred that the signals are not dependent on 
peptide-py concentration in mixture, but on the timing of the electrodeposition. If the 
same mixture is electro-deposited first in the series, the corresponding electrodes show 
the lowest signal. If it is electro-deposited last in the series, the corresponding electrodes 
would show the highest signal. It can also be inferred that once a pyrrole polymer is 
electro-deposited on an electrode surface, no more peptide-py can non-specifically 
deposit on that electrode. Additionally, the already immobilized peptide-py (stuck inside 
the pyrrole polymer) does not get rinsed during washing steps. Otherwise, signals from 
all the electrodes on which electro-polymerization took place should be similar, and no 
signal gradation should be seen. In this experiment, a section of the chip showed brighter 
signals compared to rest of the chip (Figure 12c). In this section, DMF wash was not 
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included, whereas in rest of the chip DMF wash was included. From this observation it is 
clear that the majority of the signal, if not the entire signal, is due to non-covalent 
trapping of the peptide-py in the pyrrole polymer. Further experiments, are needed to 
understand the nature of immobilization, whether specific or non-specific, and to 
optimize the peptide immobilization strategy via co-electropolymerization with an 
electroactive molecule.   
TABLE 1: Details of Experiment 1 of peptide immobilization via co-
electropolymerization of peptide-py and pyrrole. 
 
 
 
 
 
 
 
 
Experiment 1
Electrodeposition 
Steps (does not 
include 
DMF wash)
Peptide-py conc'n 
(µM) 
in pyrrole solution
Signal Intensity 
Trend
Step 1 0 Lowest
Step 2 5
Step 3 10
Step 4 20
Step 5 100
Step 6 200
Step 7 0 Highest
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TABLE 2: Details of Experiment 2 of peptide immobilization via co-
electropolymerization of peptide-py and pyrrole. 
 
Materials and Methods 
Biotin Coupling Reaction 
The coupling reaction of biotin to free amines is comparable to any other amino 
acid coupling reaction, the difference being only in concentrations. The biotin coupling 
reaction is difficult to achieve due to solubility issues. It is a highly polar molecule and, 
therefore, even most polar organic solvents such as DMF (N,N′-dimethylformamide) and 
DMSO (dimethylsulfoxide) are unable to couple biotin in regular concentrations (150-
200µM concentration). To achieve biotin coupling, the CBMX chip terminated with free 
amines is exposed to a mixture of biotin (67mg, 137mM), HBTU (O-benzotriazol-1-yl-
N,N,N′,N′-tetramethyluronium hexafluorophosphate, 95mg, 137mM), HOBT (N-
hydroxybenzotriazole, 33.5mg, 137mM), and diisopropylethylamine (130.5µL, 350mM) 
in DMF (2mL) for 30 minutes. The chip is then rinsed with DMF 3x, dichloromethane 
3x, and again with DMF 3x, then re-exposed to the coupling mixture for another 30 
minutes. After repeating the washing procedure (with an additional ethanol rinse to 
remove any residual DMF or dichloromethane), the chip is allowed to dry. 
Experiment 2
Electrodeposition 
Steps (includes 
DMF Wash)
Peptide-py 
conc'n (µM) in 
pyrrole solution
Signal Intensity 
Trend
Electrodeposition 
Steps (includes 
DMF Wash)
Peptide-py 
conc'n (µM) in 
pyrrole solution
Signal Intensity 
Trend
Electrodeposition 
Steps (does not 
include DMF 
Wash)
Peptide-py 
conc'n (µM) in 
pyrrole solution
Signal Intensity 
Trend
Step 1 0 Lowest Step 1 0 Lowest Step 1 0 Lowest
Step 2 5 Step 2 200 Step 2 200
Step 3 10 Step 3 100 Step 3 100
Step 4 20 Step 4 20 Step 4 20
Step 5 100 Step 5 10 Step 5 10
Step 6 200 Step 6 5 Step 6 5
Step 7 0 Highest Step 7 0 Highest Step 7 0 Highest
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Ferrocence Coupling Reaction 
The coupling reaction of ferrocene modified with a carboxylic acid group to free 
amines is comparable to any other amino acid coupling reaction. To achieve ferrocene 
coupling, the CBMX chip terminated with free amines is exposed to a mixture of 
ferrocene carboxylic acid (126mg, 250mM), HBTU (O-benzotriazol-1-yl-N,N,N′,N′-
tetramethyluronium hexafluorophosphate, 190mg, 250mM), HOBT (N-
hydroxybenzotriazole, 67mg, 250mM), and diisopropylethylamine (130.5µL, 350mM) in 
DMF (2mL) for 30 minutes. The chip is then rinsed with DMF 3x, dichloromethane 3x, 
and again with DMF 3x, then re-exposed to the coupling mixture for another 30 minutes. 
After repeating the washing procedure (with an additional ethanol rinse to remove any 
residual DMF or DCM), the chip is allowed to dry. 
Synthesis of Pyrrole Modified Peptide 
The coupling reaction of pyrrole modified with a carboxylic acid group to free 
amines is comparable to any other amino acid coupling reaction. To achieve pyrrole 
coupling, the NH2-YGGFLGGGK-COOH functionalized polystyrene beads with free ε-
amines is exposed to a mixture of 1H-pyrrole-1-acetic acid (35mg, 137mM), HBTU (O-
benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium hexafluorophosphate, 95mg, 137mM), 
HOBT (N-hydroxybenzotriazole, 33.5mg, 137mM), and diisopropylethylamine 
(130.5µL, 350mM) in DMF (2mL) for 30 minutes. The beads are then rinsed with DMF 
3x, dichloromethane 3x, and again with DMF 3x, then re-exposed to the coupling mixture 
for another 30 minutes. After repeating the washing procedure (with an additional ethanol 
rinse to remove any residual DMF or DCM), the beads are allowed to dry. 
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Biotin–SRP-HRP Binding and Electrochemical Detection 
The microarray was fitted with a hybridization cap and washed with PBSC before 
incubating with 5X PBSC (BioFX, Owings Mills, MD) for 20 min at 25°C and washed 
three times with 2XPBST. Microarrays were incubated for 30 min with Poly-80-HRP 
Streptavidin (Fitzgerald Industries International, Acton, MA) diluted 1:1000 in PBST. 
Arrays were washed four times with PBSC, once with PBS, and twice with pH 4 
Conductivity Buffer Substrate (BioFX). TMB Conductivity 1 Component HRP 
Microwell Substrate (BioFX) was added to the array, and it was scanned immediately 
with a PotentioSense microarray reader (CBMX Corp.). Data was quantified using 
ElectraSense software (CBMX Corp.) for ECD. 
N-terminal Endorphin Sequence – Antibody Binding and Electrochemical Detection 
This procedure is similar to biotin-SRP-HRP binding. In this procedure three 
rounds of incubation took place, the first incubation involved anti-ß-endorphin antibody 
(mouse), the second involved biotin-labeled donkey anti-mouse antibody, and the third 
incubation involved SRP-HRP fusion protein. Clone 3-E7 (monoclonal, mouse) diluted 
1/1000 in 2X PBS + 0.05% Tween from stock purchased from Chemicon International. 
Imaging was done using a PotentioSense microarray reader (CBMX Corp.). Data was 
quantified using ElectraSense software (CBMX Corp.) for ECD. 
Pyrrole Electro-Polymerization 
2µL of Pyrrole (Sigma-Aldrich, Milwaukee, WI) is added to 0.5% SDS solution 
and vortexed for approximately five minutes until pyrrole gets dissolved in 0.5% SDS 
solution. Maps defining the electrodes to be addressed are prepared and loaded in electro-
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synthesis software. Once the electro-synthesis software is ready, the pyrrole solution 
prepared is loaded into the reaction chamber of the electro-synthesis instrument. Electro-
synthesis software is commanded to apply 1.0 V for 10 s to the selected electrodes of the 
chip. Once the polymerization reaction is over, the polymerization solution is discarded 
and the reaction chamber is rinsed 2x with 0.5% SDS solution and then 2x with water. 
The chip is then taken out of the reaction chamber and dried with argon gas and imaged 
under a microscope to detect pyrrole electro-polymerization. 
Co-Electropolymerization of Pyrrole and Peptide-Py 
Different concentrations of peptide-py (NH2-YGGFLGGGK(py)-COOH) were 
added in different rounds of polymerization to polymerization solution consisting of 2µL 
of pyrrole (Sigma-Aldrich, Milwaukee, WI) in 0.5% SDS solution and vortexed for 
approximately two minutes until the pyrrole dissolved in 0.5% SDS solution. For 
copolymerization of pyrrole with peptide-py of a specific concentration, maps defining 
the electrodes to be addressed were prepared and loaded in the electrosynthesis software. 
The polymerization solution prepared was then loaded in the reaction chamber of the 
electrosynthesis instrument. Electrosynthesis software is commanded to apply 1.0 V for 
10s to the selected electrodes of the chip. Once the polymerization reaction was 
complete, the polymerization solution is discarded and the reaction chamber is rinsed 2x 
with 0.5% SDS solution and then 2x with water. Abovementioned series of steps was 
performed again with polymerization solution containing peptide-py of a different 
concentration and a different map. At last, the chip was taken out of the reaction 
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chamber, dried with argon gas, imaged under a microscope to detect pyrrole 
electropolymerization, and readied for HRP based electrochemical detection. 
MALDI Matrix Application and Characterization of Array Features 
Experimental protocol for the MALDI matrix application and characterization of 
array features is discussed in Chapter 3 Materials and Methods section. 
Non-Diffusional UV-Cleavage of Arrayed Peptides 
Experimental protocol for non-diffusional UV-cleavage of arrayed peptides is 
discussed in Chapter 3 Materials and Methods section. 
Conclusion 
Microarray detection based on electrochemical techniques is one of the effective 
approaches for analysis of biointeractions. The method has some advantages and 
limitations. Limitations are mainly due to complex circuitry and multi-channel electrical 
signal measurements. CBMX has developed the PotentioSense instrument, which 
overcomes these technical difficulties and thus CBMX custom 12K arrays can be used 
for redox applications. We have tested PotentioSense based different electrochemical 
techniques for peptide microarrays and analyzed the performance and limitations of the 
instrument. We have shown that the PotentioSense based different electrochemical 
techniques, in conjunction with MALDI mass spectrometry, can be applied to CBMX 
12K custom arrays for analyzing several microarray based redox assays. Both the 
techniques in tandem can prove to be a powerful tool in peptide microarray area. 
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Chapter 6 
Conclusion 
In the scope this thesis, electrochemically directed microarray fabrication 
technique on CBMX platform was optimized. Also, the photo-deprotection efficiency of 
the NPPOC protective group and its derivatives was investigated.    
Fabrication of high density peptide microarrays at a low cost, and their 
characterization, is a difficult problem. One approach to this problem that has been 
described here in detail is to make electrochemically-directed peptide microarrays on 
CBMX chips. This approach has a tremendous advantage over traditional microarrays in 
that the arrays can be characterized electrochemically in addition to fluorescence. The 
CBMX platform is also amenable to MALDI detection without any modifications.  
Chapters 3, 4, 5 and Appendices A-F discusses the optimization of different aspects of 
peptide microarray fabrication, its characterization, and its applications.  
Chapter 3 discusses a simple, accurate, and general MALDI mass spectrometry 
(MALDI-MS) based approach that we have developed to characterize the chemical 
composition of an in situ-synthesized microarray directly on array features. This 
approach provides chemical composition information about each microarray spot, which 
is not possible using other approaches. Due to some restrictive factors this approach has 
spatial limitations. These limitations include a greater MALDI laser focus area, difficulty 
in precisely aligning the microarray features with the laser, and difficulty in applying the 
MALDI matrix without cross-contamination of cleaved peptides of different features. By 
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improvements in these limiting factors, the spatial resolution can be significantly 
increased allowing detection of large number of array features. 
Chapter 4 and Appendices A-G discuss aspects of peptide microarray synthesis 
that were optimized. Using MALDI-MS detection method, we optimized the gating step 
efficiency; trityl groups can be deprotected electrochemically using N,N′-
diphenylhydrazine as EGA-P solution with approximately 70% efficiency. Stability tests 
of trityl and dimethoxytrityl groups to N,N′-diphenylhydrazine and hydroquinone based 
EGA-P solutions revealed that trityl groups were stable to N,N′-diphenylhydrazine but 
not to hydroquinone based EGA-P solution. DMT groups were not stable to any of the 
EGA-P solutions. Based on this study we employed trityl as amino protecting groups 
towards optimization of peptide microarray synthesis. In situ-coupling efficiency of trityl 
groups to N-terminal amino groups was also optimized. We determined the stability of t-
butyl and Boc groups during trt electrochemical deprotection and their chemical 
deprotection efficiency on CBMX chips. Less than 10% Boc and t-butyl groups were 
deprotected at the gating step. We concluded that the CBMX chips are stable to TFA for 
30 minutes through the fluorescence method and that it proved to be sufficient for 
complete deprotection of Boc and t-butyl groups. We were able to develop an orthogonal 
system where the primary amino groups are protected with trityl group, and sidechain 
groups were protected with boc and t-butyl groups. With this capability, we synthesized a 
peptide with three gating steps with an overall yield of 18%. The chemical composition 
and quantification of the synthesis products was determined by MALDI-MS detection.  
To avoid contamination caused during peptide synthesis a milder condition, 0.75µA for 
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45s using hydroquinone as EGA-P solution was developed. Several instrumentation 
challenges, such as synthesis automation, fabrication of two kinds of manual chambers 
one with low reaction volume and another which is acid-resistant to carry out TFA based 
deprotection step were solved. Some preliminary work  to generate electro-reagents that 
can deprotect different kinds of protecting groups such as base-labile, catalytically 
reducable, and organometallic labile groups were performed. The strategy to generate 
piperidine, an organic base, in situ by reducing its probase (piperidine hydrochloride), 
piperidine hydrochloride looks promising and further work should be done to optimize 
the strategy. At present we can deprotect approximately 25% of Fmoc groups upon 
application of -2.0V for 20 minutes.  
Redox enzyme mediated electrochemical detection of microarrays is one of the 
effective methods of studying protein-peptide interactions. Potentiosense microarray 
reader developed by CBMX overcomes the technical limitations of this method. These 
technical limitations include a complex circuitry and multichannel electrical signal 
measurements. A microarray system comprising of CBMX platform, MALDI-MS, and 
Potentiosense was used to search for peptide catalysts that can reduce overpotential 
associated with anodic half-reaction of water splitting, as well as to fabricate a peptide 
microarray on CBMX chip via co-electropolymerization of peptide-pyrrole and pyrrole. 
In this regard, several characteristics of Potentiosense were studied, including noise 
behavior at various voltages. We fabricated three designed peptides on a CBMX chip. 
Two of these peptides bind to manganese and showed catalytic activity on bulk gold 
electrode; the third was a control peptide. Although no catalytic activity could be detected 
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using Potentiosense, the direct characterization of synthesis using MALDI-MS and the 
ability to measure currents from microelectrodes of the chip at high voltages holds 
promise. Initial results w.r.t peptide microarray fabrication by co-electropolymerization 
of peptide-pyrrole and pyrrole suggested immobilization of peptides using this method is 
possible, but several more optimization experiments need to be conducted for 
optimization. Although the study has been primitive, we have demonstrated the potential 
of coupling CBMX chips with MALDI-MS. We have also demonstrated ECD detection 
methods to search for peptide based catalysts for challenging redox reactions, and the 
fabrication of peptide microarrays via electropolymerization, with recognizable 
applications in electrocatalyst development and drug discovery.  
A comparison study of photolysis rates and yields of free amines for NPPOC, 
derivatives of NPPOC, MeNPOC and NVOC protecting groups is described in Chapter 2. 
Firstly, a simple, efficient, and relatively non-toxic method for synthesis of NPPOC 
protected amines without using phosgene was developed. Secondly, the efficiency of 
NPPOC and its derivatives as photolabile amino protecting groups was determined. 
Photolysis studies revealed that presence of pi-system conjugated to the benzene ring of 
NPPOC group enhances the rate of photolysis and overall yield of the amines. Probably, 
the improvement in the rate of photolysis is due to enhanced stability of the reactive 
intermediate formed (Norrish Type II – diradical species) during UV cleavage. The 
improvement in overall yield of amine is due to the formation of relatively inert 
nitrostyrene side-product, compared to nitrosobenzaldehyde seen during MeNPOC and 
NVOC cleavage. Once the phenyl derivative of NPPOC was chosen as a suitable group 
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for protecting amines, it was found that the nature of protected amine (aromatic or 
aliphatic) had a strong affect on the rate of photolysis. These results could be useful in 
preparing a more efficient photolabile amino protecting group, with applications ranging 
from organic to combinatorial peptide synthesis.  
In conclusion, the electrochemical technique has interesting future applications. 
This technique can be extended to D-amino acids and unnatural amino acids, making it 
suitable for synthetic peptide library generation and drug discovery. The platform could 
be well-suited for generation of other kinds of libraries, such as oligosaccharides, peptide 
nucleic acids, and peptoids with some chemical modifications. With current yields 
(approximately 56% yield per electrochemical step), the CBMX peptide microarray 
platform could be useful to study influence of point mutations on binding characteristics. 
The features showing high binding affinity can be carefully analyzed in next rounds of 
microarray experiments to elucidate the chemical composition of real binders to the 
analyte molecule. Currently, peptide arrays are well-suited for linear epitope mapping. 
With advances in electrochemically-directed peptide synthesis, the CBMX platform 
could become well-suited for conformational epitope mapping too. Another interesting 
application of the CBMX platform involves monitoring conformational changes in 
peptide probes. Both metallo- and non-metallo-peptides could be monitored through 
redox behavior of metals as well as redox active amino acids such as tyrosine and 
tryptophan. Currently, conformational changes in proteins are detected through 
techniques such as NMR, UV absorption, electron spin resonance, circular dichroism, 
birefringence, and fluorescence spectroscopy. CBMX microarray platforms can not only 
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detect conformational changes, but they can also provide fast, relatively inexpensive, and 
detailed information about the causes of conformational changes such as nucleation 
points of folding. They can also provide clues to control and manipulate those changes. 
For example, the redox behavior of single amino acid mutations of secondary structure 
forming probe sequences can give an idea of amino acids that are important for a 
sequence to assume a secondary structure. Such amino acids, upon identification, can be 
replaced with other amino acids for manipulation of the conformation of the probe 
sequence. This could be extremely useful in finding solutions to a wide range of diseases 
called amyloidoses, which occur due to incorrect folding of proteins.
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APPENDIX A 
A STUDY OF ELECTROCHEMICAL DEPROTECTION EFFICIENCY OF TRITYL 
GROUPS USING MALDI-BASED MICROARRAY CHARACTERIZATION 
TECHNIQUE 
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The starting point in titration, 3.0V 3min, was based on the condition used by 
Maurer et al. for deprotecting boc groups. At this point, in order to further improve the 
deprotection efficiency of Trt groups, dimethoxytrityl (DMT) protecting group and 
hydroquinone as EGA-P were included in our studies. Montgomery et al. has described 
the use of Hydroquinone as EGA-P for electrochemical deprotection of DMT groups 
during oligonucleotide synthesis on CBMX chips. They employed 0.26µA and 30seconds 
condition for its deprotection. Therefore, we investigated the electrochemical 
deprotection efficiency of DMT using N,N′-diphenylhydrazine at 3.0V 10min condition, 
and Hydroquinone at 0.26µA 30s condition. It was observed that N,N′-diphenylhydrazine 
as EGA-P deprotecetd DMT with approximately 88.7% stepwise yield, and hydroquinone 
as EGA-P deprotected DMT with approximately 85% stepwise yield. The control regions 
of the chip in these experiments, where no gating step was involved, also underwent 
electrochemical deprotection. The MALDI spectra of the control regions of these 
experiments showed that 75% of the control peptide with N,N′-diphenylhydrazine, and 
80% with Hydroquinone, got electrochemically deprotected. Such electrochemical 
deprotection from the control region was undesired. Because of this, the cause of non-
specific deprotection was investigated. We also investigated the behavior of Trt with 
Hydroquinone as EGA-P. Approximately 75% of the Trt was deprotected in the gating 
step. Approximately 17% of peptides from the control region were also deprotected when 
Hydroquinone was used as EGA-P. It should be noted that when Trt was removed 
electrochemically, using N,N′-diphenylhydrazine as EGA-P, no such undesired 
deprotection from the control region was seen. Therefore, we developed a desired system 
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(250mM N,N′-diphenylhydrazine and 250mM tetrabutylammoniumhexafluorophosphate 
in DCM, 3.0V 10min) which could selectively deprotect Trt groups. The system was 
developed so that no non-specific deprotection could be seen. The results are summarized 
in Table A-1 below. 
 
TABLE A-1: % electro-deprotection of Trt and DMT groups at 3.0V 10min condition. 
% electro-deprotection 
efficiency 
N,N′- diphenyl hydrazine 
as EGA-P 
Hydroquinone as EGA-P 
Trityl protecting groups 68.4% deprotection 
No deprotection  in control 
region 
70% deprotection 
17% deprotection in 
control region 
Dimethoxytrityl protecting 
groups 
88.7% deprotection  
75.8% deprotection in 
control region 
85% deprotection 
80% deprotection in 
control region 
 
TABLE A-1: Data shown in Table A1 corresponds to the deprotection efficiency of Trt 
and DMT groups using N,N′-diphenylhydrazine and Hydroquinone. Also shown is the 
unwanted deprotection of these groups from the control region without any application of 
voltage when exposed to the two EGA-P solutions. 
To understand such non-specific deprotection during the gating step, we first 
considered any undesired electric potential, which was applied across the chip due to 
hardware malfunctioning. Consequently, similar experiments were conducted with the 
electrosynthesis instrument turned ‘ON’, but maintained at 0.0V. Surprisingly, DMT 
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groups present on the chip surface were deprotected when the chip was exposed to EGA-
P solutions at zero volts. The results are summarized in Table A2 below. 
TABLE A-2: % deprotection of DMT and Trt groups at zero volts 
Hydroquinone 
as EGA-P 
% deprotection 
at zero volts 
 N,N′-diphenyl 
hydrazine as EGA-P 
% deprotection at 
zero volts 
DMT 80%  DMT 80% 
Trt 15%  Trt stable 
 
TABLE A-2: Data shown in Table A-2 corresponds to % deprotection of DMT and Trt 
groups when exposed to Hydroquinone and N,N′-diphenylhydrazine solution. During this 
exposure the instrument was turned ON, but maintained at 0.0 volts. 
Here again, Trt remained stable to N,N′-diphenylhydrazine. At this point, it was 
inferred that there were three possible reasons for the instability of the Trt and DMT 
groups. These included (i) instability from EGA-P solutions, (ii) EGA-P solution in 
conjunction with Platinum electrode surface, or (iii) a chip with some electric potential 
due to hardware malfunctioning. Diffusion of protons from the selectively addressed 
region to the control region may not be the cause, though this aspect could not be 
completely ignored. It cannot be discounted because the deprotection was observed even 
at zero volts. The stability of Trt and DMT groups present on the chip to EGA-P 
solutions was determined by exposing the chip to EGA-P solutions without turning on the 
electro-synthesis instrument. The Trt and DMT groups underwent deprotection and 
showed similar results as observed with the application of zero volts. It was then assumed 
that either the Trt and DMT groups are not stable to EGA-P solutions or it was possible 
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that the Platinum electrode surface was influencing the deprotection when exposed to 
EGA-P solutions. Therefore, the stability of Trt and DMT groups to EGA-P solutions 
was tested using beads, instead of on the chip surface. In this experiment, a peptide NH2-
GFKGFKGFK-CONH2 with a photo-labile linker at the C-terminal was synthesized on 
PAL-resin by conventional Fmoc chemistry. The N-terminal amine of the peptide was 
protected with Trt group on one set of beads, and with DMT group on another set of 
beads. Subsets of such beads were exposed to EGA-P solutions with different 
concentrations of base, Lutidine, ranging from 0.1M to 0.5 M. The beads were then 
washed with dichloromethane and N,N′-dimethylformamide solvents and the peptide 
present on the beads were cleaved photolytically. The cleaved peptides were collected by 
filtration and characterized by MALDI mass spectrometry. The MALDI spectra showed 
peaks corresponding to the peptide with Trt and DMT groups present, intact, on the N-
terminal amine. No peaks were seen in the MALDI spectra corresponding to Trt or DMT 
deprotection upon exposure to EGA-P solutions (Figure A-1). 
  
170 
 
 
FIGURE A-1: MALDI-MS characterization of electrochemical deprotection of Trt and 
DMT groups using Hydroquinone as EGA-P. The two MALDI spectra, a & b, correspond 
to peptides with terminal glycine protected with DMT and Trt groups respectively. Both 
the peptides were exposed to Hydroquinone EGA-P solution. The MALDI spectrum did 
not show any cleavage of Trt or DMT group upon exposure to Hydroquinone solution. If 
the cleavage had taken place, a phenylalanine group should have been added to the N-
terminal of the peptide. However, the peaks in the spectrum do not show the presence of 
phenylalanine at all. Similar results were observed with N,N′-diphenylhydrazine as EGA-
P solution. 
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Based on the abovementioned set of experiments, it seems that Trt and DMT 
groups are unstable to EGA-P solutions on the chip surface. The platinum electrode 
surface is influencing the deprotection of Trt and DMT groups by EGA-P solutions. The 
mechanism of this observation is not yet clear. In literature, there are reports of Trt 
deprotection by catalytic hydrogenolysis. One of the problems with this hypothesis is that 
the catalytic hydrogenolysis reactions generally require high-pressure conditions, ranging 
from 3atm to 200atm for different kind of substrates, whereas the pressure inside the 
peptide synthesizer is usually 6psi, less than 1 atm. Another argument against this 
hypothesis could be that catalytic hydrogenolysis is not usually a fast reaction, whereas 
the chips were exposed to EGA-P solutions for not more than ten minutes. It is possible 
that some other kind of organometallic reaction mechanism was deprotecting the Trt and 
DMT groups by EGA-P solutions. Collaboration with research labs focused on 
organometallic chemistry would be helpful to discern these observations. A part of our 
research lab is focused in bioorganic chemistry, with an aim to develop tools for medical 
applications. However, organometallic chemistry, an exclusive class of synthetic organic 
chemistry, does not have much scope in our research goals.  
Nevertheless, based on this study, it was determined that with N,N′-
diphenylhydrazine as EGA-P and at 3.0V, under a 10 minute electrical condition, about 
70% electrochemical deprotection efficiency of Trt could be achieved without any non-
specific deprotection. Here we would like to demonstrate the advantages of an 
application of fluorescence and use of the MALDI detection method in conjunction with 
parallel synthesis optimization. This is compared to an application of sole fluorescence 
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method or MALDI detection method. Although we developed a system to 
electrochemically deprotect Trt using N,N′-diphenylhydrazine, the electrical condition, 
(3.0V 10min) associated with it is quite stringent. At this potential, several side redox 
transformations could be possible. Titration experiments were conducted in order to find 
an optimal electrical condition at which deprotection is high and chances of side redox 
transformations is low.  
Since several electrical conditions were to be tested, fluorescence detection 
method instead of MALDI detection method was opted. As discussed earlier, with 
fluorescence detection methods, the chemical nature of the synthesis products cannot be 
determined. However, fluorescence methods are useful for titration experiments, in which 
a large number of conditions along with multiple replicates of each condition are tested. 
The MALDI detection method is useful for direct characterization of parallel synthesis, 
but at present, not many titration conditions can be tested at once on a single chip. At 
best, we can only test six different titration conditions on a chip at one time. This 
constraint is due to the difficulty associated with applying the fine MALDI matrix across 
the chip in such a way that cleaved peptides from one feature does not get diffused to 
neighboring features. Such precise application of matrix is possible only through 
expensive instrumentation, which is generally available only in MALDI mass 
spectrometry based research labs. In addition, difficulty is associated with the software 
program that can store thousands of MALDI spectra, collected from single features of a 
microarray. It can generate a heat map based on intensities of desired and undesired 
peaks seen from each spectrum/feature.  
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Therefore, a total of twenty different titration conditions along with five replicates 
of each condition were tested using the fluorescence method on a single chip. 
Hydroquinone was used as EGA-P due to a low redox potential associated with it. A 
fluorescence assay was performed based on an N-terminal endorphin sequence (YGGFL) 
interaction with a fluorophore conjugated antibody against it. Titration conditions ranged 
from 0.25µA, 60 seconds to 0.25µA, 210 seconds and 1.2V, 60 seconds to 3.0V, 60 
seconds. The electrical conditions that were 0.75µA, 60 seconds and stronger showed  
high fluorescence signal intensities. This indicated that Trt groups were electrochemically 
deprotected from respective features. Earlier in this section we discussed the instability of 
Trt and DMT groups to the Hydroquinone system. The MALDI spectrum associated with 
the electrochemical deprotection of Trt using Hydroquinone as EGA-P at 0.5µA, 60 
seconds, showed approximately 17% deprotection of Trt from the control region. By the 
application of fluorescence and the MALDI based detection method we were able to 
develop a mild electrical condition for Trt deprotection using Hydroquinone as EGA-P, 
but also discovered that Trt is unstable to Hydroquinone on CBMX chips. Hence, 
although Trt can be deportected at a mild electrical condition, due to its instability to 
hydroquinone it may not be an optimal system for parallel synthesis. Such analysis of Trt 
deprotection would not have been possible solely by the fluorescence method and would 
have been very tedious to determine with only the MALDI method.  
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APPENDIX B 
TEST OF ALTERNATE METHODS TO ELECTROCHEMICALLY GENERATE 
ACIDS 
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Alongside optimizing the peptide microarray synthesis based on electro-generated 
acids, a few strategies for generating other kinds of reagents electrochemically were also 
tested. Specifically, we tried to generate base, oxidize metal, and generate hydrogen 
electrochemically. The idea behind this effort was to replace electro-generated acids with 
an even more efficient system of electro-deprotection. One of the ideas tested was to 
reduce piperidine hydrochloride to generate in situ piperidine, an organic base widely 
used for deprotection of Fmoc group. The chemical reaction is as follows: 
 
 
 
Many different electrical and concentration conditions were tested to generate an 
adequate amount of piperidine from piperidine hydrochloride via an electrochemical 
reduction reaction. The range of the titration conditions was 0.1M piperidine 
hydrochloride, -2.0V, and 1minute to 0.6M piperidine hydrochloride, -2.0V, and 20 
minutes. At -2.0V, 20 minutes, approximately 25% of Fmoc groups were deprotected. 
The deprotection results were inconsistent; in few trials the deprotection of 
approximately 25% of Fmoc groups (Figure B-1) was observed, but the results could not 
be replicated in all of the trials. The deprotection yields also remained constant at about 
25% and did not improve, even when stronger titration conditions were applied.  
  
   (B-1) 
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-
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FIGURE B-1: MALDI-MS characterization of electrochemical deprotection of Fmoc 
groups using piperidine hydrochloride as electro-generated base precursor (EGB-P). A 
peptide, NH2-AKFGAFGAFG-CONH2 was synthesized where the final alanine was 
coupled after electrochemical deprotection of Fmoc group of lysine via reduction of 
piperidine hydrochloride to piperidine. The MALDI spectrum corresponding to 0.6M 
piperidine Hydrochloride solution and -2.0V, 20-minute condition showed approximately 
25% removal of Fmoc groups. 
Two more strategies were tested to generate electrochemical reagents: (1) 
generate in situ hydrogen, which can deprotect Cbz groups by hydrogenolysis (Equations 
B1 & B2), and (2) oxidizing Pd(0) to Pd(II) in situ to deprotect alloc groups (Equation 
B3). The chemical equations of these strategies are as follows: 
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The equation B-1 shows that the chemical reaction to generate hydrogen in situ is 
the same as the one carried out to reduce piperidine from piperidine hydrochloride. The 
only difference was that the Cbz group was present on the N-terminal of the peptide 
instead of the Fmoc group for deprotection. The titration conditions for in situ generation 
of Pd (II) from Pd (0) was 2.4V 3min to -2.4V, 15min. None of these two methods 
showed any deprotection; therefore, it cannot be said that upon optimization these 
methods could become efficient. In contrast, given that the electrochemical setup has 
been inconsistent, these methods could not be written off completely. The idea of 
reducing piperidine hydrochloride to piperidine electrochemically is promising, as we 
have seen approximately 25% deprotection of Fmoc groups. Perhaps the efficiency of 
this reaction could be improved by playing with several titration conditions and the 
employment of different modes of counter electrodes.
H
N C O
O
CH2R NH2R + CO2 + CH3
Piperidine Hydrochloride/
Cyclohexadiene
Pt Hydrogenolysis
(B-2) 
 
Pd(OAc)2                             Pd(PPh3) R-NH2 + Products        (B-3) 
  
PPh3 R-NH(alloc) 
5% Acetic acid, 
 2.5% Base 
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APPENDIX C 
STUDY OF PEPTIDE CONTAMINATION DURING MICROARRAY SYNTHESIS 
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During the studies involving peptide synthesis yield determination and 
optimization, we encountered contamination of peptides from a different region of the 
chip in the concerned region. Such a moderate to high level of contamination could lead 
to false positives. Consequently, we went ahead and studied the problem of 
contamination carefully. The probable reasons for contamination could be (a) due to non-
specific application of voltage to silent electrodes during the gating step, (b) due to 
diffusion of protons, generated from electro-acids during the gating step, to the silent 
electrodes region, or/and (c) the deterioration of the functionalized polymer of the chip 
during the gating step or/and during synthesis.  
The pyrrole electro-polymerization experiment was performed to determine 
whether or not any hardware issues existed. As a result of which the silent electrodes 
were getting addressed. Results of the experiment suggested no non-specific addressing 
of electrodes, as no electro-polymerization took place on silent electrodes (Figure C-1). 
 
FIGURE C-1: The dark circular region in the Figure is due to pyrrole electro-
polymerization. Electric potential of 1.0V for 10s was applied on selected electrodes. The 
electrodes that were not selected did not form pyrrole polymer on its surface, as can be 
seen from Figure C-1 (bright electrodes). 
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From the experiment results, we were able to strike out the option of non-specific 
application of voltage to the electrodes. To determine whether or not the diffusion of 
protons generated during the gating step was the reason behind contamination, two 
detailed experiments were conducted. In these experiments, five different peptides were 
synthesized in five different regions of the chip. There was a sixth region present in the 
chip, which was a control region. Here, no gating step was involved. A diagram of the 
chip with the locations of six different regions and the peptides synthesized in it is shown 
in Figure C-2. 
 
FIGURE C-2: Chip design of two experiments conducted for peptide contamination 
study. In the first experiment, the chip was divided into six large regions and different 
peptides were synthesized in the six regions. In second experiment, the chip was divided 
into six small regions, each region further apart from other regions compared to first 
experiment. In both the experiments contamination could still be seen. 
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In the second experiment, the dimensions of these regions were further shortened 
to determine if the contamination of peptides could still be seen. The idea behind the 
second experiment was that if the contamination of peptides could still be seen after 
shrinking the regions and thereby increasing the distance between any two regions, then 
the contamination is not due to the diffusion of protons during the gating step. A detailed 
description for this reasoning is given in the subsequent paragraphs. In these two 
experiments, it was observed that peptides from one region contaminated the other 
region. The contamination was seen even among the two regions that were farthest apart 
from each other. For example, in experiment 1, a peptide NH2-KMAFGAFGAFG-
CONH2, which was synthesized in section-5, could be seen in the MALDI spectrum of 
section-2, in which peptide NH2-KFAFGAFGAFG-CONH2 was synthesized. Similarly, a 
peptide NH2-KGAFGAFGAFG-CONH2 synthesized in section-1, in the second 
experiment, was seen in the MALDI spectrum of section-2, in which peptide NH2-
KFAFGAFGAFG-CONH2 was synthesized. These two regions were quite far from each 
other on the chip. The abovementioned MALDI spectrum of the two experiments can be 
seen in Figure C-3a and Figure C-3b respectively. 
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                                           Section-2 (Phenylalanine coupled) 
                       
FIGURE C-3: MALDI-MS characterization of experiments conducted for peptide 
contamination study. MALDI spectrum in Figure C-3a corresponds to Section-2 of the 
Diffusion experiment 1. Along with the peptide that was synthesized in Section-2, 
peptides synthesized in other regions, such as the peptide from Section -1, Section-5, and 
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the control peptide were also seen in the Section-2 spectrum. Similarly, Figure C-3b 
corresponds to Section-2 of experiment 2. Along with the peptide that was synthesized in 
Section-2, peptides synthesized in other regions were also seen in the Section-2 spectrum.  
From these two experiments, it was concluded that the contamination of peptides 
into one region from another is not taking place due to the diffusion of protons during the 
gating step. The reasoning behind our claim is as follows: the active area of CBMX chip 
has a dimension of 10mm X 2.5mm, which translates to 25mm2 area. Each region 
designed during the first experiment had a set of 10 X 10 electrodes, which translates into 
2 mm2 area. For instance, if the electrodes in section-5 were addressed, the maximum 
area that the protons generated could diffuse in ten minutes (the electrical condition 
employed during gating step was 3.0V for 10 minutes) would be 9.31xE-5mm2 (assuming 
proton is moving in water + electrolyte medium). The diffusion of protons is fastest in a 
water + electrolyte medium. The medium in our gating step is that of an organic solvent 
(aprotic solvent) + electrolyte, in which the diffusivity of protons will be less than in a 
water + electrolyte medium. If the diffusivity of protons in a water + electrolyte medium 
itself is not sufficient for protons to reach from one region to another, it is not possible 
that the protons would diffuse and reach far-off sections in an aprotic solvent medium. 
Also, the electric field which is present in the medium between two counter electrodes 
will always direct the motion of the diffusing protons towards the counter electrode, a 
bulk platinum electrode, at a distance of 5mm. In our setup, it is minimizing the time that 
a proton can spend on the silent electrode region. Professor N.J. Tao, director of Center 
for Bioelectronics and Biosensors at Arizona State University, and an expert in 
184 
 
Electrochemistry, suggested the maximum diffusion of protons that can take place in our 
set up , in ten minutes, under 3.0V equivalent electric field and N,N′-dimethylformamide 
+ tetra-butyl ammoniumhexafluorophosphate as a medium, would be about 104µm2. This 
area is less than one-hundredth of the chip surface area and, therefore, it would not be 
possible for the protons to diffuse into other regions and lead to contamination. 
It should be noted that several precautions to prevent diffusion are employed in 
our setup. Firstly,  (a) the EGA-P precursor, N,N′-diphenylhydrazine, itself can act as 
proton acceptor and thus plays the role of chemical scavenger for protons in the EGA-P 
solution, and (b) in the chip fabrication, every electrode is surrounded by a thin, circular, 
ring-like electrode called a getter electrode. Opposite polarity can be employed to these 
getter electrodes, which can prevent the diffusion of protons (we were unable to utilize 
this feature for most of our experiments, only at a later stage did the company realize that 
we did not possess this ability and the instrument was upgraded to utilize this capability).  
From the above analysis, it can be concluded that the contamination of a specific 
region with peptides from another region is not taking place due to (a) non-specific 
addressal of electrodes or (b) diffusion of protons at the gating step. At this point, a 
plausible explanation is the deterioration of the polymer present on the chip surface due 
to strong electrical conditions employed during each gating step. Small, functionalized 
pieces of the partially degraded chip polymer move across the chip surface and get stuck 
onto different regions of the chip. These bits of polymer somehow remain stuck to the 
chip during the synthesis and, in fact, participate in the further steps of the synthesis. The 
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peptide thus fabricated on these bits of polymer show up in the MALDI spectrum as 
contamination. 
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APPENDIX D 
SEARCH FOR A MILD ELECTRICAL CONDITION TO ELECTROCHEMICALLY 
DEPROTECT TRITYL GROUPS 
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As a result of the analysis concerning contamination discussed in Appendix C, we 
searched for mild, yet optimized electrical condition for proton generation at the gating 
step. In the first several rounds of experiments, the assay involved five components as 
follows: (1) coupling of a trityl protected amino acid to the polymer present on the chip, 
(2) deprotection of trityl group from different sets of electrodes at different electrical 
conditions, (3) coupling of the biotin molecule to the deprotected amine groups, (4) 
labeling of the biotin molecule with streptavidin-fluorophore molecule, and (5) 
fluorescence based detection to find the efficiency of titration conditions. The EGA-P 
used was hydroquinone rather than N,N′-diphenylhydrazine. Researchers at CBMX have 
used hydroquinone as EGA-P for oligonucleotide microarray fabrication and have 
reported a very mild condition, 0.26µA 30s, for acid generation. The results of all of the 
trials were inconsistent, due to suspected hardware malfunctioning. Upon evaluation at 
CBMX, it was discovered that the instrument failed to employ any other mode of counter 
electrode other than the bulk platinum electrode of the instrument’s reaction chamber. 
The instrument, once upgraded at CBMX, was then capable of employing different 
modes of counter electrodes. In further experiments, the grid was employed as a counter 
electrode. Such an arrangement could be more efficient than bulk electrodes as a counter 
electrode in preventing diffusion of protons produced at gating step. After upgrading the 
instrument, experiments to search for mild electrical condition were resumed. The biotin-
based assay was not successful, and even though different parameters were changed - for 
example, a change in composition of blocking from 3% BSA to 30%BSA - no consistent 
results were seen. As a result, an N-terminal endorphin sequence – antibody interaction 
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assay was employed. In these experiments, an N-terminal endorphin sequence (YGGFL) 
was synthesized. The N-terminal end, which was protected with Fmoc group, was 
replaced with a Trityl group. The trityl group was then electrochemically deprotected at 
twenty different electrical conditions, ranging from 0.25µA, 60s to 0.25µA, 210s and 
1.2V, 60s to 3.0V, 60s. After deprotection, the chip was incubated with an anti-endorphin 
antibody conjugated with a fluorophore. Upon fluorescence detection, electrodes 
corresponding to 0.75µA, 45 seconds and all electrical conditions stronger than 0.75µA 
and 45 seconds showed fluorescence (Figure D-1). The mildest, yet consistent, electrical 
condition with the highest amount of fluorescence was 0.75µA for 45s. 
 
 
 
 
 
   
 
 
FIGURE D-1: D-1a is the fluorescence image of the chip on which twenty different 
electrical conditions were tested to search for the most efficient deprotection condition 
for trityl groups using Hydroquinone as EGA-P. Figure D-1b, shows the fluorescence 
     D-1a. 
  D-1b. 
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image of one of the replicates of 0.75µA, 45s condition. All of the replicates of 0.75µA, 
45s condition and stronger electrical conditions showed high fluorescence intensities. 
It should be noted that different assays such as biotin-fluorophore conjugated to 
streptavidin interaction, MALDI mass spectrometry, and N-terminal endorphin sequence 
– antibody interaction were performed for mild, yet efficient electrical condition 
determination. Out of the three different assays, only N-terminal endorphin – antibody 
interaction revealed best electrical conditions for trityl deprotection. A similar experiment 
with a different detection method did not reveal the best electrical condition, even after 
multiple trials. All the above-mentioned assays are extremely sensitive and should have 
shown similar results. A probable explanation could be that the MALDI detection method 
and biotin-based method involve chemical steps which may not be efficient. For example, 
in the MALDI detection method, peptides are chemically ionized using alpha-
hydroxycinnamic acid as proton donor. The biotin-based detection method involves 
chemical coupling of biotin to the N-terminal of the peptide sequence, which is a very 
difficult reaction due to the high hydrophilicity of the biotin molecule. The solvents used 
for coupling reactions are not hydrophilic enough to dissolve the biotin molecule at a 
desired concentration. Unlike MALDI and biotin-based detection methods, N-terminal 
endorphin sequence interaction, with its antibody, does not involve any chemical steps. It 
may be for this reason - it is a more efficient method for the best electrical condition 
determination. It seems that the MALDI based detection method, which has proved very 
useful in direct characterization of synthesis, could in some cases be an inefficient 
method due to the chemical ionization step involved. Perhaps it can be replaced by an 
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electrospray ionization mass spectrometry (ESI) based method to characterize simple 
peptide synthesis, as it only involves physical methods for ionization and no chemical 
step is involved. At this point in our research, there were several issues with 
instrumentation involved in this project and further analysis of microarray synthesis, such 
as stepwise yield, chemical nature of side-products, and total yield of peptide synthesis 
involving three gating steps at 0.75µA, 45seconds electrical condition could not be 
performed. Issues related to instrumentation are described in detail in Appendix E. 
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APPENDIX E 
PEPTIDE SYNTHESIZER AND ELECTRO-SYNTHESIS INSTRUMENT 
INTEGRATION AND OTHER INSTRUMENTATION ISSUES 
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The electrosynthesis instrument and the peptide synthesizer are two very different 
instruments, one designed to apply voltage across the CBMX chips and conduct 
electrochemical reactions and the other designed to execute peptide synthesis on beads. 
To make the microarray synthesis setup fully automated, it is necessary to integrate both 
these instruments. A very clever approach from Kevin Brown, a software professional at 
the Center of Innovations in Medicine (ASU), helped us achieve the integration of the 
two instruments. Rather than making the instruments communicate with each other, 
peptide synthesizer was programmed to wait at different time intervals during the 
synthesis, and during this time electrosynthesis instrument was activated automatically 
using LabVIEW software. Specifically, microarray synthesis was conducted in a reaction 
chamber of the electrosynthesis instrument. The chamber was connected to the peptide 
synthesizer and all of the synthesis steps were carried out in an automated mode through 
the peptide synthesizer. The peptide synthesizer was programmed so that it would load 
the reagents needed for electrochemical reaction into the chamber, and then temporarily 
halt the synthesis for a few minutes. During this time interval, through LabVIEW 
software, the cursor of the computer screen would automatically move and activate the 
electrosynthesis instrument software. Once this task was performed, the peptide 
synthesizer would take charge of the synthesis once again. Such an arrangement can 
potentially save labor time because it is not required for any professional to be physically 
present at the station in order to conduct the gating step manually every three hours. The 
reaction could now be conducted overnight. However, due to some issues with chamber 
design, this advantage of complete automation could not be leveraged yet. 
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The four reaction chambers present in the electrosynthesis instrument have a 
volume of 100 microliters each. Each chamber has electronic circuitry present. In 
addition to these four reaction chambers of the electrosynthesis instrument, there is a 
manifold with four reaction chambers, each having a volume of 200 microliters. These 
chambers do not have any electronic circuitry. It was observed that if complete 
microarray synthesis is conducted in the reaction chambers of the electrosynthesis 
instrument, the electronic circuitry of the chamber deteriorates quickly, due to the seeping 
of chemicals into the circuitry. It is not feasible to sacrifice the chambers for complete 
automation, as these chambers are quite expensive ($1100 per chamber) and the 
deterioration starts taking place in as little as a month. Although the capability to perform 
synthesis in fully automated mode is possible, a professional is needed at the station to 
transfer the chip between the instrument’s chambers during each gating step.  
The manual chamber is not compatible with peptide synthesizer because the 
synthesizer’s internal pressure is not enough to push the solution present in the chamber 
forward. As a result, solutions of different steps gets mixed and fail the reaction. The 
alternative is to use the reaction chambers of the electrosynthesis instrument, which can 
hold only 100 microliters of reagent. The peptide synthesizer is able to easily push the 
solution forward. The problem with this alternative is that the reagents could seep into the 
circuitry and destroy the electrical capabilities of the chamber. Doug Daniel, an associate 
research scientist at the Center for Innovations in Medicine, helped solve this problem. 
He designed a manual chamber that can hold only 100 microliters and is therefore 
compatible with the peptide synthesizer instrument. At present, we have one such 
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redesigned chamber as well as the details of the design, which can be used in the future to 
produce more such chambers. As stated previously, the CBMX chips are delicately 
designed and have a certain region that is very sensitive to chemicals. The thirteen 
connecting pads of the chip surface, which establish electrical connection between the 
electrosynthesis instrument and the microelectrodes of the chip, should be protected from 
exposure to chemicals for the proper functioning of the chip. A Teflon-based acid 
resistant chamber was built to save the chip from losing its electrical functionality. 
The electrosynthesis instrument, in the past, has often either failed to apply 
potential to the addressed electrodes or has applied potential non-specifically. It is 
because of this that a diagnostic test is necessary to check the proper functioning of the 
electrosynthesis instrument. In this regard, a pyrrole electro-polymerization test is 
conducted every now and then to ensure proper functioning of the instrument. The test is 
simple to execute and can be completed within two hours. Pyrrole undergoes electro-
polymerization upon application of potential across the chip. The mildest electrical 
condition to execute polymerization test is 0.5 V and 10 seconds. The stronger the 
electrical condition employed, the thicker the polymer becomes. The difference in 
thickness can be seen via a change in the color of the polymer under a microscope.  
The electrosynthesis instrument can potentially employ different kinds of counter 
electrodes, such as a bulk platinum electrode of the reaction chamber, a grid present in 
the chip, and neighboring electrodes in the chip. The instrument could previously be used 
only with a bulk electrode as a counter electrode, but upon upgrading the instrument’s 
software, the grid as a counter electrode option is now possible. To switch the instrument 
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to a grid as a counter electrode, two of the three pins of the instrument chamber are 
connected using a jumper. Neighboring electrodes cannot yet be employed as a counter 
electrode in the instrument that we possess due to some technical difficulties. 
Two different peptide synthesizers were used in this project. One of them was 
9050 plus peptide synthesizer manufactured by Millipore, and another was a Pioneer 
peptide synthesizer built by Applied Biosystems. We had mixed experiences with both of 
the synthesizers. Contamination was an issue with both of the synthesizers. The 
pneumatic valves of 9050 plus synthesizer were easily contaminated with solutions, 
whereas the Pioneer synthesizer’s recommended internal pressure was not enough to 
push solution forward from the synthesis reaction chamber. This issue led to 
contamination of the solutions in the reaction chamber. Spare parts of 9050 plus 
synthesizer are very difficult to secure, but its robotic station is quite robust compared to 
that of the Pioneer Synthesizer. Because we had two Pioneer synthesizers, securing spare 
parts for proper functioning of one synthesizer was not an issue. Overall, our impression 
of the 9050 plus peptide synthesizer was better than Pioneer’s, and if its spare parts can 
be secured, it should be given first priority for future experiments. It is probable that the 
use of microwave synthesizers will be an even better option. Microwave assisted peptide 
synthesis is far more accelerated than conventional synthesis, and results in high overall 
yields. It is considered favorable for long sequence synthesis and it is known to prevent 
aggregation because of heating and electrical frequency fields involved in the reaction. It 
also prevents lot of wastage of solvents and therefore lowers the cost of an experiment.  
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Some constraints with the microarray synthesis have been the incompatibility of 
the chip to strong acids and an inability to monitor the amino acid coupling and 
protecting group’s deprotection efficiencies. Issues due to incompatibility to strong acids 
are averted since the t-butyl group can be used as side-chain protecting group - the chip 
can sustain the acidic strength required for its deprotection. However, monitoring the 
efficiency of coupling and deprotection steps have proved to be difficult. Two strategies, 
(1) using IR spectroscopy to analyze chemical modification of the surface qualitatively, 
and (2) using bromophenol blue test to monitor the steps, have not been successful. It is 
probable that these two strategies could not be successful on this platform due to the 
reflective platinum surface and generation of very small amount of peptides on the 
surface. 
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APPENDIX F 
PEPTIDE MICROARRAY FABRICTION ON SILICON SUBSTRATE USING 
PHOTOLITHOGRAPHY TECHNIQUE 
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Peptide and peptidomimetics microarrays have the potential to become a powerful 
research and medical diagnostics tool. Using microarrays, a vast amount of chemical 
space can be searched for development of catalysts, drugs, synthetic antibodies etc. It can 
also serve as a medical diagnostics tool for various illnesses. In the process of 
microarray-related research and development, several algorithms can be developed and 
new concepts in science can be discovered.   
The Center for Innovations in Medicine at The Biodesign Institute at Arizona 
State University intends to use peptide microarray technology to meet customer’s 
unstated needs by providing treatment of illnesses at the presymptomatic stage. Using 
microarray technology, researchers at the center would be able to aid individuals in 
figuring out an individual’s predisposition to diseases, before the onset of the disease or 
in very early stage. This is so that the disease can be treated before it becomes life 
threatening. Towards this end, the center has been working in close collaboration with its 
spin-off company, HealthTell Inc., to fabricate peptide microarrays on silicon substrates 
using a photolithography technique. 
General Synthesis Scheme 
The initial treatment of the silicon wafers, such as thermal deposition of oxide and 
chrome deposition needed for peptide microarray fabrication, was provided by the 
collaborators at Sandia National Laboratory and the Center for Integrated 
Nanotechnologies (CINT). Each silicon wafer used is approximately 1 mm in thickness 
and 4 inches in diameter. A silicon substrate modified with chromium doping is also 
being tested, in parallel, for peptide microarray fabrication. Chromium doping provides a 
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better signal to noise ratio during the fluorescence characterization of synthesis. The 
silicon wafer, once ready for fabrication, is first silanized with (3-
Aminopropyl)triethoxysilane (APTES). The silanization is possible with various kinds of 
linkers, such as hydrophobic, hydrophilic etc. After silanization, a boc-protected amino 
acid is coupled to the free amines present on the surface. The wafer is then spin-coated 
with photoresist mixture (PRM). After spin-coating and washing with DMF, the wafer is 
spatially patterned by a localized generation of photoacid using photolithography 
instrumentation. The photoacid generated at specific areas by shining light removes the 
boc groups from amines and thus activates the irradiated features for the next coupling 
step. Multiple rounds of such spatially defined deprotection and coupling steps leads to 
the fabrication of a peptide microarray. A schematic diagram of general synthesis is 
shown in Scheme F-1. 
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SCHEME F-1: General synthesis scheme of peptide microarray fabrication on silicon 
substrates. 
Photoresist Mixture Composition Determination 
The PRM used in the fabrication process consists of PAGTf, Isopropyl 
thioxanthone (ITX), polymethylmethacrylate (PMMA), and 
propyleneglycolmonomethyletheracetate (PGMEA). The accurate concentration of each 
of these components in PRM, used by a previous team, was determined by IR and UV-
visible spectroscopy and HPLC analysis. It was found that PRM is made up of 5%w/v 
PAGTf, 5%w/v ITX, and 2.5%w/v PMMA in PGMEA. A comparison of UV-Vis, IR, 
and HPLC data of (5,5,2.5) PRM,  and a sample of old PRM can be seen in Figure F-1.  
  
Wafer 
NH2 NH2 
Spin & bake  
Photoresist 
Expose 
Bake & strip 
photoresist 
Couple next  
amino acid 
Repeat 
201 
 
 
  
 
               
                                                  
FIGURE F1: UV-Vis, IR, and HPLC analysis to determine composition of photoresist 
mixture. Image (F-1a) shows absorbance spectrum of (5,5,2.5) and old PRM. Image (F-
1b) and (F-1c) correspond to IR spectrum of (5,5,2.5) and old PRM. Image (F-1d) and (F-
1e) correspond to HPLC analysis of (5,5,2.5) and old PRM. 
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In situ Peptide Synthesis Optimization 
Following tasks were tested towards the development of peptide microarray 
fabrication on silicon wafers. 
Determination of Boc-protected amino acid coupling efficiency to available 
free amines on silanized silicon wafer. The amino acid coupling efficiency to a 
silanized silicon wafer was determined. Fluorescence signals from a silanized silicon 
wafer, taken as reference, was obtained by coupling Alexa-555 dye to APTES present on 
the surface. To a similar silanized silicon wafer, boc-β-alanine was coupled followed by 
capping with acetic anhydride. The wafer was then chemically deprotected using TFA 
and Alexa-555 dye was coupled to it. Results suggested that a substantial percentage of 
APTES did not couple to boc-β-alanine. Comparison of fluorescence signals can be seen 
in Figure F-2. 
                           
 
FIGURE F-2: Fluorescence images of the experiment to determine coupling efficiency of 
boc-protected amino acids to available free amines on silicon substrates. The right 
portion of the image (F-2a) is a control region and the left portion corresponds to a 
section of wafer to which boc-β-alanine and dye (Alexa-555) was coupled. Similarly, in 
              F-2a    F-2b 
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image (F-2b) the dark portion corresponds to section of wafer to which dye was coupled 
and the lighter region corresponds to control section (section in which no dye was 
coupled). 
 
Fluorescence based comparison of efficiency of dervatization of silicon 
substrates with β-alanine and Peg 6 linker modified with a glycine. One of the 
silanized silicon wafers was coupled with Peg-6 linker on top of which a glycine amino 
acid was coupled. β-alanine was coupled to another silanized surface. Both the 
derivatized wafers were then labeled with Alexa-555 dye. The wafer derivatized with 
glycine and Peg linker showed better fluorescence and signal-to-noise ratio compared to a 
wafer derivatized with β-alanine. The comparison of fluorescence signals from the two 
wafers can be seen in Figure F-3. 
 
 
 
 
FIGURE F-3: Fluorescence images of the silicon substrates derivatized with β-alanine 
and Peg 6 linker modified with a glycine. The darker region of image F-3a & F-3b 
corresponds to the section of the wafers to which glycine + Peg-6 and β-alanine were 
coupled respectively. The lighter regions correspond to control sections of the two 
wafers. The wafers were imaged using Alexa-555 dye. 
F-3a F-3b 
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Comparison of photo-deprotection efficiency at 260nm and 365nm. Photo-
deprotection efficiency at two different wavelengths, deep UV (260 nm) and near UV 
(365 nm) was determined by coupling Alexa-555 dye after irradiating two silanized 
wafers with the mentioned wavelengths. The silicon wafers were further sub-divided into 
regions where photo-exposure for different time intervals (0s, 1s, 2s, 3s, 14s) was carried 
out. Results of the experiment can be seen in Figure F-4. Photo-deprotection efficiency at 
260 nm seemed to show higher fluorescence signals compared to 365 nm. Also, photo-
deprotection efficiency seemed to improve from a 1s to a 3s time interval.  Photo-
deprotection efficiency at 3s and 14s seemed equally efficient. 
 
    
 
 
FIGURE F-4: Fluorescence comparison of photo-deprotection efficiency at 260nm and 
365nm. The darker region of image F-4a & F-4b corresponds to section of the wafers 
which was irradiated at 260 nm and 365 nm respectively for different time intervals (1s, 
2s, 3s, 14s). The lighter regions correspond to control sections (no irradiation) of the two 
wafers. The wafers were imaged using Alexa-555 dye. 
Comparison of photo-deprotection efficiency to chemical deprotection 
efficiency. One of the silanized silicon wafers, derivatized with Boc-Gly-Peg-6 and later 
baked with PRM, was irradiated at 260 nm. Another similar wafer was chemically 
F-4a F-4b 
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deprotected using TFA. Both the slides were then labeled with Alexa-555 dye. A 
comparison of fluorescence signals can be seen in Figure F-5. Chemical deprotection 
seemed to give marginally better fluorescence signals compared to photo-deprotection. 
            
 
FIGURE F-5: Fluorescence comparison of photo-deprotection efficiency to chemical 
deprotection efficiency. The darker region of image F-5a & F-5b corresponds to section 
of the wafers which were photo and chemically deprotected respectively. The lighter 
regions correspond to control sections of the two wafers. The wafers were imaged using 
Alexa-555 dye. 
Experimental Protocol 
UV-Vis, IR spectroscopy and HPLC analysis. UV-Vis analysis was carried out 
in a 2.00 mL-quartz cuvette with a total reaction volume of 1.00 mL. For each PRM 
sample (5,5,2.5 PRM and old PRM), background spectrum of the solvent (acetone) was 
first recorded followed by 2.00μL addition of PRM sample. The cuvette was then 
scanned for absorbance from 200 – 450 nm range using a UV-Vis spectrophotometer at 
the Center for Innovations in Medicine (CIM), Arizona State University. The absorbance 
spectrum of the two PRM samples were compared. IR analysis was performed using an 
FT-IR instrument at the Single Molecule Biophysics Research Center, at ASU. A 
background spectrum of the instrument was first recorded, followed by a recording of the 
F-5a F-5b 
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spectrum for 100µL of each PRM sample. Peaks corresponding to each component of a 
PRM sample for the two samples were compared. For the HPLC analysis, a 500x diluted 
solution of each PRM in CH3CN with 0.1% TFA was prepared. Each PRM was then 
analyzed with HPLC and areas corresponding to each component of PRM sample for the 
two samples were compared. 
Silanization with APTES. The wafer was first washed with 20mL of Piranha 
solution (50% sulfuric acid + 50% hydrogen peroxide) for 30 min. It was then washed 2x 
with 20mL deionized water and 2x with 20mL 95% ethanol. The wafer was then 
incubated with 20mL of 3% APTES in 95% ethanol for 30min. After incubation, the 
wafer was washed 2x with 20mL 95%ethanol and dried in an oven at 100°C for 60 min.    
Amino acid coupling reaction. The coupling reaction of Boc-Gly-OH and Boc-
β-Ala-OH to free amines is similar, the difference being only in concentrations. To 
achieve amino acid coupling, the silicon wafer terminated with free amines is exposed to 
a mixture of amino acid (boc-glycine: 37mg, 137mM, boc-β-ala: 52mg, 137mM), HBTU 
(O-benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium hexafluorophosphate, 95mg, 
137mM), HOBT (N-hydroxybenztriazole, 33.5mg, 137mM), and diisopropylethylamine 
(130.5µL, 350mM) in DMF (2mL) for 30 minutes. The wafer is then rinsed with DMF 
3x, dichloromethane 3x, and again with DMF 3x, then re-exposed to the coupling mixture 
for another 30 minutes. After repeating the washing procedure (with an additional ethanol 
rinse to remove any residual DMF or dichloromethane), the chip is allowed to dry. 
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Capping with acetic anhydride. The wafer is first washed 3x with 20mL DMF.  
It is then incubated with 50% acetic anhydride in DMF solution for 30 min. The wafer is 
then washed 3x with DMF, 3x with DCM, and dried with Argon gas. 
Dye-labeling and fluorescence detection. The surface of the chip was labeled 
with Alexa-555 dye (1 mg of Alexa-555 succinimidyl ester, plus 1XPBST to 50 mL) for 
1 hour at room temperature in the dark. The wafer was then removed and washed 3x with 
1XTBST for five minutes each. The wafer was then washed 3x with ddH2O, five minutes 
each. The wafer was then scanned at 650nm wavelength with 70%PMT and 100% laser.  
The Typhoon 9200 instrument at Center for Innovations in Medicine (CIM), ASU was 
used for fluorescence imaging.   
Acid based chemical deprotection. Boc groups were chemically deprotected 
using a cocktail of 94% TFA (Sigma-Aldrich, St. Louis, MO) + 2.5% triisopropylsilane 
(TIS) (Sigma-Aldrich, Milwaukee, WI) + 3.5% water. The wafer was placed in an acid-
resistant chamber and exposed to the deprotection cocktail for thirty minutes. At regular 
time intervals, the setup was shaken for better reaction. After thirty minutes, the solution 
was discarded in acid waste and the reaction setup was rinsed 5x with dichloromethane, 
5x with 5%DIEA in dichloromethane, 3x with DMF, and 5x with water. The chip was 
then dried with argon gas.
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APPENDIX G 
TECHNIQUES 
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Continuous Flow Peptide Synthesizer1,2 
A peptide synthesizer instrument is used to achieve automation of solid phase 
peptide synthesis. Peptide synthesizers can be classified as continuous flow, batch, 
parallel, and micro-wave peptide synthesizers. In continuous flow peptide synthesizers, 
the process solution is re-circulated through the reaction vessel using pumps. The 
reaction progress is usually monitored photometrically. Batch synthesizers are useful to 
produce a small batch of peptides in large scale (depending upon the instrument design, 
peptides can be produced even at the kilogram scale). Parallel peptide synthesizers are 
useful to generate a large library of peptides. These synthesizers are based on split-mix-
synthesis strategy. Microwave synthesizers allow microwave heating of process 
solutions, which can reduce synthesis time and can be useful in achieving the synthesis of 
difficult sequences. There are several vendors for the instrument, such as Invitrogen, 
Protein Technologies Inc., or PerSeptive Biosystems Inc. However, basic instrumentation 
of most of the continuous flow peptide synthesizer is quite similar. The important 
components of a peptide synthesizer are the pneumatic pump, nitrogen supply, the valve 
system, the amino acid delivery system, the solvent supply system, waste system, 
reaction vessel, fluid sensors, and the user interface software to manage the synthesizer 
(Figure G-1). 
A pneumatic pump is used in the instrument to apply pressurized air to produce 
mechanical motions, such as opening and closing of valves. Regulators are installed in 
the instrument to remove excess air pressure that occasionally builds up in the pneumatic 
system. Generally, 80 – 90psi air pressure is maintained in the unit. A nitrogen or inert 
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gas, such as argon, is connected to the unit to transfer pressurized nitrogen for the transfer 
and mixing of solutions. Regulators are employed to maintain desired pressure (roughly 
6psi) in the unit. The valve system is a unique combination of valves, which provide 
common solution supply ports to the reaction vessel. They are made up of chemical 
resistant materials such as Teflon. Additionally, there are electromechanical valves which 
actuate the regular valves.   
An amino acid delivery system generally includes a stage where 20 vessels, 
corresponding to 20 amino acids, can be held. A robotic system, which as per the 
software, prepares and delivers the correct activated amino acid solution to the reaction 
vessel. A solvent reservoir system is also present in the unit to deliver solvents, such as 
DMF, DCM, acetonitrile, and capping solution to the reaction vessel. The reagents in the 
solvent delivery system are pressurized under nitrogen. The waste system is the only exit 
route for the solutions in an otherwise fully enclosed unit. Waste sensors present in the 
unit identify when the waste reagent bottle is filled and needs replacement. The reaction 
vessel in a unit could be multiple volumes designed for small scale, medium scale, and 
large scale synthesis.  Fluid sensors present in the unit constantly monitor the supply 
status of reagents in the unit. 
The user interface software of a peptide synthesizer controls the execution and 
monitoring of peptide synthesis. The software executes each chemical step and moves to 
the next on completion through a serial communication. Files for the execution of 
synthesis can be manipulated to customize synthesis protocols. The software program 
also generates a synthesis report and performs data calculations. 
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FIGURE G-1: A picture of continuous flow peptide synthesizer manufactured by 
PerSeptive Biosystems. 
Matrix-assisted Laser Desorption Ionization (MALDI) Mass Spectrometry 3,4,5 
MALDI mass spectrometry, developed by Hillenkamp and Karas, is a powerful 
analytical technique for identification and characterization of peptides, proteins, 
oligonucleotides, carbohydrates, and many other biomolecules. In this technique, a 
sample is first co-crystallized with a large excess of matrix compound. The matrix 
usually is a UV absorbing, weak acid. Some of the commonly used matrix compounds 
are α-cyano-4-hydroxycinnamic acid, 2,5-dihydroxybenzoic acid, and sinapinic acid. The 
matrix solutions are commonly prepared in a mixture of nanopure water and HPLC grade 
acetonitrile or methanol containing 0.1% Trifluoroacetic acid (TFA). The matrix absorbs 
laser light energy and transfers some of the energy to a sample, resulting in vaporization 
of the sample-matrix mixture. At the same time, the matrix also ionizes the sample 
molecules by accepting or donating protons with the sample molecules. It produces 
quasi-molecular ions for MALDI detection. 
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In a MALDI instrument there are three types of mass analyzers. They are  (1) a 
linear time-of-flight (TOF) analyzer, (2) a TOF reflectron, and (3) a Fourier Transform 
analyzer. In linear TOF analysis, ions of different masses are provided with same amount 
of energy and allowed to pass through a field-free path of usually l-2 m in length (Figure 
G-2). Here, they are separated in space and time-of-flight, according to their motion 
equation t = c × m per U1/2 (where t denotes the flight time, m the ion mass and U the 
acceleration potential, respectively). At the end of the drift path, ions, within a time span 
of some tens to some hundreds of µs, arrive at the detector (an ion with lower mass will 
show up before an ion with higher mass). In a TOF reflectron, the time spent by ions in 
the TOF tube is increased and kinetic energy distribution is decreased, with the help of an 
electrostatic analyzer. The TOF reflectron analyzers provide peaks with high resolution 
when compared to linear TOF analyzers. This is at the expense of sensitivity. Better 
resolution in TOF analyzers can also be achieved by a method called delayed extraction 
(DE). In this method, ions are allowed to cool for approximately 150ns before 
accelerating to the analyzer. This helps by lowering the K.E distribution among ions, 
leading to a decrease in the temporal spread of ions. As a result, an increase in resolution 
and accuracy can be seen in a MALDI spectrum. 
In a Fourier transform analyzer, ions orbit in the presence of a magnetic field. 
While orbiting, the ions are excited by a radio frequency radiation. Excitation of the ion 
generates a detectable image current. The time-dependent image current is Fourier 
transformed to obtain component frequencies, which, in turn, is dependent on mass to 
charge the ratio of ions. High accuracy and increased resolution can be achieved using 
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Fourier transform analyzer. The analyzer is also well suited for tandem mass 
spectrometry. 
The MALDI peaks of amino acids and different groups widely used in peptide 
synthesis can be found in Appendix H. 
 
FIGURE G-2: Schematic of MALDI-TOF6 
Ultraviolet-visible (UV-Vis) Spectroscopy7   
Ultraviolet-visible (UV-Vis) radiation wavelengths range from 100Å – 7800Å. 
The energy associated with the UV-Vis radiation, when absorbed by molecules, can 
excite electrons from a lower energy level to higher energy level. Three types of electrons 
are present in a molecule: sigma-bond electrons, pi-bond electrons and non-bonding 
electrons. Sigma-bond electrons are most stable, and require higher energy for transition. 
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These electrons generally absorb deep-UV radiations for transition. Pi-bond electrons are 
less stable compared to sigma-bond electrons, and can be excited with UV and visible 
light radiations. Non-bonding electrons are generally the least stable electrons and can be 
excited from their ground state by UV and visible light radiations.  
A sample, when exposed to a UV-visible radiation spectrum, absorbs radiation 
with a frequency that matches the energy difference between a possible electronic 
transition within the molecule. A spectrophotometer records and plots the degree of 
absorption (A) of different wavelengths of the UV-visible region. At λmax, the sample 
absorbs the maximum amount of light. Conjugation can lead to reduction in the energy 
difference between HOMO and LUMO of the molecule, thereby making the molecule 
absorb radiations of near UV and visible region. 
Beer-Lambert Law can be used to determine concentration of absorbing species in 
a sample. 
                                                    A= log10 (I0/I)=ε.c.L                                       (G-1)                                                      
Where ‘A’ is absorbance, I0 is the intensity of incident light, I is the intensity of 
transmitted light, ‘ε’ is a constant known as the extinction coefficient, ‘c’ is the 
concentration of the sample, and ‘L’ is the path length through the sample.   
The ratio I/I0 is known as transmittance. A UV-Vis spectrophotometer measures 
absorbance based on transmittance. 
                                                    A = -log10(%T/100)                                       (G-2)                                                                        
A sample is generally placed in liquid phase in a UV spectrophotometer for 
measurement. The sample holder, known as cuvette, is a transparent cell usually made of 
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fused quartz, as it is transparent to UV and visible radiations. The internal width of these 
cuvettes is generally 1cm. 
A spectrophotometer usually consists of a radiation source, a sample holder, a 
monochromator with a diffraction grating, and a detector (Figure G-3). Common 
radiation sources employed in spectrophotometers are a tungsten-halogen lamp, a 
deuterium arc lamp, a xenon arc lamp, and light emitting diodes. The two most common 
types of detectors employed are photocell and photomultipliertube detectors. In a 
photocell detector, a photon hits the cathode of the cell to eject an electron, which moves 
towards the anode. The electric current signal thus generated is proportional to the energy 
of the photon. The electric signal is processed and converted into the absorption 
spectrum. A photomultiplier detector (PMT) is based on the photoelectric effect. Photons 
eject electrons from the surface of a photomultiplier tube, which then ejects secondary 
electrons from the collision to another surface. The secondary electron then produces 
multiple electrons through several collisions with photosensitive material placed in the 
PMT setup. Multiple secondary electrons, thus generated, are directed towards the anode 
generating an amplified electric signal. Due to the capability to amplify signals, a 
photomultiplier tube is sensitive to photons of low energy. 
A spectrophotometer instrument can be based on a single-beam or a double-beam 
technique. In a single-beam technique, the radiation can reach the detector only through 
the sample cell. Therefore, I0 can be measured only in a different step, without the 
presence of a sample in the instrument. In a double-beam technique, the radiation is split 
into two beams, one passing through the sample cell, which measures ‘I’, and another 
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avoiding it, which measures ‘I0’. Some double-beam instruments have two detectors, 
measuring I and I0, at the same time. Others have a single detector in which one beam is 
blocked to measure the intensity of the other beam at a certain time. 
 
FIGURE G-3: Working principle of a UV-vis spectrophotometer8.  
Infra-Red (IR) Spectroscopy8 
Infrared spectroscopy, one of the two types of vibrational spectroscopy, involves 
irradiation of a sample with infrared radiations. The infrared radiations with similar 
frequency to that of different vibrational modes of bonds and groups of a molecule are 
absorbed by the sample and reflect in the IR spectrum. Only vibrations which involve a 
change in dipole moment are IR active. The vibration that does not involve a change in 
dipole moment is analyzed through Raman spectroscopy. The infrared region spans from 
4000 – 400 cm-1. The frequencies of the radiations of the infrared region can resonate 
with rotational frequencies and fundamental vibrational frequencies as well as overtones 
and harmonics of bonds and groups of molecules.   
An IR instrument records and plots transmittance or absorbance of different 
frequencies of an IR region. An IR spectrum of each molecule is unique, since every 
molecule has a unique environment, due to the different atoms and bonds present. Thus, 
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the IR spectrum is also known as a molecular fingerprint of a compound. The intensity of 
the peaks in the IR spectrum also gives an idea about the concentration of the compound 
present in the sample.  
Fourier Transform Infrared Spectrometry (FTIR) involves the measurement of all 
infrared frequencies simultaneously (Figure G-4). FTIR instruments consist of an optical 
device known as interferometer. The interferometer produces a signal encoded with all of 
the infrared frequencies that can be read quickly, allowing analysis of several samples in 
a small time frame. 
Generally, interferometers possess a beam splitter, which divides the incoming 
infrared beam into two beams. One beam is reflected from a fixed mirror and another is 
reflected from a moving mirror. The two reflected beams are then recombined. The signal 
exiting from the interferometer is the result of the two beams interfering with each other. 
This signal is called an interferogram, and its every datapoint is a unique piece of 
information about all of the IR frequencies radiated through the sample. Thus, all of the 
IR frequencies are measured simultaneously using the interferometer. The interferogram 
encoding all of the IR frequencies is decoded computationally using the Fourier 
transformation. Once processed computationally, a frequency spectrum plotting intensity 
vs wavenumber is collected.   
With the advent of FTIR spectrometers, sample preparation has become 
simplified to a great extent. A very small amount of solid or liquid sample that can cover 
the diamond tip of the stage of the instrument is sufficient for collecting spectrum. It is a 
218 
 
non-destructive technique, and the sample can be recovered after analysis. Furthermore, a 
sample can be placed directly in the instrument without any sort of preparation. 
 
 
FIGURE G-4: Working principle of a FT-IR spectrometer8. 
Nuclear Magnetic Resonance (NMR) Spectroscopy9  
NMR spectroscopy is an extremely powerful analytical technique for structural 
determination of organic molecules. A wide variety of nuclei such as 1-H, 13-C, 15-N, 
and 31-P are studied in this technique. A nucleus with an odd number of protons and/or 
neutrons is associated with a nuclear spin. A nucleus (charged species), when spinning, 
generates a magnetic field. When an external magnetic field is applied to the spinning 
nucleus, the nucleus aligns itself in either alpha-state (lower energy state; the direction of 
magnetic field of nucleus is the same as the direction of external magnetic field) or beta-
state (higher energy state; the direction of the magnetic field of the nucleus is opposite to 
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the direction of the external magnetic field). An alpha-state nucleus, when irradiated with 
a photon of radio frequency equal to the energy difference between alpha and beta states, 
absorbs the energy and flips to beta state. The frequency at which such flipping takes 
place is called a resonating frequency. For example, in proton-NMR, a radio frequency 
radiation of 300MHz is applied to flip a nucleus if the strength of the external magnetic 
field is 70459 gauss. However, all of the protons do not have the same environment in a 
molecule. The surrounding electrons of each proton have influence with their magnetic 
fields, altering the value of the net external magnetic field acting upon a specific proton. 
Thus a stronger magnetic field than 70459 gauss would be required to flip a proton with 
surrounding electrons at 300MHz radio frequency radiation. Protons that are more 
shielded with electrons resonate at higher field (upfield) and protons that are less shielded 
with electrons resonate at a lower field (downfield). The more the proton is downfield, 
the more its corresponding signal will be towards the left side of the spectrum.  
The number of signals in a 1-HNMR spectrum shows the number of different 
kinds of protons present in a molecule, and the location of the signals show the extent of 
the de-shielding effect on the proton. The schematics of a NMR spectrometer can be seen 
in Figure G-5. 
In order to prevent interference in signals from solvent, generally deuterated 
compunds such as deuterated water, acetone, methanol, chloroform, dimethylsulfoxide or 
compounds containing no protons such as carbon tetrachloride and carbon disulfide are 
used as solvents. In a sample preparation, a small amount of tetramethyl silane (0.1%v/v) 
is added as an internal standard. Because silicon is less electronegative than carbon, 
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protons in tetramethyl silane are highly shielded, and the location of its signal is given an 
arbitrary value of zero in the spectrum. Signals from organic molecules are generally 
found downfield to the TMS signal.   
The x-axis of the NMR spectrum is called delta-scale. The location of a signal on 
the delta-scale is called a chemical shift of the proton. It is defined as a ratio of shift 
downfield from TMS (Hz) to spectrometer frequency (MHz). The units of chemical shift 
is parts per million (ppm). 
                   Chemical shift = shift downfield from TMS (Hz)                         (G-3) 
           Spectrometer frequency (MHz) 
                                                                                                           
In 1-HNMR, the splitting of signals can be seen. Equivalent protons do not split 
the signal, but neighboring non-equivalent protons split the signal according to the ‘N+1 
rule’: N+1 peaks are observed within a signal if it is split by ‘N’ number of equivalent 
protons. When non-equivalent protons are four or more bonds apart, generally, splitting 
of signals is not observed. The distance between peaks in a signal is called the coupling 
constant. Two nonequivalent protons splitting each other will have the same coupling 
constant. Protons whose imaginary replacement can form stereoisomers are non-
equivalent and split each other in the 1-HNMR spectrum. 
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FIGURE G-5: Working principle of a NMR instrument9. 
Fluorescent Microarray Image Scanner10,11   
Fluorescence based microarray imaging systems involve excitation of dye 
incubated on a microarray substrate, collection of fluorescence signals, and generation of 
a digital image of a fluorescence signal (Figure G-6). Laser excitation, along with a 
photomultiplier tube (PMT) detector, is the common method used in these systems to 
acquire images. A laser with a wavelength similar to λmax of dye and a few microns in 
diameter scans the substrate exciting the dye. Laser excitation of a dye can be achieved in 
a few microseconds, as higher power density monochromatic light can be focused on a 
small spot of the surface while scanning. The emitted fluorescence signals are collected 
by the PMT. The signal is amplified by PMT, which is then processed into a digital 
image, showing the fluorescence signal intensity from each pixel position. Compared to 
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other kinds of detectors, the PMT detector is considered to have a high signal to noise 
ratio (SNR). SNR is calculated as: 
              SNR = (signal – background)/standard deviation of background   (G-4) 
The magnitude of the emitted signal can be changed by adjusting the electric 
potential applied to the PMT. An electric current produced by incident light can be 
amplified as much as 108 times using a PMT. PMTs have optimum electric potential 
range. An incident photon colliding with a PMT set at lower potential than its optimum 
range would not generate an electric signal. At the same time, if the PMT is set at a 
higher potential than its range, SNR efficiency is likely to go down. Although quantum 
efficiency (the amount of electronic signal emitted from a device relative to the number 
of incident photons) of PMTs is less than CCD detectors, PMTs are preferred in 
microarray imaging scanners due to their high resolution and other design parameters. 
Laser design in scanners could be confocal or non-focal. A confocal design is 
generally used to image a thick sample, such as cells or tissues. A confocal design has a 
narrow depth of focus. Because of this, only thin slices of the sample are imaged at a 
time. By repeated scanning at different depths, all layers of a thick sample can be imaged. 
All of the images can then be stitched together to construct a 3D image of the sample. 
Because microarray surfaces are generally flat and background signals are emitted from 
the same plane as the real signals, confocal design may not provide an added advantage 
compared to non-focal design.   
Two types of microarray scanners are available: one in which lenses move and the 
platform is fixed while scanning, and another in which lenses are fixed and the platform 
223 
 
moves while scanning. Performance of the scanners with fixed lenses are usually better, 
due to less scanning errors. Another feature of a scanner that affects its performance is 
the numerical aperture. It is defined as:  
                                                        N = nsinƟ                                                  (G-5) 
Where ‘N’ is numerical aperture, ‘n’ is the refractive index of environment in 
which lens is working, and ‘Ɵ’ is the half-angle of maximum cone of light that can enter 
or exit lens. 
Scanners with high numerical aperture values are considered to be efficient 
microarray scanners. Some other parameters that decide efficiency of a scanner are 
reproducibility, sensitivity, scanning speed, and durability. 
 
FIGURE G-6: Working principle of a fluorescent image scanner12. 
High-performance Liquid Chromatography13  
It is a powerful analytical tool used to separate solution-phase mixtures into its 
chemical constituents. The basic principle of HPLC is the same principle as column 
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chromatography. Instead of letting the solution-phase drip through the column by gravity, 
in this technique, the solution-phase is run through the column under high-pressure 
(approximately 400 atm). This makes the separation process faster. Owing to smaller 
particle size and efficient packing of the stationary phase, the interaction between the 
molecules of the mobile phase and the stationary phase is greatly improved. This leads to 
an efficient separation of mixtures.   
Depending on the polarity of the stationary and mobile phase, there are two types 
of HPLCs: (1) Normal phase HPLC and (2) Reverse phase HPLC. 
Normal phase HPLC. In this type of HPLC, the stationary phase is a highly 
polar material, usually silica, and the mobile phase is relatively non-polar. The most non-
polar component of the mixture to be separated is eluted first, and the least non-
polar/most polar component of the mixture is eluted last.   
Reverse phase HPLC. In this type, the polarities of the stationary and the mobile 
phase are reversed, compared to the polarity of the phases in Normal phase HPLC. 
Usually, silica is modified with an 8 or 18-carbon long hydrocarbon chain to make the 
stationary phase non-polar. Common solvents used for mobile phase are usually ethanol 
or a mixture of water and ethanol. The most polar component of the mixture is eluted 
first, and the most non-polar component of the mixture is eluted last.   
Generally, the length and inside width of the column for both normal and reverse 
phase is 150-250 mm and roughly 4.6mm respectively.   
Retention Time. Retention is the time taken by a specific component of the 
mixture to pass through the column. Retention time of a chemical compound depends 
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upon various factors. These may be the nature of the stationary and mobile phase, 
pressure, and temperature. There is a possibility that two different chemical compounds 
have the same retention time under similar conditions. Therefore, it is valuable to 
characterize the separated component through UV-Vis, IR, NMR, and mass spectrometry. 
Nevertheless, retention time can serve as quick indicator of the nature of the chemical 
component. 
UV-Vis spectroscopy based detection. Quantitative determination of 
components of a mixture can be done using a UV-Vis spectrophotometer as a detector in 
the HPLC instrument. Many organic compounds absorb radiation of wavelengths falling 
in UV-Vis region. The amount of light absorbed by a compound is proportional to its 
concentration. The retention time and concentration of a pure sample of a component 
under similar HPLC conditions could be used to determine the concentration of the 
component. 
HPLC coupled to mass spectrometer. The HPLC and mass spectrometer, 
coupled together, is widely used in analytical chemistry. The components, separated 
through the HPLC column, are fed into the mass spectrometer instrument.  It then ionizes 
the compound, accelerates it through the time-of-flight tube and detects the m/z peaks of 
the molecule and its fragments. The mass spectrum can be compared to the database to 
find the chemical nature of the compound. 
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FIGURE G-7: Schematic of a HPLC instrument14. 
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APPENDIX H 
ABBREVIATIONS, SIDE-CHAIN RESIDUES, AND ACID DISSOCIATION 
CONSTANT VALUES OF AMINO ACIDS  
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TABLE H-1. Abbreviations, side-chain residues, and pKa values of amino acids 
Amino Acid, 
3-let. abbr., 1-let. abbr. Side chain residue (R)  
Acidic/basic 
/neutral 
pKa  
(α-carboxylic acid, 
 α-amino, side-chain) 
Alanine, Ala, A -CH3  Neutral 2.35, 9.87 
Asparagine, Asn, N -CH2CONH2  Neutral 2.02, 8.80 
Cysteine, Cys, C -CH2SH  Neutral 2.05, 10.25,  
8.00 
Glutamine, Gln, Q -CH2CH2CONH2  Neutral 2.17, 9.13 
Glycine, Gly, G -H  Neutral 2.35, 9.78 
Isoleucine, Ile, I -CH(CH3)CH2CH3  Neutral 2.32, 9.76 
Leucine, Leu, L -CH2CH(CH3)2  Neutral 2.33, 9.74 
Methionine, Met, M -CH2CH2SCH3  Neutral 2.28, 9.21 
Phenylalanine, Phe, F -CH2(C6H5)  Neutral 2.58, 9.24 
Proline, Pro, P -CH2CH2CH2-  Neutral 2.00, 10.60 
Serine, Ser, S -CH2OH  Neutral 2.21, 9.15 
Threonine, Thr, T -CH(OH)CH3  Neutral 2.09, 9.10 
Tryptophan, Trp,W -CH2(C8H6N)  Neutral 2.38, 9.39 
Tyrosine, Tyr, Y -CH2(C6H4OH)  Neutral 2.20, 9.11, 
 10.07 
Valine, Val, V -CH(CH3)2  Neutral 2.29, 9.72 
Aspartic Acid, Asp, D -CH2COOH  Acidic 2.10, 9.82, 
3.86 
Glutamic Acid, Glu, E -CH2CH2COOH  Acidic 2.10, 9.47, 
4.07 
Arginine, Arg, R CH2(CH2)2NHC(NH)NH2  Basic (strong) 2.01, 9.04, 
12.48 
Histidine, His, H -CH2(C3H3N2)  Basic (weak) 1.77, 9.18, 
6.10 
Lysine, Lys, K -CH2CH2CH2CH2NH2  Basic 2.18, 8.95, 
10.53 
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APPENDIX I 
MASS TO CHARGE RATIO VALUES OF AMINO ACIDS AND FEW GROUPS 
FREQUENTLY USED IN PEPTIDE SYNTHESIS 
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TABLE I-1. m/z values of amino acids and few groups frequently used in peptide 
synthesis 
Amino acid Monoisotopic 
residue mass 
Monoisotopic 
mass 
Hydrophobicity Other 
groups 
m/z value 
Alanine 71 89 1.0 Fmoc +223.25 
Arginine 156.1 174.1 -7.5 Boc +101.125 
Asparagine 114 132 -2.7 Trt +243.325 
Aspartic acid 115 133 -3.0 t-bu +57.116 
Cysteine 103 121 0.17 Acetyl +43.045 
Glutamic acid 129 147 -2.6 Piperidide 
adduct 
+67 
Glutamine 128.1 146.1 -2.9 Tmpp +575.69 
Glycine 57 75 0.67 CONH2 +44.033 
Histidine 137.1 155.1 -1.7 alloc +85.082 
Isoleucine 113.1 131.1 3.1 Bn +91.133 
Leucine 113.1 131.1 2.2 Bz +105.116 
Lysine 128.1 146.1 -4.6 Pbf +253.336 
Methionine 131 149 1.1 Cbz +135.142 
Phenylalanine 147.1 165.1 2.5 H2O +18.015 
Proline 97 115 0.29 Na +22.989 
Serine 87 105 -1.1 K +39.098 
Threonine 101 119 -0.75 H +1.008 
Tryptophan 186.1 204.1 1.5 DMT +303.381 
Tyrosine 163.1 181.1 0.08 NH2 +16.023 
Valine 99.1 117.1 2.3 COOH +45.017 
 
